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SUMMARY 
Visual impairment adversely affects the quality of life of the sufferer and is a major 
economic burden. Retinal degenerative diseases are one of the leading causes of visual 
impairment. Photoreceptor loss is a hallmark of many retinal degenerative diseases such as 
age-related macular degeneration (AMD). There are many genetic and environmental factors 
resulting in this photoreceptor loss. One such factor is hypoxia, as age-related changes in 
the retina may result in a hypoxic microenvironment. At the cellular level the hypoxic 
response is mainly executed by transcription factors called – hypoxia inducible factors 
(HIFs), which are heterodimers composed of a hypoxia-responsive - α subunit (HIFA) and a 
constitutively expressed β subunit (HIFB). HIFA is degraded under normoxic conditions by a 
Von hippel lindau (VHL) - mediated mechanism and stabilized under hypoxic conditions in an 
oxygen dependent manner. Earlier research in our lab showed that conditional knockdown of 
Vhl by the Cre-Lox system in the rod-photoreceptors (using an Opsin promoter to drive CRE 
expression) resulted in stabilization of HIF1A and HIF2A, and most importantly this resulted 
in cell death and loss of retinal function at older age.  
Here, I show that this degeneration is due to HIF1A as in the mice with the double 
knockdown of Vhl and Hif1a in the rods, this phenotype was completely rescued. Further 
characterization revealed that other features such as the blood vessels, retinal pigment 
epithelium and bruch’s membrane were not severely affected. To analyze molecular and 
cellular changes I compared the transcriptomes of retinas when HIF1A is stabilized or 
deleted in the rods, which revealed the differential regulation of several genes. On 
stabilization of HIF1A there is a potential metabolic shift in energy production to glycolysis 
from oxidative phosphorylation. According to the transcriptome data, one of the major groups 
of genes upregulated in the HIF1A stabilized mice included complement factors and hence 
these were further characterized. But our studies revealed that complement factors are not 
direct targets of HIF1A and are most likely upregulated as part of the ongoing degeneration 
mechanisms in these mice. Lastly, the knockdown of Hif1a in the hypoxic retina, by 
subretinal injections of Adeno-associated viruses packaging shRNA against Hif1a was 
envisioned as a gene therapy for combating degeneration. Towards this goal I performed in 
vitro analysis of different siRNAs against Hif1a that could be further used for injections.  
One of the candidates from the transcriptome data - Stanniocalcin 2 (Stc2) was 
selected for further analysis. I was able to show that both Stc2 and its paralog Stc1 are 
expressed in the retina, but only Stc2 is hypoxia responsive and regulated in a HIF1A- 
dependent manner. Further I showed that the normal expression of Stc2 is in the inner 
nuclear layer (INL) and the ganglion cell layer (GCL), and the protein localizes to the 
neurofilaments. The retinal morphologies of both the Stc1 and Stc2 knockout mice were 
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normal, indicating that Stc2 may not be essential for the normal development of the retina, 
but may be involved in hypoxic stress mechanisms.  
In addition to hypoxic stress, the retina is also susceptible to pH changes and the 
ensuing acidosis during degeneration. Hence, we analysed a class of proton sensing G- 
protein coupled receptors (GPRs) – Gpr4, Gpr65 and Gpr68 in the retina. Our studies 
revealed that all the three Gprs are expressed in the retina, but only Gpr65 is upregulated 
during induced (light damage model) and inherited (rd10 mice) degeneration. Knockout mice 
lacking GPR65 had normal retinal structure and function, but the additional loss of Gpr65 in 
rd10 mice accelerated degeneration.  
Understanding the complex cellular responses to stress is important for recognising 
therapeutic targets and development of an effective therapy. In this context, my work sheds 
light on stress related mechanisms in retinal degeneration with specific focus on the role of 
the key transcription factor HIF1A in photoreceptor death and survival.  
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ZUSAMMENFASSUNG 
Sehbehinderungen und Blindheit beeinträchtigen nicht nur die Lebensqualität der Patienten, 
sondern stellen auch eine erhebliche ökonomische Belastung für Betroffene und die 
Gesellschaft dar. Eine der häufigsten Ursachen für Sehbehinderungen sind degenerative 
Erkrankungen der Netzhaut, zu denen zum Beispiel die altersabhängige Makuladegeneration 
(AMD) zählt. Ein Kennzeichen von AMD und vielen anderen Netzhautdegenerationen ist der 
irreversible Verlust von Sehzellen.  
Zahlreiche genetische oder umweltbedingte Faktoren können zum Verlust der Sehzellen 
führen. Einer dieser Faktoren ist Sauerstoffarmut (Hypoxie), die auch durch normale 
altersbedingte Veränderungen in der Netzhaut entstehen kann. Dies führt zu einer 
hypoxischen Reaktion der Zellen, welche hauptsächlich durch die Aktivierung von ‘hypoxia 
inducible factors’ (HIFs) charakterisiert ist. HIFs sind heterodimere Transkriptionsfaktoren, 
die aus einer Sauerstoff-sensitiven alpha (HIFA) und einer konstitutiv exprimierten beta 
Untereinheit (HIFB) aufgebaut sind. HIFA wird bei normaler Sauerstoffkonzentration 
hydroxyliert und durch einen proteolytischen Mechanismus rasch abgebaut, der durch das 
Van Hippel Lindau (VHL) Protein kontrolliert wird. Unter hypoxischen Bedingungen greift 
dieser Mechanismus nicht und HIFA wird in Abhängigkeit der Sauerstoffkonzentration 
stabilisiert. Frühere Untersuchungen in unserem Labor haben gezeigt, dass die konditionelle 
Inaktivierung von Vhl in den Stäbchen die Stabilisierung beider isoformen, HIF1A und HIF2A 
in Normoxie bewirkt, und vor allem, dass dies zu einem altersabhängigen Verlust der 
Netzhautfunktion durch das Absterben der Sehzellen führt.  
In meiner Dissertation gelang es mir zu zeigen, dass der Grund für diese langsam 
fortschreitende Erblindung die chronische Stabilisierung des HIF1A Proteins ist, denn der 
Phänotyp wurde durch die Zusätzliche Inaktivierung von HIF1A (nicht aber von HIF2A) 
vollständig unterdrückt. Ich zeigte weiter, dass die durch HIF1 hervorgerufene Degeneration 
weder die Blutgefässe, noch das retinale Pigmentepithel oder die Bruch’sche Membran stark 
beeinträchtigte, sondern spezifisch die Sehzellen betraf. Um die molekularen und zellulären 
Veränderungen beim Degenerationsprozess zu analysieren verglich ich die Transkriptome 
von Netzhäuten mit stabilisiertem oder inaktiviertem HIF1A in den Stäbchen. Dies führte zur 
Identifizierung von einer grossen Anzahl von Genen die durch die chronische Stabilisierung 
von HIF1A ein verändertes Expressionsmuster aufwiesen. Durch die Stabilisierung von 
HIF1A wurden zum Beispiel mehrere Gene verstärkt exprimiert, die eine Verlagerung der 
Energieproduktion von der oxidativen Phosphorylierung zur Glykolyse bewirken können. 
Dies könnte zu einer verminderten Energieproduktion führen und somit ein Hauptgrund für 
den Zelltod der Photorezeptoren sein. Eine andere identifizierte Gruppe von differenziell 
regulierten Genen kodierte für verschiedene Faktoren des Komplementsystems. Da diese 
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Faktoren wesentlich an der Entwicklung von AMD beim Menschen beteiligt sind, habe ich 
diese Gruppe im Hinblick auf die Degeneration weiter charakterisiert. Die Daten deuten 
darauf hin, dass die Aktivierung der Komplementgene nicht direkt durch Stabilisierung von 
HIF1A, sondern durch die Degeneration, also sekundär, ausgelöst wurde. Um die durch 
HIF1A ausgelöste Netzhautdegeneration therapeutisch angehen zu können, habe ich 
begonnen siRNA Sequenzen gegen Hif1a in der Zellkultur zu testen, um die Sequenz mit der 
höchsten Effizienz zu definieren. Diese Sequenz soll als shRNA in adeno-assoziierte Viren 
verpackt und durch subretinale Injektionen der viralen Partikel in die Sehzellen eingeschleust 
werden. Das mittelfristige Ziel ist, mit dieser gentherapeutischen Massnahme die 
Degeneration zu stoppen oder zumindest zu verlangsamen. 
Aus den Transkriptom-Daten wählte ich das stark regulierte Stanniocalcin 2 (Stc2) für 
weitere Untersuchungen aus. Ich konnte zeigen, dass sowohl Stc2 als auch sein Paralog 
Stc1 in der Netzhaut exprimiert werden, aber nur Stc2 auf Hypoxie reagiert. Weiter gelang es 
mir zu zeigen, dass Stc2 vornehmlich in der inneren Körnerschicht und der 
Ganglienzellschicht exprimiert wird und dass das STC2 Protein hauptsächlich in den 
Neurofilamenten der Ganglienzellen lokalisiert ist. Da die Netzhautmorphologien von Stc1 
und Stc2 knockout Mäusen normal war, scheint Stc2 für die normale Entwicklung der 
Netzhaut nicht essentiell zu sein, könnte aber an der Antwort auf einen hypoxischen Stress 
beteiligt sein.  
Die Netzhaut ist nicht nur anfällig auf hypoxischen Stress, sondern auch auf die Veränderung 
des pH-Wertes und der daraus folgenden Azidose während einer Degeneration. Deshalb 
analysierten wir auch die Expression einer Klasse von G-Protein-gekoppelten Rezeptoren 
(GPRs) – Gpr4, Gpr65 und Gpr68 in der Netzhaut. Unsere Untersuchungen zeigten, dass 
die Netzhaut alle drei Gprs exprimiert, dass aber nur Gpr65 auf eine Degeneration reagiert. 
Die Expression von Gpr65 war sowohl in einem induzierten (Lichtschaden) als auch einem 
vererbten (rd10) Degenerationsmodell stark erhöht. Mäuse ohne GPR65 entwickelten eine 
normale Netzhautstruktur und –funktion, zeigten aber in rd10-Mäusen einen leicht 
beschleunigten Verlust der Sehzellen.  
Für die Entwicklung einer effektiven Therapie für Erblindungserkrankungen ist es wichtig, die 
komplexen molekularen Reaktionen der Netzhautzellen auf Stress zu verstehen. Meine 
Arbeit gibt in diesem Zusammenhang Aufschluss über die stressbedingten Mechanismen in 
der degenerativen Netzhaut unter besonderer Beachtung der Rolle des zentralen 
Transkriptionsfaktors HIF1A beim Tod von Photorezeptoren. 
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1. INTRODUCTION 
1.1 The Retina 
1.1.1 Vision and the eye 
Vision is one of the most important sensory systems by which humans perceive their 
surroundings. The visual system aids in discerning the location, shape, size, colour, texture 
as well as movement of objects. The human visual system has the ability of processing 
information over a broad range of stimulus intensities – from faint starlight to bright sunlight.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
Figure 1. Structure of the eye and organization of the retina. (A) Eyes are the optical part of the visual system 
that send transmitted light for synaptic processing to the retina. (B) The retina is composed of different cell types 
with specialized functions – RPE: Retinal Pigment Epithelium, C: Cone photoreceptors, R: Rod photoreceptors, 
H: Horizontal cells, B: Bipolar cells, A: Amacrine cells, M: Muller cells, G: Ganglion cells. (C) The different 
cells are organized in stratified layers – RPE: Retinal Pigment Epithelium, OS: Outer Segments (of 
photoreceptors), IS: Inner Segments, ONL: Outer Nuclear Layer, OPL: Outer Plexiform Layer, INL: Inner 
Nuclear Layer, IPL: Inner Plexiform Layer, GCL: Ganglion Cell Layer. A schematic representation of the 
different layers of retinal vasculature is shown – Deeper plexus (red line), Intermediate plexus (green line) and 
the Primary plexus (Blue line). (Figure adapted from Sung CH et al, 2010) 
Eyes are the organs of vision, which send signals via the optic nerve to the brain. At the front 
of the eye is the cornea - a specialized transparent tissue that allows light to enter the eye. 
The coloured part of the eye is the iris and the opening in its centre is the pupil. Behind this is 
the lens, whose refractive ability is controlled by ciliary muscle. The ciliary muscle is 
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connected to the lens by zonular fibers, made predominantly of the connective tissue protein 
fibrillin and when the ciliary muscle relaxes, the zonular fibers apply tension on the lens, in 
order to focus light onto the retina. This plays an important role in accommodation to light. 
The innermost layer of the eye is the retina, which processes and sends signals to the visual 
cortex in the brain (Purves et al., 2008) (Figure 1A). 
1.1.2 Structure of the retina 
During development, the retina forms from the optic vesicle of the diencephalon, and hence 
is part of the central nervous system. The retina is a complex tissue composed of stratified 
layers of different cell types interspersed by the retinal vasculature (Figure 1B and 1C). 
1.1.2.1 Retinal pigment epithelium (RPE) 
The RPE is a single-cell layer of melanin-containing cells. It reduces the back scattering of 
light entering the eye. The RPE cells have microvilli that extend into the photoreceptor layer 
and surround the outer segments (Figure 1B). The RPE cells have many functions, including 
the 2 critical roles – first they help in clearing the disks that are shed by the outer segments 
of the photoreceptors and most importantly they help in the regenerating and recycling of the 
photopigment molecules that have been exposed to light (Strauss, 2005). In addition to these 
functions, the RPE forms a barrier between the choroid and the inner retina (blood-retina 
barrier), and hence protects the retina from the harmful particles being circulated in the 
blood, as well as from triggering an immune response. But, while protecting the inner retina, 
it also provides the oxygen and essential nutrients, which are selectively transported across 
the membrane.   
1.1.2.2 Retinal Neurons 
There are five different types of neurons – photoreceptors, bipolar cells, horizontal cells, 
amacrine cells and ganglion cells. The cell bodies are stacked together in layers named 
nuclear layers – the cell bodies of photoreceptors form the outer nuclear layer (ONL), the cell 
bodies of bipolar cells, horizontal cells and amacrine cells form the inner nuclear layer (INL) 
and the ganglion cell bodies form the ganglion cell layer (GCL). The processes and synaptic 
connections of these cells form two distinct layers called the outer plexiform layer (OPL) and 
the inner plexiform layer (IPL) (Sung and Chuang, 2010). There are two types of 
photoreceptors – rods and cones. These are the light sensitive cells of the retina involved in 
phototransduction. The bipolar cells are so named because they have two processes 
extending on either sides of the cell body. A bipolar cell accepts signals from the 
photoreceptors (either rods or cones, not both) as well as horizontal cells and then relays this 
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to ganglion cells either directly or via the amacrine cells. Horizontal cells are laterally 
interconnecting neurons that integrate and regulate the signals from the photoreceptors. 
Their cell bodies are in the INL and their processes are in the OPL. They are mainly 
responsible for maintaining the visual system’s sensitivity to contrast over a broad range of 
light intensities. The amacrine cells are postsynaptic to bipolar cells and presynaptic to the 
ganglion cells with their processes in the IPL. There are more than 20 different sub-types of 
amacrine cells that are thought to contribute to retinal function in distinct ways although 
relatively little is known about them. There are several different sub-types of ganglion cells 
that receive and integrate signals from amacrine and bipolar cells. The axons of the ganglion 
cells and some displaced amacrine cells are packed into a nerve fibre layer (NFL), and the 
axons of the ganglion cells converge to form the optic nerve (Masland, 2001). 
1.1.2.3 Retinal glial cells 
In addition to the neurons there are three types of glial cells in the retina. The Muller cells are 
the principle glial cells in the retina. They span almost the entire width of the retina. They are 
involved in supplying metabolic products to the neurons, protecting neurons from stress, and 
phagocytosis of neuronal debris (Bringmann et al., 2006). Astrocytes are the second type of 
glial cells. They do not develop from the retinal progenitors, but enter the retina from the 
brain during development. Their main known function is the involvement in the development 
of the primary plexus of vasculature (Schnitzer, 1988). The third type of retinal glial cells is 
the microglia, which are often described as the immune cells of the retina. They are 
constantly surveying the surroundings, can get activated on receiving stress signals, and 
migrate to the region of insult in case of neuronal stress (Chen et al., 2002). 
1.1.2.4 Retinal Vasculature 
The retina is a tissue with a high metabolic demand for oxygen and to supply this it has an 
extensive vascular system. This demand for oxygen and nutrients is fulfilled by the vascular 
system which has two parts – the choroidal vasculature and the retinal vasculature (Figure 
1C). In vascularized retinas (rodents, primates, cats etc), the choroid mainly supplies to the 
outer retina (the photoreceptors), and the retinal vasculature provides for the inner layers 
(especially the plexiform layers depend on this system). Certain species with avascular 
retinas depend solely on the choroidal system. Avascular retinas are generally thinner than 
the vascular ones, as they are limited by the ability of the choroidal system to provide oxygen 
by diffusion across all retinal layers. The disadvantage of vascularized retinas is that the 
blood vessels scatter light that reduce the light reaching the photoreceptors and also affects 
visual acuity as vessels take up space of the other cell types. But over time the retinas of 
most species have evolved towards a vascular system providing a compromise between 
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efficient supply of oxygen and visual sensitivity. The retinal vasculature has three distinct 
layers or plexi. The primary plexus forms a network in the inner retina at the nerve fibre layer. 
It consists of arteries and veins that both emerge and exit via the optic nerve. This layer then 
forms two parallel inter-connected layers at the plexiform layers – the intermediate plexus 
and the deeper plexus (Figure 1C). However, the metabolic demands of photoreceptors are 
mainly fulfilled by choroidal vasculature (Fruttiger, 2007). 
1.1.3 Structure and function of photoreceptors 
The outer nuclear layer is composed of 2 types of photoreceptors – rods and cones. The 
rods and cones differ in several properties like shape, distribution across the retina, 
photopigment, as well as the synaptic connections they form, and these differences 
contribute to their specialized functions in different aspects of vision (Purves et al.,2008). 
Structurally the photoreceptor consists of a cell body that contains the cell organelles. On 
one side of the cell body are the axons that end at the synaptic terminal, which forms 
synapses with the neurons from the inner nuclear layer. On the other side of the cell body is 
the photoreceptor segment. The segments are divided into two parts – the inner and the 
outer segments. The inner segments are rich in mitochondria and meet the high metabolic 
demand of the photoreceptors. The outer segments are specialized structures that contain 
stacked membranous disks (Figure 2A and 2B), which form a rod-like structure and cone-like 
structure in rods and cones respectively. The disk membranes have trans-membrane 
proteins called opsins (Figure 2C and 2D), which are G-protein coupled receptors of the 
retinylidene family, and the associated chromophore – retinal (Blaurock and Wilkins, 1969; 
Blaurock, 1972). Outer segments of the rods are cylindrical in shape and those of cones 
have a conical shape. The opsin in rods is called rhodopsin. In cones there are 3 types of 
opsins, which respond to different regions of the visible spectrum – OPN1LW (long 
wavelength), OPN1ML (middle wavelength) and OPN1SL (short wavelength) (Marc and 
Sperling, 1977). 
The photoreceptors are involved in the process of phototransduction, wherein a photon 
absorbed by the retinal triggers a series of molecular responses and biochemical reactions 
that convert the absorbed light into an electrical stimulus that can be sent to the brain for 
processing. The molecular events in phototransduction can be broadly divided into 5 steps. 
The first step involves the absorption of light by rhodopsin, which photo-isomerizes 11-cis-
retinal to the all-trans-retinal conformation. The second step involves rhodopsin to undergo 
several conformational changes, generating metarhodopsin I and metarhodopsin II (MII). MII 
is the active form of rhodopsin and is crucial for the catalytic activation of the G protein 
transducin. Transducin is a trimeric protein composed of α, β and γ subunits, which in the 
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inactive state is bound to guanosine diphosphate (GDP). In the third step, MII rhodopsin 
interacts with transducin, which leads to the exchange of GDP for GTP and the separation of 
the α subunit (Gα) from the trimeric complex. The Gα is the active portion of transducin, 
which interacts with phosphodiesterase (PDE) to propagate the signal to the next step. 
Phosphodiesterase is a heterotetrameric protein composed of one α and one β subunit, 
which form the catalytic core to hydrolyze cyclic guanosine monophosphate (cGMP) to GMP. 
Two γ subunits bind the α and β heterodimer and inhibit their hydrolytic activity. In the fourth 
step, active Gα interacts with PDE, the γ subunits inhibition on the enzymatic activity of PDE 
is released. Finally in the fifth and last step, PDE hydrolyses cGMP to GMP closing cGMP 
nucleotide-gated ion channels and hyperpolarizing the cells. 
 
Figure 2 Structure of the photoreceptors (A) A cone photoreceptor with distinctively cone-shaped outer segment 
in contrast to the (B) rod photoreceptor. (C) The outer segments are composed of membranous disks containing 
transmembrane proteins called rhodopsin. (D) The rhodopsin molecule is composed of the protein opsin and the 
chromophore – retinal. (Figure 2D adapted from www.wordpress.mrreid.org) 
Cyclic nucleotide gated channels in outer segments control the influx of calcium ions (Ca2+) 
thereby keeping the photoreceptor cells constantly depolarized in darkness. Intracellular 
cGMP levels determine whether these channels are open or closed thereby controlling the 
influx of Ca2+ ions. In the depolarized state, photoreceptors continually release glutamate 
neurotransmitter at the photoreceptor synaptic cleft. In contrast, in the presence of light, as 
cGMP is hydrolyzed to GMP by PDE, the intracellular levels of cGMP decrease. As a result 
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cyclic nucleotide gated channels close, Ca2+ influx ceases and the cell hyperpolarizes. In the 
hyperpolarized state the release of glutamate is reduced proportionally to the intensity of the 
light stimulus. This adaptive response of glutamate release to light signal, is carried to 
second order neurons such as the bipolar cells (Arshavsky et al., 2002). 
The rod system is extremely sensitive to light but has low spatial resolution, whereas the 
cone system has high spatial resolution (in the macula where the cones are concentrated) 
but low light sensitivity. The rod system aids in vision at lowest levels of illumination (scotopic 
vision) and the cone system becomes active at higher illuminations such as indoor light 
(photopic vision). The human eye is capable of detecting luminance from 10-6 cd/m2 to 108 
cd/m2. A single photon can elicit a response from a rod photoreceptor, whereas more than 
100 photons would be required to elicit a similar response from a cone photoreceptor (Fein 
and Szuts, 1982). 
In the human retina, the number of rods (about 90 million), exceeds the number of cones 
(about 4.5 million) hence the density of rods is higher than cones in most part of the retina. 
But the central region of the retina called the macula has a cone rich region called the fovea 
(Figure 1A), which is responsible for high visual acuity (Provis et al., 1998). In fact loss of 
photoreceptors in the macula (macular degeneration) is one of the leading causes of 
blindness. 
1.2 Retinal Degeneration  
Damage and death of photoreceptors cause degeneration of the retina, which might 
eventually lead to vision impairment and blindness. Genetic mutations responsible for 
inherited retinal degenerations have been identified, but the exact molecular mechanisms 
causing photoreceptor death is not well understood, especially in complex, multi-factorial 
diseases such as Age-related Macular Degeneration (AMD). 
1.2.1 Age-related Macular Degeneration (AMD) 
Age-related Macular Degeneration (AMD) is a leading cause of blindness among the elderly. 
The prevalence of AMD increases with age, affecting about 2% of the population at the age 
of 40, and one in four people by age of 80 (Group, 2004). Several population-based 
epidemiological studies have provided estimates of prevalence of the disease among various 
racial/ethnic groups worldwide. These observations consistently conclude that the incidence 
of both - geographic atrophy (dry AMD) and the neovascular form (wet AMD) is rare before 
55 years of age, and becomes common in people above the age of 75, and the occurrence is 
more common among the white population than the blacks (Klein et al., 2004). 
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1.2.1.1 Types and Symptoms  
AMD is typically defined by the death of RPE cells and photoreceptors in the macular region 
of the retina, which leads to loss of central vision. Hence AMD patients have a blurry spot in 
their field of vision, and the size of this spot depends on the extent of degeneration. There 
are two forms of AMD – dry form (geographic atrophy) and the wet form (neovascular AMD). 
Dry AMD is the chronic form of the disease that occurs progressively, and leads to visual 
impairment of varying degree in different patients. On the other hand, wet AMD can occur 
abruptly and rapidly leads to blindness if left untreated. Wet AMD occurs only in 10-15% of 
the AMD patients, and typically the patients first develop the dry form before progressing into 
the wet form of the disease (Ferris III et al., 2013). 
With increasing age the efficiency of RPE cells in clearing the degradation products of the 
photoreceptor outer segments is reduced (Boulton, 1991). This results in lipofuscin 
accumulation in the lysosomes of RPE cells. Lipofuscin consists of several molecules, 
dominantly the fluorophore A2E – a by-product of the visual cycle (Suter et al., 2000). 
Another early indication of AMD is accumulation of drusen in the macular region. Drusen are 
tiny soft extracellular material, which accumulate between the RPE and Bruch’s Membrane 
(BM). In the aging retina the RPE cells become less efficient with the clearance of 
extracellular debris, and the accumulation of few small drusen is a normal age-related event. 
However, the accumulation of excessive amounts of large drusen indicates the onset of dry 
AMD. Clinically AMD is defined based on number and type of drusen (large and soft), 
pigmentary changes in the macula and the extent of geographic atrophy. The drusen 
accumulation is often accompanied by hyper/hypo pigmentation of the RPE. Slight thickening 
of the Bruch’s membrane (BM) occurs as a normal aging process, but in AMD patients 
irregular thickening of the BM is observed. In early/ intermediate stages the visual acuity is 
often affected (Rickman et al., 2013; Holz et al., 2014). 
The late stage is distinguished by scotomas in the macular region that lead to progressive 
loss of central vision. The patients also have decreased night vision. In some patients there 
is abrupt invasion of blood vessels into the RPE and retina – choroidal neovascularization 
(CNV). The ingrowing blood vessels develop poorly, and result in blood leakage in the retina, 
causing discomfort and a rapid progression of vision loss (Rickman et al., 2013). 
1.2.1.2 Risk Factors 
AMD is a multi-factorial disease hence there is no single cause for the disease. However 
there are several environmental and genetic risk factors that increase the propensity towards 
developing AMD. 
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Environmental factors – Studies have shown a strong correlation of AMD with smoking, 
with more than a 2 fold increased incidence of AMD in smokers compared to non-smokers. 
Obesity and higher BMI also increased the risk of AMD (Seddon and Chen, 2004). Increased 
plasma levels of C-reactive protein (due to inflammation) (Seddon et al., 2006), or 
complement activation fragments Bb and C5a have been independently implicated as risk 
factors (Reynolds et al., 2009). On the other hand dietary intake of lutein and zeaxanthin 
showed a protective effect, and reduced the risk (Seddon et al., 1994). Exposure to bright 
sunlight is also a risk factor. 
Genetic factors – Several genes have been identified to be associated with AMD. These 
genes have been shown to be associated with high-density lipoprotein collagen, cholesterol, 
collagen, extracellular matrix and mechanisms such as angiogenesis (Consortium, 2013). 
Many of these genes are involved in the complement pathway. CFH R1210C was the first 
rare penetrant mutant to be reported for AMD (Raychaudhuri et al., 2011). Rare variants in 
C3, Cfi and C9 have also been shown to confer a high risk (Seddon et al., 2013). 
1.2.1.3 Available treatments 
Currently there is no cure available for AMD. Most of the therapies/ treatments provided are 
either aimed at delaying the onset of the disease or at controlling the progress into severe 
late stage symptoms and vision loss. 
Preventive/ delaying measures - Several studies have shown benefits of dietary intake of 
macular carotenoids – lutein and zeaxanthin and food rich in these nutrients (Seddon et al., 
1994). It has also been shown that dietary supplements containing high doses of antioxidants 
and minerals (vitamin C and E, beta-carotene, and zinc) delayed the progression from 
intermediate to advanced stage of the disease (Group, 2001). Another potentially beneficial 
supplement is Omega-3 fatty acid, which is present in enriched amounts in fish (SanGiovanni 
et al., 2008). Lifestyle factors that can be modified are – avoidance of smoking (Seddon et 
al., 1996), controlling obesity, increasing physical exercise (Seddon et al., 2003) and 
reducing exposure to bright sunlight (Mitchell et al., 1998). 
Wet AMD treatments – Laser photocoagulation is a method by which newly formed vessels 
are destroyed using a laser. It was shown effective in a study in the 1980s but is much less 
used now due to a risk of immediate moderate visual loss after treatment (Group, 1986). 
Photodynamic therapy was used in the 1990s. It is a two-stage process wherein verteporfin 
(a photosensitising dye that accumulates in the neovascular membranes) is injected and 
then activated by infrared light. This generates oxygen-free radicals that damage the 
endothelium resulting in the closure of newly formed vessels (Bressler, 2001). 
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Anti-VEGF (Vascular Endothelial Growth Factor) is currently the most widely used therapy to 
control CNV. VEGF plays a key role in the development of new vessels, this led to the 
development and testing of several VEGF inhibitors that can be provided to patients as 
intravitreal injections at regular intervals (Dixon et al., 2009; Mitchell, 2011). 
As mentioned earlier only 10-15% of the patients develop wet AMD and the remaining suffer 
from the dry form. But there is no treatment available and the development of therapies for 
dry AMD remains an unmet medical need. 
1.2.2 The Complement System and AMD 
1.2.2.1 The complement pathways 
The immune system has two parts – the innate immune system, which provides the first line 
of defence against pathogens and does not change over the course of a person’s lifetime 
and the adaptive immune system, which adapts and develops when exposed to pathogens. 
The complement pathway is part of the innate immune system. The main functions of the 
complement system are - cell lysis of microorganisms, removal of foreign particles and dead 
cell debris, recruitment and activation of inflammatory cells, regulation of antibody 
production, and elimination of immune complexes. 
The complement system has 3 pathways – classical, lectin and alternative pathway. These 
three differ in their mode of activation and the components/factors that are involved in the 
cascade (Figure 3). Binding of circulating C1q to antigen-antibody complexes activates the 
classical pathway. The C1 complex consists of C1q and two molecules each of C1r and C1s. 
The binding of the recognition subcomponent C1q to the Fc portion of immunoglobulins 
results in autoactivation of the serine protease C1r. C1r then cleaves and activates C1s, 
which translates the activation of the C1 complex into complement activation through the 
cleavage of C4 and C2 to form a C4bC2a enzyme complex. C4bC2a acts as a C3 
convertase and cleaves C3, which results in products that bind to and cause the destruction 
of invading pathogen. The Lectin Pathway is initiated by the binding of either mannose-
binding lectin (MBL) or ficolin — associated with MBL-associated serine protease 1 
(MASP1), MASP2, MASP3 and small MBL-associated protein (sMAP) — to an array of 
carbohydrate groups on the surface of a bacterial cell. Similar to C1s, MASP2 is responsible 
for the activation of C4 and C2, which leads to the generation of the same C3 convertase 
(C4bC2a) as in the classical pathway. MASP1 is able to cleave C3 directly. The alternative 
pathway is initiated by the low-grade activation of C3 by hydrolyzed C3 (C3(H2O)) and 
activated factor B (Bb). The activated C3b binds factor B (B), which is then cleaved into Bb 
by factor D (D) to form the alternative pathway C3 convertase, C3bBb. Once C3b is attached 
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to the cell surface, the amplification loop consisting of the alternative-pathway components is 
activated, and the C3-convertase enzymes cleave many molecules of C3 to C3b, which bind 
covalently around the site of complement activation. After activation the three pathway recruit 
different factors, but all pathways merge at the C3 hydrolysis step, and then further culminate 
in the formation of a cytolytic membrane attack complex (MAC) (Fujita, 2002; Purves et al.). 
 
 
Figure 3 Activation mechanisms of complement pathways and the complement factors involved   (A) The 
Classical Pathway is initiated by the binding of the C1 complex to antibodies that are bound to antigens on the 
surface of the pathogen. (B) The lectin pathway is activated when mannose-binding lectin recognises and binds 
to specific carbohydrates on the pathogen surface. (C) The alternative pathway is in a continuous low-level 
activation state, and is characterized by spontaneous hydrolysis of C3 to C3a and C3b. (Figure adapted from 
Fujita T, 2002) 
 
1.2.2.2 Implications in AMD 
As mentioned earlier, AMD is a multi-factorial disease and several genetic polymorphisms 
have been associated with the disease. Many of these high-risk associated genes are part of 
the complement system, such as – Complement Factor H (CFH) (Edwards et al., 2005; 
Hageman and Anderson, 2005; Haines et al., 2005; Klein et al., 2005), Complement 
component 3 (C3) (Despriet et al., 2009; Maller et al., 2007; Park et al., 2009; Yates et al., 
2007), Complement Factor B (CFB) and Complement component 2 (C2) (Gold et al., 2006; 
Jakobsdottir et al., 2008). In European and North American population it was shown that 
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CFH and CFB/C2 variants accounted for 75% of all AMD cases (Gold et al., 2006). The total 
population risk attributable to the variants of the C3 gene was estimated to be 14.5% 
(Despriet et al., 2009). There is evidence for some protective haplotypes of CFH. This is due 
to the deletion of two members of the CFH family – CFHR1 and CFHR3, which act 
downstream and modulate the function of C5 convertase (Hageman et al., 2006). Hence, 
several studies have shown and new studies continue to show that mutations in genes of the 
complement pathway increase the risk/ provide protection from developing AMD (Anderson 
et al., 2010). 
In addition to genetic linkage studies, biochemical examination of the drusen composition 
revealed the presence of complement factor fragments/ components. Immunochemical and 
proteomic analysis of drusen showed the presence of immunoglobulins, activated 
complement components (C3a, C3b, Cfb, C5 and C5a), complement regulators (vitronectin, 
clusterin, and cfh, acute phase proteins and the Alzheimer’s disease amyloid-beta peptide). 
Other oxidative stress and inflammation related components were also present – oxidized 
lipids, microglia and macrophage cells (Anderson et al., 2010). These genetic-association 
and drusen composition studies suggest that the disease has a chronic inflammatory 
component and have led to the ‘inflammation model’ of AMD pathogenesis. 
1.2.3 Animal models to study AMD 
AMD is a complex disease with multiple factors  - age, genetics, diet and lifestyle, that 
contribute to the onset. In addition the time and extent of manifestation of the symptoms vary 
among individual patients (Evans, 2001). This makes it very difficult to emulate all the 
features of the disease in a single AMD animal model. Therefore, there are several different 
animal models that are used to study and test therapies for various aspects of the disease 
(Ramkumar et al., 2010). 
Anatomically and physiologically the primate retina would be the most suitable model for 
AMD study because they possess a macula, but factors like limited supply, ethical concerns, 
financial constraints and the challenge of genetic modifications restrict their utilization. 
Instead, several mouse models have been and continue to be developed for AMD research 
despite the significant differences between human and mouse retina. The most important 
difference being the lack of a macula – the region where the cone photoreceptors are 
concentrated in the human retina. Mice are nocturnal animals, yet the photoreceptor ratios 
are comparable with the mouse retina composed of 97% rods and 3% cones, and human 
retina with 95% rods and 5% cones (Carter‐Dawson and Lavail, 1979). But, mice have only 
two cone types – S-cones (blue light) and M-cones (green light), while the human retina has 
in addition a third type – L-cones (red light) (Szel et al., 1992). It has been hypothesized that 
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RPE phagosomes cause drusen accumulation via the basal pathway into the bruch’s 
membrane (Mishima and Hasebe, 1978). However, in mice lysosomal bodies accumulate in 
the RPE cytoplasm and are extruded into the sub-retinal space, hence drusen accumulation 
is difficult to detect in aged mice (Mishima and Kondo, 1981). 
Mouse models with mutations in several genes such as ABCR and ELOVL4, known to cause 
the juvenile macular dystropy – Stargardt disease, are often used for study as these display 
the phenotype of RPE and photoreceptor atrophy, and also show elevated levels of lipofuscin 
and its by-product A2E (Mata et al., 2001; Vasireddy et al., 2006; Vasireddy et al., 2009). 
An important aspect of AMD pathology is inflammation – microglia activation and 
accumulation and macrophage infiltration (Karlstetter and Langmann, 2012; Perez and 
Caspi, 2015). As outlined above, mutations in several complement factor genes are highly 
correlated with the disease and biochemical analysis of drusen revealed the presence of 
complement factor fragments, pro-inflammatory cytokines and chemokines. Genetic 
mutations in the Cfh gene are highly correlated with the disease (Raychaudhuri et al., 2011). 
CFH is a negative regulator of the alternative complement pathway and inhibits C3. Hence in 
Cfh-/- mice an accumulation and activation of C3 is observed. In addition these mice had 
reduced visual function at old age and significant thinning of the bruch’s membrane (Coffey 
et al., 2007). CCL2 and its receptor CCR2 are responsible for recruiting and modulating the 
function of macropahges. Both Ccl2-/- and Ccr2-/- mice developed several features of AMD 
including sub-retinal deposits similar to drusen, late degeneration and choroidal 
neovascularization (CNV) at 24 months of age (Ambati et al., 2003). Retinal microglia cells 
express the CX3 chemokine receptor 1 (CX3CR1) affecting microglia migration and 
activation. Cx3cr1-/- mice showed significant thinning of the outer retina at 18 months of age 
(Combadière et al., 2007). The Ccl2-/-;Cx3cr1-/- showed more severe and an early onset of 
the phenotype (Tuo et al., 2007).  
Apart from the genetic models for inflammation related genes, an induced model was 
developed by immunizing mice with carboxyethylpyrrole (CEP)-modified serum albumin. 
CEP is formed as an oxidation product of docosahexaenoic acid (DHA), which then interacts 
with and modifies tissue proteins. The levels of CEP-modified proteins is elevated in AMD 
patients compared to age-matched controls. The CEP-immunized mice showed RPE atrophy 
and loss, accumulation of BlamD (basal laminar deposits), accumulation of complement 
factors and thickening of BM (Hollyfield et al., 2008). 
Inefficient metabolism results in accumulation of lipids and proteins in the sub-RPE and BM 
region, resulting in impaired transport of nutrients to the photoreceptors. Neprilysin is a 
peptidase that is required for the break-down of Aβ peptides. Neprilysin-/- mice showed RPE 
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abnormalities at old age, though this did not affect the photorecptors or result in CNV 
induction (Iwata et al., 2001 ; Yoshida et al., 2005).  
Apolipoprotein E (apoE)  is important for lipid and cholesterol metabolism and genetic 
association studies have shown many APOE polymorphisms to be risk factors for AMD. 
ApoE-/- mice had an early onset (starting at 2 months of age) of RPE abnormalities that 
worsened with age (Dithmar et al., 2000). Transgenic mice expressing one of three APOE 
isoforms – apoE2, apoE3 or apoE4 were raised on a low/high fat diet. The mice on a high-fat 
diet showed certain AMD features with varying severity (Malek et al., 2005).  
The retina consumes high levels of oxygen (Sickel, 1972), hence being suseptible to 
oxidative stress resulting from molecular changes and cellular damage caused by reactive 
oxygen species (ROS). One of the important anti-oxidants responsible for clearing ROS is 
superoxide dismutase (SOD). There are three isoenzymes – SOD1 (cytosolic), SOD2 
(mitochondrial) and SOD3 (extracellular), with SOD1 being most abundant in the retina. 
Sod1-/- mice show drusen-like deposits, thickening of BM and CNV at 10 months of age 
(Imamura et al., 2006). Sod2 mutants do not survive till adulthood (Sandbach et al., 2001). 
But AAV mediated knock-down of Sod2 in the RPE of WT mice showed several features in 
an age-dependent manner including thinning of the ONL (Justilien et al., 2007). 
About 10-15% of the patients develop wet AMD (Ferris III et al., 2013). Most sucessfully used 
CNV model uses lasers to mechanically induce lesions resulting in CNV. Vegf is the main 
factor involved in angiogenesis, but Vegf overexpression alone does not suffice, as a 
compromise to the BM is essential for CNV induction.  Several models have shown that a 
combination of laser induction, VEGF and inflammatory cytokines’ expression has been most 
successful in inducing CNV. (Grossniklaus et al., 2010).  
Several age-related changes such as thickening of BM, lipofuscin accumulation, 
choriocapillary changes, reduced clearance ability of RPE cells may contribute to restricted 
oxygen supply from the choroid to the outer retina. And as these features are further 
enhanced in AMD patients, it has been postulated that the AMD retinas are hypoxic. Also 
hypoxic related genes are involved in mechanisms implicated in AMD - such as oxidative 
stress, angiogenesis and inflammation (Arjamaa et al., 2009a). But, so far a specific model to 
study hypoxic aspects of the disease in the retina has not been available. 
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1.3 Hypoxia and Retinal Degeneration 
1.3.1 Hypoxia in health and disease 
Hypoxia is defined as a condition of low/ inadequate levels of oxygen. Healthy people may 
experience systemic hypoxia while climbing mountains resulting in altitude sickness. In fact, 
populations of people living at high altitudes, such as Tibetan tribes are often studied to 
analyse genetic and metabolic adaptations that allow them to survive the hypoxic conditions 
(Beall, 2006; Simonson et al., 2010). 
Prematurely born infants may experience systemic hypoxia, as the lungs may not be 
completely developed and fully functional. Hence they are placed in an incubator with 
continuous positive airway pressure (Baraldi and Filippone, 2007). But on the other hand, 
these infants are at a risk of developing retinopathy of prematurity (ROP) as the oxygen 
provided causes the retinal vessels to develop in an arbitrary manner resulting in poorly 
developed vessels, retinal detachment and severe vision problems in some cases (Gilbert, 
2008). 
Local hypoxia occurs when oxygen supply gets restricted in specific tissues such as during 
ischemic insults. Ischemia is the restriction of blood supply to the tissue. When the blood is 
unable to carry oxygen and nutrients to specific tissues, hypoxia ensues and when this 
condition is prolonged, cell death and tissue damage occurs. In case of patients who 
experienced a stroke, parts of the brain tissue may get hypoxic and be irreversibly damaged 
(Dirnagl et al., 1999). 
Cellular hypoxia is a hallmark of cancers, as the tumor microenvironment is usually hypoxic 
(Vaupel and Mayer, 2007). Cancer cells’ survival and proliferation depends on several 
genetic and metabolic adaptations to overcome limitations in oxygen and nutrient supply. 
One such well-studied mechanism is angiogenesis (sprouting of new blood vessels), which 
occurs when hypoxic tumor cells send signals to the surrounding vessels to fulfil their energy 
demands (Carmeliet and Jain, 2000; Vaupel and Mayer, 2007). Also tumor cells often have 
mutations in mitochondrial genes that impair oxidative phosphorylation, hence there is a 
metabolic switch to aerobic glycolysis to produce energy (Warburg effect) (Semenza, 2007; 
Vander Heiden et al., 2009). 
1.3.2 Hypoxia Inducible Factors 
At the cellular level, the hypoxic response is mediated by transcription factors called Hypoxia 
Inducible Factors (HIFs). The target genes that are transcribed by HIFs are involved in 
diverse mechanisms such as – angiogenesis, cellular metabolism, apoptosis, ROS formation 
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and oxidative stress, extracellular matrix regulation, immune response and inflammation 
(Majmundar et al., 2010; Semenza, 2012). 
1.3.2.1 HIFs – types and structure 
HIF is a heterodimer composed of an α and a β subunit (Wang et al., 1995). The HIFβ 
subunit also known as aryl hydrocarbon receptor nuclear translocator (Arnt) is constitutively 
expressed and has a nuclear localization. On the other hand the HIFα subunit is also 
constitutively expressed but immediately degraded in the presence of oxygen (normoxic 
conditions) with a half-life of 5 minutes (Aimee et al., 1998).   
 
 
Figure 4. Structure and DNA-binding of HIF. (A) Schematic representation of HIF1a and HIF2a. The α subunit 
of HIF consists of the bHLH and PAS domains, as well as the transactivation domain (TAD). The NAD region 
overlaps with the oxygen-dependent degradation domain (ODDD) and consists of the conserved proline residues 
(marked as P) that are hydroxylated by PHDs. The conserved arginine (marked as N) that is hydroxylated by 
FIH is present at the CAD. (B) On translocation to the nucleus the α subunit forms a heterodimer with the β 
subunit to form the functional HIF that binds the target genes’ HRE element to regulate transcription. 
There are three HIFα paralogs– HIF1α, HIF2α and HIF3α as well as 3 paralogs of HIFβ – 
HIF1β, HIF2β and HIF3β (Lisy and Peet, 2008). The oxygen dependent regulation and 
transcription activity of both HIF1α and HIF2α are well characterized, whereas the regulation 
and activity of HIF3α is not well understood. The Hif3α gene has several splice variants and 
some studies have also postulated a negative regulation by HIF3α. A splice variant of HIF3α 
has been shown to form a dimer with HIF1β, and prevent its dimerization with HIF1α, thereby 
inhibiting transcription of target genes (Gu et al., 1997; Makino et al., 2001). 
Both the α and β subunits are members of the basic helix-loop-helix/Per-Arnt-Sim 
(bHLH/PAS) family of transcription factors, and they both contain transactivation domains. 
The bHLH and PAS domains are present in both the subunits and are required for the 
recognition and binding of the hypoxia-responsive elements (HRE) in the promoter region of 
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the target genes (Figure 4B). The HRE is composed of the core-HRE or the HIF-binding site 
(HBS) containing the sequence – T(A/G)CGTG and the HIF ancillary sequence (HAS), which 
is an imperfect inverted repeat of this sequence. In addition the α subunit has an oxygen-
dependent degradation domain (ODDD) (Kimura et al., 2001). This domain contains two 
proline residues that are critical for its oxygen dependent regulation – P402 and P564 in 
HIF1α and P405 and P531 in HIF2α. The transactivation domain (TAD) is composed of two 
main regions – N-terminal transactivation domain (NAD) and C-terminal transactivation 
domain (CAD) (Figure 4A). The two domains do not have much amino acid similarity 
implying distinct and divergent functions. A study comparing the two domains revealed that 
CAD is the most important domain controlling the regulation of most HIF target genes. The 
CAD has an asparagine residue that is critical for the oxygen dependent binding of 
transcriptional co-activators (Dayan et al., 2006; Jiang et al., 1997). 
1.3.2.2 Molecular Mechanism of HIF1α stabilization 
In normoxic conditions, prolyl hydroxylases (PHDs) hydroxylate the HIF1α subunit at the 
specific proline residues (P402 and P564) (Jaakkola et al., 2001). Three PHDs capable of 
performing this hydroxylation have been recognised – PHD1, PHD2 and PHD3 (Bruick and 
McKnight, 2001). Hydroxylated HIFA is recognized by the Von-Hippel-Lindau (VHL) which 
recruits elongin-C/ elongin-B/ cullin-2 E3-ubiquitin-ligase protein complex (Cockman et al., 
2000; Maxwell et al., 1999). The E3 ubiquitin ligase in this protein complex poly-ubiquitinates 
HIF1A targeting the protein for proteosomal degradation (Ohh et al., 2000). Hence, under 
normoxic conditions the α subunit is degraded rapidly. Furthermore, Factor inhibiting HIF 
(FIH) (Mahon et al., 2001) hydroxylates HIF1α at an aspargine residue present in the CAD 
preventing recruitment of p300 (a transcriptional co-activator) and thus transcription of HIF 
target genes (Mahon et al., 2001).  
These hydroxylation events are O2 dependent and hence under hypoxic conditions PHD and 
FIH do not hydroxylate HIFα. As a result HIFα cannot be targeted by VHL- E3-ubiquitin-
ligase complex for degradation and HIF1α gets stabilized, translocates to the nucleus, 
associates with HIF1β and the p300 co-activator (Gu et al., 2001) and regulates transcription 
of target genes. The FIH has been shown to be more tolerant to hypoxia than the PHDs, 
hence as the O2 levels reach a particular threshold the PHDs lose their activity first, resulting 
in the expression of NAD-dependent target genes, and at more severe hypoxia, when FIH 
loses its activity, CAD-dependent targets are also expressed (Koivunen et al., 2004). This 
oxygen-dependent VHL mediated mechanism of regulation of the α subunit is one of the 
main mechanisms controlling cellular HIF activity (Figure 5). HIF2α has also been shown to 
be regulated in a similar manner (Loboda et al., 2010). 
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 Figure 5. Schematic representation of the molecular mechanism of oxygen-dependent stabilization and 
degradation of HIF1α. Under normoxic conditions, HIF1α is hydroxylated by PHDs and FIH. The hydroxylation 
event allows the recognition and binding by VHL, which is part of a protein  complex. The ubiquitin-ligase in the 
complex ubiquitinates HIF1α, thereby resulting in its proteosomal degradation. On the other hand, under 
hypoxic conditions PHDs do not hydroxylate HIF1α which evades the VHL-mediated degradation, gets 
stabilized, translocates to the nucleus and causes transcription of the target genes. 
1.3.2.3 HIF1 target genes and responses 
Hypoxia and stabilization of HIF results in the transcription of several genes that may be 
involved in pro-survival mechanisms such as angiogenesis, warburg effect and cell migration 
that allow tumor growth. On the other hand long term effects may be detrimental to the cells 
as in regulation of ECM, apoptosis and ROS accumulation.  
Angiogenesis is the mechanism of sprouting of blood vessels from pre-existing ones and is 
required when a tumor grows beyond the size that can be supported by diffusion from 
existing vasculature. The HIF1 and HIF2 target gene Vegf (Vascular endothelial growth 
factor) is one of the best analysed HIF targets involved in angiogenesis (Ema et al., 1997). 
Anti-VEGF therapy is often used to control tumor growth and is presently also the only known 
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effective therapy to control wet AMD (Mitchell, 2011). Other HIF1 targets involved in 
angiogenesis are Tgf-β3 (transforming growth factor), leptin and endoglin. And other targets 
such as nitric oxide synthase 2, heme-oxygense-1 and endothelin-1 can increase the 
permeability of vessels and cause vasodilation (Maynard and Ohh, 2007). 
 
 
Figure 6. Schematic representation of major energy  producing cellular mechanisms. Glucose is converted to 
pyruvate by the multi-step process of glycolysis. Under aerobic conditions this is further converted to Acetyl-
CoA by the pyruvate dehydrogenase complex (PDC). Components of the PDC are tighly regulated by the 
opposing effects of pyruvate dehydrogenase kinase (PDK), which inhibits the complex and Pyruvate 
dehydrogenase phosphatase (PDP), which activates the complex. Acetyl-CoA in the mitocondria enters the TCA 
cycle as well as undergoes oxidative phosphorylation to produce energy. Under anaerobic conditions Lactate 
dehydrogenase (LDH) acts on the pyruvate converting it to lactate and producing lower amounts of energy than 
produced by oxidative phosphorylation (For each glucose molecule 2 ATPs are produced by glycolysis, whereas 
30 ATPs are gained from each glucose molecule by oxidative phosphorylation).  
Cells normally produce energy by both glycolysis and oxidative phosphorylation, wherein 
pyruvate produced during the last step of glycolysis gets converted to acetyl-CoA under 
aerobic conditions, and undergoes multiple steps of oxidative phosphorylation in the 
mitochondria to produce energy. Under anaerobic conditions the pyruvate is converted to 
lactate instead of acetyl-CoA producing lower amounts of energy (Figure 6). It has been 
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observed that cancer cells have a much higher glycolytic rate even under aerobic conditions, 
indicating that cancer cells produce most of their energy by aerobic glycolysis. This metabolic 
switch from oxidative phosphorylation to glycolysis is known as the ‘Warburg effect’. HIF1 is 
involved in enhancing this effect by upregulating the enzymes involved in glycolysis such as 
hexokinase-2, glucose-6-phosphate isomerase and pyruvate kinase M2 (PKM2), Pyruvate 
dehydrogenase kinase (Pdk) as well as glucose transporters such as GLUT1 and GLUT3 
(Stubbs and Griffiths, 2010). 
HIF1 targets that are involved in cell migration are AMF (autocrine motility factor), urokinase-
type plasminogen activator receptor (uPAR), E-cadherin and chemokine receptor 4. Growth 
and survival factors that are HIF1 mediated include TGF-α (transforming growth factor), 
survivin, COX-2 (cyclooxygenase), PDGF (platelet-derived growth factor), IGF-2 (insulin-like 
growth factor) and insulin-like growth factor binding proteins (IGFBPs) (Erler et al., 2006; 
Esteban et al., 2006; Graham et al., 1999; Liu et al., 2006). EPO (erythropoietin) is another 
HIF-mediated protective factor. It is a secreted glycoprotein that prevents apoptosis of early 
erythroid progenitor cells and allows their differentiation. Epo has been shown to have a HIF-
dependent transcriptional regulation under hypoxic conditions, that results in an EPO 
upregulation followed by an increase in erythrocyte population and thus in the oxygen 
transport capacity of the blood (Jelkmann, 2004). In the retina, it has been shown that 
hypoxic preconditioning protects the tissue from subsequent toxic insult (degeneration by 
light exposure) and locally produced EPO among other factors has been suggested to be 
responsible for this protective effect (Grimm et al., 2002; Caprara and Grimm, 2012; Grimm 
and Willmann, 2012). 
Short-term hypoxia may induce protective or pro-survival factors, but long-term hypoxia may 
be detrimental to tissue health as HIF1 also has the potential to induce several pro-apoptotic 
genes including Bnip3 (BCL2/ adenovirus E1B 19 kDa interacting-protein 3) and DDIT4 
(DNA damage inducible transcript 4) (Bruick, 2000; Shoshani et al., 2002; Sowter et al., 
2001). Vhl is one of the main regulators of HIF1α and in the retina, it has been shown that 
photoreceptor specific knock-down of Vhl resulted in stabilization of HIF1α, and these mice 
had photoreceptor loss and severe retinal degneration after 1 year of age (Lange et al., 
2011). 
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1.3.3 Hypoxia in the retina 
The retina is known to consume more oxygen than most other tissues and hence is highly 
sensitive to alterations in oxygen levels, and hypoxia has a diverse range of effects on retinal 
function. 
1.3.3.1 Hypoxia in retinal development   
In the retina hypoxia plays an important role during early developmental stages, wherein it 
aids in the proper development of the retinal vasculature. Vascular endothelial growth factor 
(VEGF), involved in the process of vasculogenesis and angiogenesis is a target of the HIF 
transcription factors, which are the main regulators of the hypoxic response. So local hypoxia 
at the NFL and GCL result in the increased production of VEGF by astrocytes and ganglion 
cells that results in the formation of the primary plexi of the vasculature. Furthermore VEGF 
poduction by Muller cells is crucial for angiogenic sprouting of the deeper plexi. It was shown 
that mice lacking HIF1A failed to develop the intermediate plexi, whereas the primary and 
deeper plexi seemed less affected (Caprara et al., 2011). On the other hand mice with over-
stimulated HIF1A also failed to develop the correct vessel architecture, as the vessels 
penetrated all cell layers- including the ONL (Kurihara et al., 2010; Lange et al., 2011). 
During early development many retinal neurons undergo apoptosis, before the retina 
achieves the correct neuronal cell number and tissue architecture. Spatially and temporally 
controlled occurrence of hypoxia aids in this process of developmental apoptosis (Stone et 
al., 1995; Yancopoulos et al., 2000). 
1.3.3.2 Hypoxia in retinal protection  
Prolonged hypoxia is detrimental to the tissue, but several studies have shown that short 
term or acute hypoxia might have protective effects. It was shown that mice that were 
preconditioned with hypoxia were protected against damage by bright light that results in 
photoreceptor degeneration in non-preconditioned wild type mice. Such hypoxic 
preconditioning also protected against ischemia-reperfusion injury (Ara et al., 2011; Chouker 
et al., 2012; Zhan et al., 2011). This is most likely because acute hypoxia activates protective 
mechanisms by causing cells to secrete factors that might help the tissue cope with a 
subsequent toxic insult. One such hypoxia-induced factor is erythropoietin (EPO) that was 
shown to partially protect the photoreceptors in some situations (Grimm et al., 2002). 
Identification of such factors could be one approach towards developing therapies for 
preventing retinal degeneration (Grimm et al., 2002; Grimm et al., 2007). 
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1.3.3.3 Hypoxia in retinal degeneration and disease  
Hypoxia during the early stages of development aids in the development of the retinal 
vasculature, but in the developed retina hypoxia may result in pathological choroidal 
neovascularization. These newly formed vessels penetrate the RPE and grow into the 
neuronal retina, but develop inadequately eventually leaking blood into the retina. This 
occurs in patients with wet AMD. Many age-related changes such as thickening of the 
Bruch’s membrane, reduced ability of choriocapillaries to supply nutients and oxygen, drusen 
accumulation, reduced clearance capability of RPE cells and accumulation of products of 
oxidative stress are responsible for a reduced blood oxygen supply to the inner retina leading 
to mild but chronic hypoxia in dry AMD patients (Arjamaa et al., 2009b). 
Glaucoma is the second leading cause of blindness worldwide. An increased intraocular 
pressure (IOP) and damage to ganglion cells are distinct features of the disease. But clinical 
features also include vascular abnormalities and impaired blood flow, that may cause 
hypoxia. Post mortem donor eyes showed higher staining for HIF1α in the retina and optic 
nerve head of glaucoma patients (Tezel and Wax, 2004). 
Retinopathy of Prematurity (ROP) is a condition occuring in infants born prematurely. In utero 
the oxygen tension averages around 32 mmHg, while in normal room air the oxygen tension 
is between 60-100 mmHg. At full-term the retinal vasculature is completely developed, but in 
case of infants born pre-term the development is incomplete and the relative hyperoxic 
experience may prevent complete development of vessels due to the lack of hypoxia-induced 
angiogenic factors such as VEGF. It has been shown that administration of VEGF or EPO 
during the vaso-obliterative phase can preserve the retinal vasculature from hyperoxia-
induced drop-out (Chen and Smith, 2007). 
1.3.4. HIF1α in the retina 
In new-born mice the total HIF1α level is high and decreases as the retina gets vascularized 
(Grimm et al., 2005). In the adult retina Hif1α has been detected in all the retinal layers 
although the spatio-temporal distribution varies during development. A systemic knock-out of 
Hif1α is mostly lethal, hence conditional knock-outs are used to elucidate it’s function/ effect. 
Knockdown of Hif1α in adult rod photoreceptors (Thiersch et al., 2009) and Muller cells (Lin 
et al., 2011) did not result in morphological or functional abnormalities. But when Hif1α was 
knocked down in most cells of the developing retina, the intermediary plexus of vasculature 
failed to develop (Caprara et al., 2011). On the other hand, stabilization of HIF1α by knocking 
down the Vhl gene resulted in severe degeneration, gliosis and reduction in retinal function in 
older mice (Lange et al., 2011). In addition, stabilization of HIF1α in the retina was shown to 
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affect retinal vasculature resulting in reduced density and defects in the vasculature. These 
vascular defects in the Vhl knock-down mice could be rescued by injecting VEGF inhibitor, or 
by genetic inactivation of Hif1α, but not Hif2α (Kurihara et al., 2010). 
Exposure to light causes retinal degeneration and in mice, is used as an experimental model 
for induced degeneration (Grimm and Remé, 2013). It was shown that when mice were 
treated with hypoxia (6 hrs at 6% O2)(hypoxic preconditioning), they were protected from 
light-induced retinal degneration. These hypoxic pre-conditioned mice showed HIF1α 
stabilization and the extent of protection varied with the extent of hypoxia – 6-10% O2 
showed highest HIF1α stabilization and protection, 14% O2 showed intermediate protection 
which was further reduced at 18% O2 (Grimm et al., 2002; Grimm et al., 2007). The rod 
photoreceptor specific deletion of Hif1a did not affect the structure and function of the retina, 
and these mice also displayed protection to light damage conferred by hypoxic 
preconditioning (Thiersch et al., 2009). Taken together, these studies reveal that acute or 
short term hypoxia may upregulate some pro-survival genes that activate protective 
mechanisms, whereas long-term hypoxic effects might tend more towards cell death and 
degeneration (Grimm and Willmann, 2012). 
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AIM OF THE THESIS 
The retina is a metabolically active tissue with high oxygen consumption hence is sensitive to 
hypoxia. The transcription factor HIF1 is a master regulator of the hypoxic response. In our 
lab it was shown that long-term inactivation of Vhl in the rod photoreceptors results in retinal 
degeneration. The main focus of my thesis was to study HIF1A, which is involved in hypoxic 
stress, but as a side project I also studied a receptor – GPR65, which is involved in pH 
stress. 
The specific aims of my thesis are as follows – 
1. HIF1A in the rod photoreceptors 
• Characterization of the rod-specific single (Vhl) and double (Vhl and Hif1a) 
knockdown mice. 
• In vitro studies for testing siRNAs against Hif1a that could be used for therapy. 
2. HIF1A target genes in the retina 
• Comparison of the transcriptomes of the rod-specific single (Vhl) and double (Vhl and 
Hif1a) knockdown mice. 
• Analysis of complement factors. 
• Role of a HIF1A target gene - Stanniocalcin2 in the retina. 
3. pH stress in the retina 
• Role of proton sensing G-protein coupled receptors in the retina. 
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3. RESULTS 
3.1. Hypoxic stress and HIF1A in the retina 
3.1.1 Rod-specific knockdown of Vhl and Hif1a 
 
 
Hif1a knockdown rescues retinal degeneration caused by Vhl deletion. 
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ABSTRACT 
 
Several age-related changes affect the oxygen and nutrient supply to the retina and might 
cause a mild but chronic state of hypoxia. The retina is a metabolically active tissue with high 
oxygen consumption and is hence sensitive to hypoxia. The cellular hypoxic response is 
mainly executed by transcription factors called hypoxia inducible factors (HIFs). Earlier, it 
was shown that rod-specific deletion of Von Hippel-Lindau (Vhl) results in stabilization of 
HIF1A and HIF2A, which causes retinal degeneration at older age. Here we show that HIF1A 
is responsible for this degeneration, as the additional deletion of Hif1a rescues this 
phenotype. Furthermore, the stress related mechanisms activated in the mice with 
stabilization of HIF1A and HIF2A are not observed on Hif1a deletion. A comparison of retinal 
transcriptomes on rod photoreceptor specific stabilization and deletion of HIF1A revealed 
several differentially regulated genes. Analysis of some enzymes suggested a potential 
metabolic shift in cellular energy production from oxidative phosphorylation to glycolysis. 
 
 
Keywords: Vhl, Hif1a, hypoxia, retinal degeneration, metabolism
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INTRODUCTION 
Age-related macular Degeneration (AMD) is the leading cause of blindness among 
the elderly – a survey estimates 50 million people to be affected by AMD worldwide. The 
cause of AMD is multifactorial including ageing (Evans, 2001), smoking (Thornton et al., 
2005) and genetic predisposition (Evans, 2001). AMD can be categorized into two types – 
dry AMD and wet (exudative) AMD. The dry form of AMD is characterized by the formation 
and accumulation of drusen (extracellular deposits between the RPE and Bruch’s 
membrane), and occurrence of geographic atrophy. AMD is a multi-factorial disease; hence 
several animal models are used to emulate the different features and study the mechanisms 
involved. Several age-related changes such as reduced density of choriocapillaries, 
thickening of the bruch’s membrane, drusen accumulation, inability of the RPE to clear 
lipofuscin and by-products of oxidation, as well as a genetic predisposition and lifestyle 
contribute to a mild but chronic hypoxia in the aged and diseased retinas. Hypoxia and 
oxidative stress have been implicated in the pathogenesis of AMD (Beatty et al., 2000). 
Thus, a hypoxia model for degeneration would shed light on the molecular mechanisms 
involved in photoreceptor loss and retinal degeneration. 
Transcription factors called hypoxia inducible factors (HIFs) are known to be involved 
in the regulation of gene expression in response to reduced oxygen levels (Webb et al., 
2009). HIF is a heterodimer composed of an α and a β subunit (HIFA and HIFB) (Wang et 
al., 1995). The HIFB subunit also known as aryl hydrocarbon receptor nuclear translocator 
(Arnt) is constitutively expressed and has a nuclear localization. On the other hand the HIFA 
subunit is also constitutively expressed but immediately degraded in the presence of oxygen 
(normoxic conditions) with a half-life of 5 minutes (Aimee et al., 1998).  There are three HIFA 
paralogs– HIF1A, HIF2A and HIF3A as well as 3 paralogs of HIFB – HIF1B, HIF2B and 
HIF3B (Lisy and Peet, 2008). In normoxic conditions, prolyl hydroxylases (PHDs) hydroxylate 
the HIF1A subunit at specific proline residues (Jaakkola et al., 2001). Hydroxylated HIFA is 
recognized by Von-Hippel-Lindau (VHL) which recruits elongin-C/ elongin-B/ cullin-2 E3-
ubiquitin-ligase protein complex (Cockman et al., 2000; Maxwell et al., 1999). The E3 
ubiquitin ligase in this protein complex poly-ubiquitinates HIF1A targeting the protein for 
proteosomal degradation (Ohh et al., 2000). Hence, under normoxic conditions the A subunit 
is degraded rapidly. Furthermore, Factor inhibiting HIF (FIH) (Mahon et al., 2001) 
hydroxylates HIF1A at an aspargine residue preventing recruitment of p300 (a transcriptional 
co-activator) and thus transcription of HIF target genes (Mahon et al., 2001). These 
hydroxylation events are O2 dependent and hence under hypoxic conditions PHD and FIH do 
not hydroxylate HIF1A. As a result HIFA cannot be targeted by VHL- E3-ubiquitin-ligase 
complex for degradation and HIF1A gets stabilized, translocates to the nucleus, associates 
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with HIF1B and the p300 co-activator (Gu et al., 2001) and regulates transcription of target 
genes. HIF2A has also been shown to be regulated in a similar manner (Loboda et al., 
2010). 
On deletion of Hif1a in the developing retina using the Pax6 promoter, the 
intermediary plexus of vasculature failed to develop (Caprara et al., 2011). Furthermore pan-
retina deletion of Vhl results in reduced vascular density, degeneration and loss of function 
(Kurihara et al., 2010; Lange et al., 2011b). It was shown that the rod photoreceptor-specific 
deletion of Hif1a did not affect the morphology and function of the retina (Thiersch et al., 
2009), but the deletion of Vhl (causing stabilization of HIF1A and HIF2A in the rods) resulted 
in an age-related slowly progressing retinal degeneration and loss of function (Lange et al., 
2011a). HIF1A and HIF2A have distinct target genes hence potentially activate different 
molecular pathways. To assess if the degeneration is caused by HIF1A, we generated 
double knock-down mice with rod photoreceptor-specific deletion of Vhl and Hif1a. In 
addition comparison of the retinal  transcriptomes of Opsin-Cre;Vhlflox and Opsin-
Cre;Vhlflox;Hif1aflox mice revealed differential regulation of several potential HIF1A target 
genes. 
EXPERIMENTAL PROCEDURES 
Animals, Genotyping and verification of CRE-mediated sequence deletion - Animals 
were treated in accordance with the regulations of the veterinary authority of Zurich and the 
statement of the Association for Research in Vision and Ophthalmology (ARVO) for the use 
of animals in vision research. All mice were kept at the animal facility of the University 
Hospital Zurich in a light-dark (12h:12h) cycle with food and water ad libitum. Light was 
maintained at 60 lux at cage level during the light period. Mice were euthanized by CO2 
inhalation followed by cervical dislocation.  
The 129S-Vhlhtm1jae/J-mice, which have loxP sites flanking exon1 and part of the promoter of 
the Vhl gene (both the alleles are floxed and hereafter these mice are referred to as Vhlflox), 
were purchased from Jackson laboratory (Bar Harbour, USA), the Opsin-Cre mice were 
acquired from Yun-Zheng Le (Oklahoma, USA) and the Opsin-Cre;Vhlflox mice were 
generated as described earlier (Lange et al., 2011a). The Hif1αflox/flox mice  (hereafter referred 
to as Hif1αflox) were kindly provided by R.Johnson (UCSD, USA) and M.Gassmann (UZH, 
Switzerland). The Vhlflox mice were crossed with Hif1αflox mice to generate Vhlflox;Hif1αflox and 
further with Opsin-Cre mice to generate Opsin-Cre;Vhlflox;Hif1αflox. 
The presence or absence of the Cre transgene was detected by PCR using the following 
primer pair: forward – 5’-AGG TGT AGA GAA GGC ACT TAG C-3’ and reverse – 5’-CTA 
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ATC GCC ATC TTC CAG CAG G-3’. In the presence of the transgene the amplification 
resulted in a 411 bp fragment. DNA was isolated from retinal tissue and the excision of the 
Vhl gene was tested by PCR using the following primers  - forward-excised – 5’-CTG GTA 
CCC ACG AAA CTG TC-3’, forward-unexcised- 5’-CTA GGC ACC GAG CTT AGA GGT 
TTG CG-3’ and reverse-both- 5’CTG ACT TCC ACT GAT GCT TGT CAC AG-3’. The 
excised allele was identified as a 260 bp fragment and the unexcised allele as a 460 bp 
fragment. Similarly the excision of Hif was tested by PCR using the following 3 primers – 
forward-unexcised – 5’-GCA GTT AAG AGC ACT AGT TG-3’, forward-excised-5’-TTG GGG 
ATG AAA ACA TCT GC-3’ and reverse-both-5’-GGA GCT ATC TCT CTA GAC C-3’. The wt 
allele is amplified as a 240 bp fragment; floxed allele as a 260 bp fragment and the excised 
allele is a 270 bp fragment. 
Transcriptome analysis – Retinas were isolated from 10-12 week old animals (N = 3) of the 
following genotypes - Vhlflox;Hif1αflox (control), Opsin-Cre;Vhlflox (single knock-down) and 
Opsin-Cre;Vhlflox;Hif1αflox (double knock-down). RNA was isolated using the QIAGEN 
RNeasy isolation kit (Qiagen, Hilden, Germany), including a DNase treatment step to digest 
residual genomic DNA. The samples were further processed at the Functional Genomics 
Centre Zurich (FGCZ, Zurich, Switzerland). The RNA was processed using standard 
procedures and hybridized to Agilent Mouse 44K Microarray (Agilent Technologies, Santa 
Clara, USA). The lists of upregulated and downregulated genes were provided by the FGCZ 
and were subsequently filtered to generate lists of genes with fold change ≥ 2 and pValue < 
0.05. To group differentially regulated genes according to their biological function; the Agilent 
IDs were imported into Database for Annotation, Visualization and Integrated Discovery 
(DAVID Bioinformatics Resources, National Institute of Allergy and Infectious Diseases, NIH, 
USA) (Huang et al., 2008). 
Hypoxic treatment of animals – WT mice were exposed to reduced oxygen levels (7% O2) 
in a chamber with food and water ad libitum. By altering the O2:N2 ratio, O2 was reduced to 
the desired level in steps of 2% over a time period of 1 hr. Mice were kept at 7% O2 for 6 hrs, 
and then retinas were immediately isolated for western blot analysis (as controls). 
Light exposure – WT mice were dark-adapted overnight (16 h). Pupils were dilated with 1% 
cyclogyl (Alcon, Risch, Switzerland) and 5% neosynephrine (UrsaPharm, Saarbrücken, 
Germany) 30 minutes before exposure to 15’000 lux of white light for 2 hours. After exposure 
retinas were isolated from these mice for western blot analysis (as controls). 
Morphology and light microscopy – To analyze retinal morphology by light microscopy, 
eyes were enucleated and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3) 
at 4°C overnight. After fixation, cornea and lens were removed, and the eyecup was 
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separated into a superior and an inferior half by cutting through the optic nerve head. The 
trimmed tissue was washed in cacodylate buffer, contrasted with osmium tetroxide (1%, 1 h, 
room temperature), dehydrated by incubations in increasing ethanol concentrations, and 
embedded in Epon 812. Semi-thin sections (0.5 µm) were prepared and counterstained with 
toluidine blue. An Axioplan digitalized microscope (Zeiss Meditec, Jena, Germany) was used 
to examine the slides.  
RNA isolation, cDNA synthesis and semiquantitative real-time PCR – Retinas were 
isolated through a corneal incision and immediately snap frozen in liquid nitrogen. Total RNA 
was isolated using RNeasy isolation kit (catalogue number: 74104, Qiagen, Hilden, 
Germany) or the High Pure RNA isolation kit (catalogue number: 11828665001, Roche 
Diagonistics, Basel, Switzerland). Residual genomic DNA was removed by a DNase I 
incubation step. RNA (650-1000 ng) was reverse transcribed using oligo(dT) and M-MLV 
reverse transcriptase (catalogue number: M1701, Promega, Madison, WI, USA). 10 ng of 
cDNA was used for gene expression analysis by semiquantitative real-time PCR using a 
LightCycler 480 instrument (Roche Diagnostics), the LightCycler 480 SYBR Green I Master 
mix (catalogue number: 04887352001, Roche Diagonistics), and specific primer pairs (Table 
1). The primer pairs were designed to span large intronic sequences or to cover exon-intron 
boundaries. Gene expression was normalized to actin beta (Actb), and relative quantification 
was calculated using the comparative threshold method (ΔΔCT). 
Western Blotting – Retinas were homogenized in 0.1 M Tris-HCL (pH 8) at 4°C and the 
protein content was determined using Bradford assay. Proteins (30 µg each) were separated 
by SDS- polyacrylamide gel electrophoresis using a 10% gel, and then blotted onto a 
nitrocellulose membrane by semi-dry transfer. After blocking the membrane for 1 hr with 5% 
non-fat dry milk (Bio-Rad, Munich, Germany) in TBST (10 mM Tris/HCl[pH8], 150 mM NaCl, 
and 0.05% Tween-20) membranes were incubated overnight with the primary antibodies 
(dilution 1:500) (Table 2). This was followed by incubation with HRP-conjugated secondary 
antibodies for 1 hr at room temperature. The protein bands were then visualized using the 
Renaissance Western Blot Detection Kit (PerkinElmer Life Sciences, Boston, MA, USA). 
Immunofluorescence on retinal cryosections – Eyes were enucleated and fixed in 4% 
paraformaldehyde (PFA) overnight. The cornea and lens were removed and the eye-cups 
were transferred into a tube containing 30% sucrose in phosphate buffered saline (PBS). 
Eye-cups were then embedded in tissue cryoprotective medium (Leica Microsystems 
Nussloch GmbH, Nussloch, Germany) and snap – frozen in a 2-methylbutane bath cooled in 
liquid nitrogen. 12 µM thick sections were cut through the optic nerve head on a cryostat 
(Leica), air-dried, and stored at -80°C till further use. The retinal sections were incubated with 
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blocking solution (3% goat serum + 0.3% Triton-X in PBS) for 1 hr at room temperature. 
Then the primary antibody was applied and left at 4°C overnight (Table 2). Slides were 
washed 3 times with PBS followed by incubation with Cy2 or Cy3 conjugated secondary 
antibodies (Jackson Immunoresearch, Soham, UK) in blocking solution (dilution = 1:500) for 
1 hr at room temperature. After 3 PBS washes the sections were nuclei-stained with DAPI, 
and the slides were mounted with the anti-fade medium Mowiol (Calbiochem, San Diego, 
CA, USA). Immunofluorescently labeled proteins were visualized using an Axioplan 
fluorescence microscope (Carl Zeiss AG). 
RPE flatmount preparation and analysis - Eyes were enucleated and incubated in 2% 
paraformaldehyde (PFA) in 0.1 M phosphate buffer pH 7.4 (PB, 0.081 M Na2HPO4, 0.019 M 
NaH2PO4.3H2O) for 5 minutes. Cornea and lens were removed and the remaining tissue was 
left in PB-salt (PB containing 140 mM NaCl and 2.7 mM KCl) for 20 minutes to allow the 
retina to separate from the eyecup. The retina was removed gently and the eyecup 
containing the RPE cut into a ‘‘clover-leaf’’ shape and post-fixed in 4% PFA in PB for 1 hr. 
Flat mounts were blocked with blocking solution (3% normal goat serum, 0.3% Triton X-100 
in PBS) for 1 hr and incubated with the primary antibody anti-β-catenin (1:300 in blocking 
solution) overnight at 4°C. After washing 3x for 10 mins in PBS, Cy3- conjugated anti-mouse 
secondary antibody (1:200 in blocking solution; Jackson ImmunoResearch, Soham, UK) was 
applied for 2 hrs. Flat mounts were washed with PBS and mounted with anti-fade medium 
(10% Mowiol 4–88 (wt/vol); Calbiochem, San Diego, CA, USA; 25% glycerol (wt/vol); 0.1% 
1,4-diazabicyclo [2.2.2] octane in 100 mM Tris, pH 8.5). The RPE sheets were examined 
using a digitalized fluorescence microscope (Axioplan 2; Carl Zeiss AG).  
Four images were acquired from different quadrants of each retinal flatmount from 3 animals 
(A total of 12 images were analyzed for each genotype/condition). Quantification was done 
by manually counting the number of RPE cells. 
Lactate assay – Both retinas were isolated in a single tube and homogenized in water, 
centrifuged and the supernatant was collected for lactate determination. Reactions were 
prepared with the Lactate Rapid Test kit  (Catalogue number: LAC342, Diaglobal GmBH; 
Berlin, Germany) and measured using the Lactate Photometer Plus DP 110 (Diaglobal 
GmBH; Berlin, Germany). 
Statistical analysis – Statistical analysis was performed using Prism 4.0 software 
(GraphPad, San Diego, CA, USA). All data are presented as mean ± standard deviation 
(SD). The number of samples (N) used for individual experiments is given in the figure 
legends. Student’s t-tests were used to measure the statistical differences of means and 
differences between two groups. A P value below 0.05 was considered significant. 
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RESULTS 
Successful knockdown of Vhl and Hif1a in rod photoreceptors 
 The genomic DNA extracted from the retinas of 11 week old Opsin-Cre;Vhlflox and 
Opsin-Cre;Vhlflox;Hif1aflox mice and their corresponding controls (lacking Cre) were analyzed 
for the excision of the floxed sequence in Vhl and Hif1a. In the presence of Cre, Vhl was 
successfully excised from both Cre expressing mice (260 bp band). All mice show the 
unexcised allele (460 bp band), as the retinal genomic DNA consists of DNA from all cell 
types, whereas the excision is only in a specific cell type (rod photoreceptors). PCR for Hif1a 
resulted in the amplification of the WT allele (240 bp band) in case of the single knockdown 
mice, the floxed allele in case of the Vhlflox;Hif1aflox control mice (260 bp band) and the floxed 
and excised allele (270 bp band) in case of the Opsin-Cre;Vhlflox;Hif1aflox mice. Hence, these 
mice showed successful knockdown of the Vhl and the Hif1a gene (Figure 1A). 
 Then we analyzed whether the knockdown of Vhl resulted in stabilization of the HIF1A 
protein. Retinal protein extracts from 11 week old mice revealed increased levels of HIF1A 
and HIF2A under normoxic conditions in the Opsin-Cre;Vhlflox mice, whereas the Opsin-
Cre;Vhlflox;Hif1aflox mice had HIF2A stabilized but not HIF1A. As expected both HIF1A and 
HIF2A were also detected in animals treated with hypoxia (7% O2 for 6 hrs), but not in the 
normoxic controls. (Figure 1B). 
 Furthermore, to test if the stabilized HIF1A is transcriptionally active, we checked the 
expression of some known target genes. We observed a significant upregulation of 
Adrenomedullin (Adm), Vascular endothelial growth factor (Vegf) as well as Signal 
transducer and activator of transcription (Stat3) in the Opsin-Cre;Vhlflox mice. Moreover, the 
gene expression of Vhl and Hif2a did not vary, but Hif1a was downregulated as expected in 
the Opsin-Cre;Vhlflox;Hif1aflox mice (Figure 1C). Thus, our mice showed the inactivation of Vhl 
and Hif1a, resulting in the stabilization or absence of functionally active HIF1A under 
normoxia. 
Deletion of Hif1a rescues HIF1A-mediated degeneration phenotype 
 Earlier work in our lab showed that long-term inactivation of Vhl under normoxic 
conditions in the rods caused photoreceptor death resulting in retinal degeneration and 
functional loss (Lange et al., 2011a). This was again confirmed by morphological analysis of 
the Opsin-Cre;Vhlflox mice which, had normal retinal structure at 11 weeks but severe 
degeneration at 6 months of age. On the other hand the additional deletion of Hif1a in the 
Opsin-Cre;Vhlflox;Hif1aflox mice rescued this degeneration phenotype and the retinas of these 
mice were comparable to controls at 11 weeks and 6 months of age (Figure 2A). 
Results 
 
 38 
Quantification of the retinal thickness revealed a 30% loss in the ONL from 11 weeks to 6 
months of age, which further deteriorated by 1 year of age (data not shown). There was not 
much difference at 11 weeks, but at 6 months of age, thickness of the photoreceptor layer 
(PR), ONL and outer segments was significantly reduced in the Opsin-Cre;Vhlflox mice, while 
the double knockdown mice appeared similar to controls (Figure 2B). 
Rod-specific stabilization and inactivation of HIF1A does not have a significant effect on the 
other retinal cell types 
The RPE cells are important for the general health maintenance of the photoreceptors 
(Fuhrmann et al., 2014) and have a crucial role in the visual cycle (Bok, 1993). Hence, it is 
not a surprise that they are affected during disease processes. In AMD patients there is 
geographic atrophy caused by loss of RPE cells and photoreceptors (Holz et al., 2014), thus 
we prepared retinal flatmounts stained with beta-catenin to analyze the state of the RPE in 
our mice at 11 weeks and 6 months of age. The shape and the size of RPE cells did not vary 
between the different genotypes. In some regions of the Opsin-Cre;Vhlflox RPE the beta-
catenin appeared to have a more cytoplasmic localization, but this observation was not 
consistent (Figure 3A). Also the RPE of these mice at 6 month of age had vacant regions 
with no cells, but this is most likely an artifact from mechanical damage during tissue 
preparation. This is also supported by the evidence from immunostaining of retinal 
cryosections of 6 month-old mice with RPE65, which show that the RPE is structurally intact 
at 11 weeks and 6 months of age (Figure 3B). 
 Immunostaining on retinal cryosections at 11 weeks showed normal structure of the 
RPE, rods and cones, though in the Opsin-Cre;Vhlflox mice the structure of the retina is 
slightly disorganized especially at the outer segments and the ONL, indicating an onset of 
degeneration. There appear to be fewer SWL cones, but the levels were comparable when 
tested by qPCR (data not shown). At 6 months of age the RPE appears intact, but about 
30% of the photoreceptors are lost and the ONL is thinner as seen by the nuclear staining 
(Figure 3B). 
 One of the most important mechanisms triggered by hypoxia is angiogenesis, and 10-
15% of all AMD patients’ progress into the wet form of the disease characterized by aberrant 
vessel formation and leakage (Holz et al., 2014). Thus, we analyzed the blood vessels in 
these mice, which is elaborated in Section 3.1.2. 
Rod-specific HIF1A stabilization activates stress-pathways in the retina 
Degeneration is preceded by stress signaling pathways (Beatty et al., 2000; Samardzija et 
al., 2012) and hence, we tested some genes that are activated in stress related mechanisms. 
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We observed a significant upregulation of Caspase 1 (Casp1), CCAAT/ enhancer binding 
protein (C/EBP), delta (Cepbd), Endothelin 2 (Edn2), Fibroblast growth factor 2 (Fgf2) and 
Stat3 in the Opsin-Cre;Vhlflox mice at 11 weeks of age. This upregulation was not observed at 
6 months of age, most likely because the cells that have the HIF1A stabilized are lost by this 
age (Figure 4A). 
 When the levels of protein was tested in these mice, we observed a stabilization of 
HIF1A at 11 weeks of age in the Opsin-Cre;Vhlflox mice, with protein levels much higher than 
the controls or the Opsin-Cre;Vhlflox; Hif1aflox mice. At 6 months of age, HIF1A was still 
detected but the levels appeared comparable to the Opsin-Cre;Vhlflox; Hif1aflox. STAT3 levels 
were higher in the Opsin-Cre;Vhlflox mice and interestingly remained high at 6 months of age. 
HIF2A was detected in the Opsin-Cre;Vhlflox, Opsin-Cre;Vhlflox; Hif1aflox and hypoxic control 
mice as expected, but the levels of HIF2A was much higher in the Opsin-Cre;Vhlflox;Hif1aflox 
mice at 6 months of age, suggesting that the long-term presence of HIF2A is not detrimental 
to the photoreceptors. The phosphorylated and active form of STAT3 – pSTAT was detected 
only in the Opsin-Cre;Vhlflox mice and hypoxic controls, reiterating the relation between 
HIF1A and STAT3 (Kim et al., 2008; Pawlus et al., 2014) (Figure 4B). 
 Retinal gliosis is an early sign of stress experienced by the retina. This is observed as 
activated Muller cells and astrocytes (Pekny et al., 2014; Wang and Wong, 2014). We 
observed higher levels of GFAP proteins (marker for gliosis) in the retinal sections of Opsin-
Cre; Vhlflox mice, which further increased at 6 months of age (Figure 4C). Taken together the 
gene expression and protein levels emphasized and supported the evidence that the 
stabilization of HIF1A in photoreceptors activates stress related pathways that eventually 
result in death and degeneration. 
 For a clearer understanding of the different mechanisms involved, it is important to 
systematically analyze specific components of the stress pathways with regard to hypoxia 
and retinal degeneration. As a first step towards this goal, we compared the transcriptomes 
of the mice with Vhl inactivated in the rods to the mice lacking both Vhl and Hif1a in the rods. 
The results from this analysis are elaborated in Section 3.1.3. 
A potential shift in metabolism occurs in the Opsin-Cre; Vhlflox mice 
Normal cells produce energy by the efficient process of oxidative phosphorylation, 
whereas cancer cells produce energy by glycolysis. This metabolic shift in energy production 
is termed Warburg effect (Vander Heiden et al., 2009a). Since cancer cells thrive in a 
hypoxic microenvironment, hypoxia is implicated and HIF1A is associated with this 
phenomenon. We wanted to test if such a metabolic shift occurs in a hypoxia-like situation as 
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seen in the Opsin-Cre;Vhlflox mice. We observed an upregulation of lactate dehydrogensae a 
- Ldha (Figure 5B) and pyruvate dehydrogenase kinase 1 - Pdk1 (Figure 5A). LDHA is the 
enzyme that catalyzes the interconversion of pyruvate and lactate in the terminal step of 
glycolysis. Under aerobic conditions pyruvate enters the mitochondria to undergo oxidative 
phosphorylation, but oxygen deficiency drives lactate production (Gatenby and Gillies, 2004). 
However, when we tested the levels of lactate, the difference observed was not significant 
(Figure 5D). It is known that there are several monocarboxylate transporters (MCTs) that aid 
in the immediate and efficient efflux of the lactate produced (Bergersen and Eid, 2014), and a 
study reported that in rats the transporters – MCT1, MCT2, MCT3 and MCT 4 are distributed 
throughout the retina (Chidlow et al., 2005). A quick search through the transcriptome data 
for monocarboxylate transporters revealed that Mct4 had a 4-fold upregulation on 
stabilization of HIF1A. We could confirm this upregulation by qPCR although the variation 
within the sample group was high. (Figure 5C). In most healthy normal cells, the pyruvate 
from glycolysis is converted to Actely-CoA by the enzyme complex - pyruvate 
dehydrogensae complex (PDC). This step is regulated by the action of pyruvate 
dehydrogenase phosphatase (PDP), which activates it and PDK that inhibits it (Holness and 
Sugden, 2003). We observed a 5-fold upregulation in Pdk1 expression on stabilization of 
HIF1A (Figure 5A). In addition the catalytic and regulatory components of Pdp1 showed a 
downregulation in the transcriptome data, but we were not able to confirm this by real-time 
PCR. Nonetheless, together these observations hint towards a potential metabolic shift in the 
energy production in a HIF1A-dependent manner. 
DISCUSSION 
The Opsin-Cre;Vhlflox mice showed stabilization of HIF1A and in the Opsin-
Cre;Vhlflox;Hif1aflox mice both Vhl and Hif1a were inactivated in the rod photoreceptors (Figure 
1A and 1B). On deletion of Vhl, HIF1A protein was stabilized and functional as observed by 
the upregulation of some target genes – Adm, Vegf and Stat3 (Figure 1C). Adm encodes for 
a small signal peptide shown to be hypoxia regulated and a HIF1A target (Sena et al., 2014). 
VEGF is involved in angiogenesis and implicated in wet AMD (Mitchell, 2011). STAT3 is 
transcription factor involved in stress signaling. Some studies have suggested that HIF1A 
and STAT3 together modulate the expression of Vegf (Jung et al., 2005).  
The inactivation of Vhl results in the accumulation of stable HIF1A and HIF2A 
proteins, and this results in severe degeneration and loss of function (Lange et al., 2011a). 
We observed that this degeneration is due to HIF1A and not HIF2A, as the additional 
deletion of Hif1a with Vhl, resulted in the rescue of phenotype. The Opsin-Cre;Vhlflox;Hif1aflox 
mice had a retinal morphology comparable to controls at 6 months of age (Figure 2A). In 
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addition the stable HIF1A protein was detected in the Opsin-Cre;Vhlflox at 11 weeks of age, 
but not at 6 months of age, most likely because the cells accumulating HIF1A were lost by 
this age. HIF1A protein was not detected in the double knockdown mice. HIF2A protein was 
detected in both genotypes at 11 weeks of age, and the levels were even higher in the 
double knockdown mice at 6 months of age (Figure 4B), further confirming that the 
accumulation of HIF1A and not HIF2A results in photoreceptor death and degeneration. 
Degeneration was also observed by immunohistochemistry, where there was a clear 
reduction in rhodopsin staining and thinning of the ONL at 6 months of age (Figure 3B). Also 
the rod specific transducin – Gnat1 gene expression levels were significantly reduced at 6 
months of age (Figure 4A).  
RPE atrophy is one of the main clinical features of AMD (Holz et al., 2014); therefore 
we proceeded to test the effect of HIF1A stabilization and inactivation in the rods on the RPE 
structure and function. The RPE flatmounts stained with beta-catenin at 11 weeks and 6 
months of age did not show any major differences in structure and number (Figure 3A). 
However, in several areas of the 6-month-old Opsin-Cre;Vhlflox retinal flatmounts, beta-
catenin did not have a clear localization at the cell membranes, but was present in the 
cytoplasm as well as the nucleus (Figure 3A). Beta-catenin has dual and distinct functions in 
the cell - it maintains cellular structural integrity as part of the adherens junction and also acts 
as a transcription factor (Ben-Ze'ev, 1999). A study on RPE cells in vitro showed that 
oxidative stress affected the integrity of the cells and caused cytoplasmic localization of beta-
catenin (Bailey et al., 2004). Hence, the nuclear and cytoplasmic localization may hint 
towards secondary effects of the hypoxia-like situation and death of photoreceptors on the 
RPE. At 11 weeks and 6 months of age the RPE is intact as also evidenced by the 
immunohistochemical analysis (Figure 3B). It would be important to investigate the RPE 
changes at older age when most photoreceptors are lost. 
STAT3 signaling is activated on phosphorylation (Imada and Leonard, 2000), and the 
phosphorylated STAT3 (pSTAT3) was observed only in the Opsin-Cre;Vhlflox mice, 
suggesting the activation of JAK-STAT pathway on stabilization of HF1A. But interestingly, 
the levels of Stat3 gene (Figure 4A) and of pSTAT3 protein remained high even at 6 months 
of age (Figure 4B), when most of the HIF1A-stabilized cells are probably lost suggesting that 
Vhl deletion may cause HIF1A stabilzation by a STAT3 mediated mechanism. But this might 
not be the case, as the pSTAT3 is not detected in the Opsin-Cre;Vhlflox; Hif1aflox mice, 
indicating the requirement of HIF1A for STAT3 activation. Hence, it is likely that HIF1A 
activates mechanisms that result in STAT3 activation in adjacent cells types, and these 
mechanisms persist even after HIF1A-stabilzed cells are lost, and may be responsible for the 
near complete degeneration observed at older age. Additional investigations to test STAT3-
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mediated mechanisms in different retinal cell types will be essential to establish and 
understand this connection. 
Cells produce energy in the cytoplasm by glycolysis and further by a more efficient 
mitochondrial mechanism of oxidative phosphorylation. In cancer cells mutations in 
mitochondrial genes (Gasparre et al., 2013), hypoxia (Weljie and Jirik, 2011), and lower ATP 
content (Vander Heiden et al., 2009b) are all reasons for tumor cells to switch from oxidative 
phosphorylation to glycolysis (Warburg effect) (Stubbs and Griffiths, 2010; Vander Heiden et 
al., 2009a). Relying on glycolysis for extended periods of time may result in energy 
deprivation as lesser energy is produced from this process compared to oxidative 
phosphorylation (Stubbs and Griffiths, 2010). The gene expressions for all three subunits of 
Ldh were tested in the normal WT retinas. Ldha had a very high expression in the retina, and 
very low levels of Ldhb and Ldhc were detected (data not shown). Ldha levels were higher in 
Opsin-Cre;Vhlflox mice, but this did not result in a significant accumulation of lactate (Figure 
5B and D). There could be two reasons - LDH can drive the pyruvate to lactate conversion 
and vice versa, depending on the availability of NADH and NAD+, so lactate can be 
converted back to pyruvate. This could be tested by measuring the levels of pyruvate in 
these mice. Another more likely possibility is that the lactate produced is immediately 
shuttled away from the cells into the blood stream for clearance (Bergersen and Eid, 2014) or 
for usage as a metabolite by other cell types (Brooks, 2009). This is supported by the higher 
levels of the transporter Mct4 that we observed in the mice with Ldha upregulation. Mct4 was 
tested because it was the only transporter that showed a 4-fold upregulation in the 
transcriptome analysis. It would be crucial to observe the localization of the MCT4 protein in 
the retina for a better understanding of mechanisms involved. Apart from the occurrence of 
aerobic glycolysis an important aspect of this effect is the reduction of oxidative 
phosphorylation. We observed a 5-fold upregulation of Pdk1 (Figure 5A), which inhibits the 
PDC complex hence preventing the entry into the mitochondrial energy processes. This has 
been shown in several studies to be one of the crucial indicators of Warburg effect (McFate 
et al., 2008). Taken together, these observations strongly hint towards a potential metabolic 
shift in the retinas with HIF1A stabilized and further testing of specific metabolites and 
proteins in the different mice will be required to confirm this hypothesis. 
In conclusion the stabilization of HIF1A in the rod photoreceptors results in activation 
of stress related pathways and a potential metabolic shift in energy production mechanisms 
that may eventually result in retinal degeneration. These changes observed are essentially 
due to HIF1A and not HIF2A; hence targeting Hif1a could be potentially used as a therapy to 
rescue hypoxia-mediated degeneration in the aged retinas. 
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FIGURE LEGENDS 
Figure 1. Successful knockdown of Vhl and Hif1a in the rod photoreceptors. (A) PCR 
amplification of the floxed and excised fragments of the Vhl and Hif1a gene from the genomic 
DNA isolated from total retinal tissue of 11 week old mice. The floxed and excised fragments 
of the Vhl allele have lengths of 460 bp and 260 bp respectively, and the amplified fragments 
of the Hif1a excised, floxed and wt allele have lengths of 270 bp, 260 bp and 240 bp 
respectively. (B) Western blot analysis of HIF1A and HIF2A protein levels in (CRE-) and 
(CRE+) Vhlflox and Vhlflox;Hif1aflox mice at 11 weeks of age, and control mice [N-Normoxia, H-
Hypoxia (6 hr at 6% O2), LD-Light damage (2 hr at 13000 lux)]. ACTB served as the loading 
control. (C) Relative gene expression of Adm, Vegf, Stat3, Vhl, Hif1a and Hif2a in (CRE-) 
controls (black bars), Opsin-Cre; Vhlflox (red bars) and Opsin-Cre;Vhlflox;Hif1aflox mice (blue 
bars) at 11 weeks of age. . Expression was determined by semi-quantitative real-time PCR, 
normalized to Actb and expressed relative to the levels in Vhlflox (set to 1). Shown are mean 
values ± SD of N = 3. Significance was tested using the Student’s t-test (* P < 0.05, ** P < 
0.01, ns-not significant). 
 
Figure 2. Deletion of Hif1a rescues HIF1A-mediated degeneration phenotype. (A) Retinal 
morphology of Vhlflox;Hif1aflox, Opsin-Cre;Vhlflox and Opsin-Cre;Vhlflox;Hif1aflox mice at 11 
weeks and 6 months of age. Shown are representative images of N = 3 retinas per genotype 
and time point. Scale bar: 50 µM. (B) Retinal thickness measured across the retina and 
averaged for four different regions in 3 sections per retina (total of 12 images measured for 
each genotype). Shown are measurements of the photoreceptor layer (PR), outer nuclear 
layer (ONL), inner segments (IS) and outer segments (OS) at 11 weeks and 6 months for the 
Vhlflox;Hif1aflox (black bars), Opsin-Cre;Vhlflox (red bars) and Opsin-Cre;Vhlflox;Hif1aflox (blue 
bars). Measurements in each group are normalized to the control - Vhlflox;Hif1aflox (100%). 
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Shown are mean values ± SD for N = 3. Significance was tested using Student’s t-test (* P < 
0.05, ** P < 0.01, *** P < 0.001, ns- not significant). 
 
Figure 3. Rod-specific stabilization and inactivation of Hif1a does not have a significant 
effect on the other retinal cell types. (A) RPE flatmounts of the different genotypes at 11 
weeks and 6 months of age, immunostained for β-catenin. Shown are representative images 
of N = 3 mice per genotype. The number of RPE cells was counted from 12 images per 
genotype (4 images of N = 3 mice). (B) Retinal cryosections of the different genotypes 
immunostained for RPE65 (RPE), rhodopsin (Rod photoreceptors), cone-SWL (Short 
wavelength cone photoreceptors) and co-stained with DAPI (nucleus) at 11 weeks and 6 
months of age. Scale bar: 50 µM  
 
Figure 4. HIF1A stabilization results in activation of stress related mechanisms. (A) Relative 
gene expression of Casp1, Cepbd, Edn2, Fgf2, Gnat1 and Stat3 in (CRE-) controls (black 
bars), Opsin-Cre;Vhlflox (red bars) and Opsin-Cre;Vhlflox;Hif1aflox mice (blue bars) at 11 weeks 
and 6 months of age. Expression was determined by semi-quantitative real-time PCR, 
normalized to Actb and expressed relative to the levels in Vhlflox (set to 1). Shown are mean 
values ± SD of N = 3. Significance was tested using Student’s t-test (* P < 0.05, ** P < 0.01, 
*** P < 0.001). (B) Western blot analysis of HIF1A, STAT3 and pSTAT3 protein levels in 
(CRE-) and (CRE+) Vhlflox and Vhlflox;Hif1aflox mice at 11 weeks and 6 months of age, and 
control mice [N-normoxia, H-hypoxia (6 hr at 6% O2), LD-light damage (2 hr at 13000 lux)]. 
ACTB served as the loading control. (C) Retinal flatmounts immunostained for GFAP and co-
stained with DAPI (nucleus) at 11 weeks and 6 months of age. Scale bar: 50 µM. 
 
Figure 5. Potential metabolic shift occurs on stabilization of HIF1A. Relative gene expression 
of (A) Pdk1, (B) Ldha and (C) Mct4 in (CRE-) controls (black bars), Opsin-Cre;Vhlflox (red 
bars) and Opsin-Cre;Vhlflox;Hif1aflox mice (blue bars) at 11 weeks and 6 months of age. 
Expression was determined by semi-quantitative real-time PCR, normalized to Actb and 
expressed relative to the levels in Vhlflox (set to 1). (D) Lactate levels in (CRE-) controls (black 
bars), Opsin-Cre; Vhlflox (red bars) and Opsin-Cre; Vhlflox; Hif1aflox mice (blue bars) at 11 
weeks of age, represented relative to the levels in Vhlflox (set to 1). Shown are mean values ± 
SD of N = 3. Significance was tested using the Student’s t-test (* P < 0.05, ** P < 0.01, *** P 
< 0.001).  
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Table 1. Primers used for semiquantitative real-time PCR 
 
Gene Forward primer Reverse primer Annealing temp (°C) 
Amplicon 
(bp) 
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 62 153 
Adm TTCGCAGTTCCGAAAGAAGT GGTAGCTGCTGGATGCTTGTA 62 77 
Casp1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC 60 138 
Cebpd CTTTTAGGTGGTTGCCGAAG GCAACGAGGAATCAAGTTTCA 60 70 
Edn2 AGACCTCCTCCGAAAGCTG CTGGCTGTAGCTGGCAAAG 60 64 
Fgf2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG 62 158 
Gnat1 GAGGATGCTGAGAAGGATGC TGAATGTTGAGCGTGGTCAT 58 209 
Hif1a TCATCAGTTGCCACTTCCCCA CCGTCATCTGTTAGCACCATC 60 198 
Hif2a GGAGCTCAAAAGGTGTCAGG CAGGTAAGGCTCGAACGATG 60 61 
Ldha GGCACTGACGCAGACAAG CTCATTGATTCCATAGAGAC 62 201 
Mct4 CCGCTCTGCAGTGTGTGTGT GCCAGACCCAAGCCAGTGAT 62 155 
Pdk1 GTTGAAACGTCCCGTGCT AGTCTCCTCGACGGATTCTGT 62 170 
Stat3 CAAAACCCTCAAGAGCCAAGG TCACTCACAATGCTTCTCCGC 62 133 
Vegf ACTTGTGTTGGGAGGAGGATGTC AATGGGTTTGTCGTGTTTCTGG 60 171 
Vhl GAGGGACCCGTTCCAATAAT TTGGCAAAAATAGGCTGTCC 60 364 
 
 
 
Table 2. Antibodies used for immunofluorescence on retinal sections/ flatmounts 
 
Protein Host Supplier Catalogue number Dilution 
RPE65   rabbit Pineda antibodies, Berlin, Germany Pin-5 1:500 
RHO mouse Sigma, st. Loiuis, MO, USA O4886 1:1000 
Cone-SWL goat Santa Cruz, Dallas, TX, USA Sc-14363 1:500 
Beta - catenin rabbit BD Biosciences, Allschwill, Switzerland 610153 1:300 
GFAP mouse Sigma, st. Loiuis, MO, USA G3893 1:500 
500  
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3.1.2. Analysis of retinal vessels 
 
Figure 7. Analysis of the fundus and the leakage of blood vessels. Images of the fundus (top) and the 
retinal blood vessels - fluorescein angiography (bottom) of the Opsin-Cre;Vhlflox and Opsin-
Cre;Vhlflox;Hif1aflox and their corresponding controls - Vhlflox and Vhlflox;Hif1aflox (lacking the CRE) 
mice at 11 weeks and 6 months of age. Shown are representative images from N= 3 for each genotype 
at each time point. 
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Figure 8. Analysis of the primary, intermediate and deep plexus of retinal blood vessel layers. Retinal 
flatmounts of the Opsin-Cre;Vhlflox and Opsin-Cre;Vhlflox;Hif1aflox and the corresponding controls - 
Vhlflox and Vhlflox;Hif1aflox (lacking the CRE), immunostained for blood vessels (with Isolectin) at 11 
weeks and 6 months of age. Images for each layer are acquired separately and digitally post-
processed in different colors – red (deeper plexus), green (intermediate plexus) and blue (primary 
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plexus). The bottom panel shows a merged image of all three layers. Shown are representative images 
from N= 3 for each genotype at each time point. 
Analysis of retinal vessels 
The retina relies on the choroid and the retinal vasculature for supply of oxygen and 
nutrients, hence vessel dystrophy is often observed as a cause or consequence during 
retinal degeneration.  We analyzed the vessels by fluorescein angiography, but did not 
observe any particular anomalies. In some mice a scar was seen in the fundus images with 
corresponding vessel leakage (arrow in Figure 7), but these were observed only in a few 
mice (also in the controls). We repeated the analyses for these mice at later time points (4, 6, 
9 and 12 months) to monitor the development or changes. But in most cases the scars and 
the corresponding leakage remained the same (data not shown). In the fundus images of the 
Opsin-Cre;Vhlflox mice dark spots were observed due to the degeneration process, already at 
11 weeks of age and these were particularly distinct at 6 months of age. 
Retinal flatmounts were prepared and immunostained for the blood vessels. Then 
each of the layers – superficial, intermediate and deep plexus, was imaged separately. At 11 
weeks of age, the deep plexus of the Opsin-Cre;Vhlflox mice seem less dense. There were 
some differences in the intermediate layer too, but these were more difficult to discern, as the 
layers could not be distinguished well, so the images of deep and intermediate layers appear 
merged. This distinction becomes even more difficult at 6 months of age as due to the 
degeneration and thinning of the retina, the layers seem to be overlapping. Nonetheless, 
there were no major differences in the vessel structure as seen in the flatmounts, and no 
vessel leakage, as seen by fluorescein angiography.  
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3.1.3. Testing siRNAs against Hif1a 
Long-term stabilization of HIF1A in the rods results in degeneration whereas in mice lacking 
HIF1A the retina is intact. Hence as a future therapeutic approach, we wanted to test the 
rescue of phenotype in Opsin-Cre;Vhlflox mice by knock-down of Hif1a by RNA interference 
using small-interfering RNAs (siRNAs). The siRNA sequences could be used to design small 
hairpin RNAs (shRNAs), as they are more stable upon transfection and less likely to be 
degraded by cellular RNAses. The shRNA would be then packaged into adeno-associated 
vector – AAV2/8, which has been shown to successfully target the photoreceptors (Koch et 
al., 2012). The Hif1a-shRNA packaged into AAVs can then be injected sub-retinally into the 
Opsin-Cre;Vhlflox mice to test for the rescue of the degeneration phenotype (Figure 9A). For 
this 4 different pre-designed sequences were ordered from a company (Dharmacon, Wohlen, 
Switzerland) and tested in NIH3t3 cells after 6 hours hypoxia. Seq1 was not efficient, Seq2, 
Seq3 and Seq4 were able to knock-down Hif1a, with Seq2 being the most efficient 
(Figure9B). From Seq2 we would need to design the shRNA and testing the shRNA requires 
an expression vector.  
We received a plasmid expressing shRNA against Hif1a (Hif1a-shRNA-IF) (kindly 
provided by Prof.Ian Frew) and decided to test the efficiency of this sequence compared to 
Seq2. The functional part of this shRNA (named siRNA-IF) was ordered for testing. Both the 
Seq2 and siRNA-IF were equally efficient in the knock-down of Hif1a (Figure 9A)  
Sequencing of the Opsin-Cre;Vhlflox mice revealed some differences in binding 
regions of the siRNAs in the mouse and human Hif1a sequence – 2 bp difference for Seq2 
and 1 bp difference for siRNA-IF (Figure 9D). Hence, we ordered human and mouse specific 
sequences of both Seq2 and siRNA-IF. These were then tested in mouse cells (NIH3t3) and 
human cells (HEK). And we observed that the mouse specific sequence was efficient in 
mouse cells while the human sequence was not efficient and vice versa, even though the 
difference is in just 1-2 bp. The Hif1a-shRNA-IF received is mouse specific, but in the future 
if this is translated for gene therapy experiments in mice or human clinical trials then care 
has to be taken to design very specific sequences. The Hif1a-shRNA-IF plasmid was sent to 
our collaborators (Prof. Martin Biel’s lab in LMU, Munich, Germany) for cloning and 
packaging into the AAVs. 
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Figure 9. In vitro testing of siRNAs against Hif1a. (A) Schematic representation of the intended use of 
the siRNAs for silencing the Hif1a gene in the Opsin-Cre;Vhlflox mice to rescue the degeneration 
phenotype. (B) Western blot analysis of HIF1A in NIH3t3 cells kept at hypoxia (H) - 0.2% O2 or 
normoxia (N) for 2, 4, 6 and 8 hours. bACTIN was used as the loading control. (C) Western blot 
analysis for HIF1A after treatment with 4 different siRNAs against Hif1a – Seq1, Seq2, Seq3 and 
Seq4, scrambled siRNA (-ve control) and untransfected control (untrans). (D) Specific binding regions 
of the Hif1a siRNAs. The UTR is in red, exons in yellow, Seq1, Seq2, Seq3 and Seq4 are shown as 
purple arrows, and the sequencing primers are shown as green arrows. The short interfering portion 
of the Hif1a-shRNA-IF is shown as a pink arrow.  
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Figure 10. Testing of human and mouse specific Hif1a siRNAs. (A-B) Western blot analysis of HIF1A 
in NIH3t3 cells (A) and HEK cells (B) treated with mouse and human Hif1a-specific sequences for 
siRNA-2 and siRNA-IF. Treated cells were kept at hypoxia (H) – 0.2% O2 for 6h or normoxia (N). 
Controls were treated with scrambled siRNA (+) or left untransfected (-). bACTIN was used as the 
loading control. (C) The sequence of Hif1a-shRNA-IF showing the functional short interfering portion 
(siRNA-IF) as a pink arrow, the hairpin loop as a green arrow and the stem forming the sequence as 
purple arrows. (D) The mouse and human specific sequences of siRNA-2 and siRNA-IF with the 
differences highlighted in red. 
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3.2. HIF1A target genes in the retina 
3.2.1 Transcriptome analysis 
The Opsin-Cre;Vhlflox mice have HIF1A and HIF2A stabilized while the Opsin-
Cre;Vhlflox;Hif1αflox mice lack HIF1A in the rod photoreceptors. Since HIF1 is a major 
transcription factor involved in regulation of many genes, these mice can be used to identify 
the HIF1 target genes in the rods. Retinas were isolated from 10-12 week old animals (N = 3) 
of the following genotypes - Vhlflox;Hif1αflox (control), Opsin-Cre;Vhlflox (single knock-down) 
and Opsin-Cre;Vhlflox;Hif1αflox (double knock-down) and the transcriptomes were acquired as 
described earlier (Methods – 3.1.1). 
Generation of lists – A list of genes was generated by comparing the transcriptomes of the 
Opsin-Cre;Vhlflox samples to Opsin-Cre;Vhlflox;Hif1αflox samples. This list should contain all the 
HIF1 target genes in the rods. The list was filtered to get results with pValue < 0.05 for the 
upregulated genes and pValue < 0.5 for the downregulated genes. Similarly filtered lists were 
generated by comparing the control with the single knock-down. This list should comprise of 
all the genes regulated by HIF1 as well as HIF2 (HIF2A is VHL-regulated by mechanisms 
similar to HIF1A). Further a third list was acquired by comparing the control to the double 
knock-down wherein only HIF2 is present and hence the list must essentially comprise of 
HIF2A target genes. These were then sorted starting from the maximum fold change and the 
top 50 genes in each category are listed in Table 1. 
Functional groups – All the upregulated genes from the first list (double vs single) were 
entered into the online analysis software – DAVID. This resulted in Table 2, which is a list of 
all the functional groups [enrichment scores between 17.02 (group1) to 0.07 (group9)]. The 
group 1 comprises of crystallins, which are major proteins in the lens – this could indicate a 
contamination from the lens in the retinal tissues. But there have been some recent studies 
showing enzymatic activities of certain crystallins as well as their expression in the retina 
(Jones et al., 1999; Magabo et al., 2000). Hence, it would be worthwhile to test the role of 
crystallins in the healthy and degenerating retina, especially in connection with hypoxia. The 
group 2 consisted of several secreted proteins, some (Angptl7, Rspon1, Bpil3, Stc2) of which 
have been implicated in hypoxic mechanisms. The group 4 consists of complement factors, 
which are implicated in AMD and hence were analyzed further (3.2.2). 
Validation of selected candidates – Some of the HIF1A regulated candidates from the list 
were selected to verify the transcriptome data - Alpha 2 macroglobulin (A2M) is a large 
plasma protein that acts as an anti-protease and inactivates various proteinases. It is 
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implicated in Alzheimer’s disease, which is an age-related progressive degenerative disease 
(Blacker et al., 1998; Rudrasingham et al., 1999). A disintegrin and metalloproteinase with 
thrombospondin motifs 4 (ADAMTS4) is an enzyme responsible for the degradation of 
aggrecan (a proteoglycan of the cartilage) and brevican (a brain specific extra-cellular matrix 
protein) (Nakamura et al., 2000; Song et al., 2007). Adrenomedullin (ADM) is a peptide 
hormone that has been shown to be hypoxia regulated and may function as a vasodilator 
(Deville et al., 2010). Caspase 1 (CASP1) is an enzyme with proteolytic functions that is 
involved in developmental apoptosis, and has been shown to be hypoxia-mediated (Kim et 
al., 2003). Chemokine (C-C motif) ligand 2 (CCL2) is chemokine that recruits immune cells 
and is involved in inflammation and has been shown to be HIF1-regulated (Mojsilovic-
Petrovic et al., 2007). CCAAT/enhancer-binding protein delta (CEBPD) is a transcription 
factor that is involved in the regulation of apoptosis and cell proliferation (Balamurugan and 
Sterneck, 2013). Cleavage and polyadenylation specific factor 3-like (CPSF3L) is a protein 
involved in RNA processing as part of an integrator protein which is composed of 12 subunits 
(CPSF3L is subunit 11 of the integrator) (Baillat et al., 2005). Endothelin 2 (EDN2) is a 
protein shown to be hypoxia induced in many systems, has vasocontrictive functions (Ling et 
al., 2013), and is involved in angiogenesis in the retina (Rattner et al., 2013). Basic fibroblast 
growth factor (FGF2) is a protein present in the basement membrane, is involved in 
angiogenesis and shown to reduce retinal degeneration in rats (Lau et al., 2000). Glial 
fibrillary acidic protein (GFAP) is present in the activated retinal astrocytes and glia cells and 
indicates stress and gliosis (Erickson et al., 1987; Grosche et al., 1995). Glycosylation-
dependent cell adhesion molecule-1 (GLYCAM1) is a proteoglycan ligand expressed in 
endothelial cells in lymph nodes. It is able to bind to the receptor L-selectin and attracts 
leukocytes to site of inflammation (Suguri et al., 1996). Ladinin-1 (LAD1) is a protein 
component of the basement membrane and is responsible for maintaining stability of the 
ECM (Motoki et al., 1997). Leukemia inhibitory factor (LIF) is an interleukin 6 class cytokine 
that affects cell growth by inhibiting differentiation. The cytokine binds to the LIF receptor and 
activates the JAK/STAT and the MAPK pathways (Kunisada et al., 1996). In the retina Lif is 
expressed in Muller cells and has been shown to have protective and prosurvival properties 
(Joly et al., 2008). Lysyl oxidase like 4 (LOXL4) is elevated in Head and neck carcinoma and 
may be involved in oxidative stress (Molnar et al., 2003). Myosin VII A (MYO7A) is a 
mechanochemical protein and part of the myosin family. It is implicated in Usher syndrome (a 
rare genetic disorder resulting in deafness and visual impairment) (Williams and Lopes, 
2011). Neuregulin 4 (NRG4) belongs to a family of proteins that bind to the EGF receptors 
and may mediate prosurvival mechanisms (Falls, 2003). Oocyte specific homeobox 6 
(OBOX6) is a protein involved in development although the Obox6 null mice developed 
normally and were fertile (Cheng et al., 2007). Peroxisome proliferator activated receptor 
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alpha (PPARA) is a nuclear receptor and a transcription factor that is activated during energy 
deprivation (Kliewer et al., 1994). Pituitary tumor-transforming gene 1 (PTTG1) is involved in 
cell-cycle regulation and the Pttg1 nulll mice have normal retinal morphology and function 
(Yetemian and Craft, 2011). Smoothelin like-2 (SMTNL2) is not well characterized but a 
study showed it to be part of the MAPK pathway (Gordon et al., 2013). Signal transducer and 
activator of transcription 3 (STAT3) is a transcription factor that is activated by various 
cytokines and acts via the JAK/STAT pathway. In the retina Stat3 was shown to promote 
survival of photoreceptors in inherited degeneration models (Jiang et al., 2014). 
Stanniocalcin 2 (STC2) is a secreted glycoprotein upregulated in several cancers and shown 
to be involved in store operated calcium entry (Zeiger et al., 2011). Transglutaminase 3 
(TGM3) is an enzyme that catalyzes cross-linking of peptides in a calcium dependent 
manner and implicated in dermatitis (Taylor et al., 2015). Vascular endothelial growth factor 
(VEGF) is a secreted protein, which is hypoxia-regulated and involved in angiogenesis 
(Ferrara et al., 2003). Anti-VEGF is provided as a therapy for wet AMD (Mitchell, 2011). Most 
of the genes tested showed the expected trend – A2M, Adm, Casp1, Cebpd, Edn2, Fgf2, 
Gfap, Lad1, Lif, Loxl4, Obox6, Smntl2, Stat3, Stc2 and Vegf were upregulated significantly in 
the Opsin-Cre;Vhlflox mice compared to the Opsin-Cre;Vhlflox;Hif1aflox mice. Myo7a and Pttg1 
were downregulated, but there was variation in the expressions of these genes in the 
controls as well. Some of the genes – Adamts4, Ccl2, Cpsf3l, Glycam1, Nrg4, Tgm3 and 
Ppara did not show differential regulation, although these genes were shown as highly 
upregulated in the gene chip analysis (Figure 11). 
 HIF1 is a major transcription factor, and hence the genes regulated by HIF1 may be 
involved in many signaling pathways. The activation of these pathways could then further 
cause upregulation of other genes, which may not be direct targets of HIF1. Hence, many of 
the upregulated genes in the transcriptome data could be due to a secondary effect of HIF1A 
stabilization. Additionally the VHL complex could be involved in the other cellular 
mechanisms, and thus effects of mechanisms unrelated to HIF1A cannot be excluded. 
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Figure 11. Validation of selected genes from the transcriptome data. Relative expression of the 
selected genes in Vhlflox (black bars), Opsin-Cre;Vhlflox (red bars), Vhlflox;Hif1aflox (black bars) and 
Opsin-Cre Vhlflox;Hif1aflox (blue bars) mice at the age of 11 weeks. Expression was determined by 
semi-quantitative real-time PCR, normalized to Actb and shown relative to the levels in Vhlflox (set to 
1). Shown are mean values ± SD of N = 3. Significance was tested using Student’s t-test (* P < 0.05, 
** P < 0.01, *** P < 0.001). 
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3.2.2 Complement hypothesis and analysis 
AMD is a multi-factorial disease and there are several features of the disease that manifest 
to varying degrees in different patients. Some age-related changes such as drusen 
accumulation, inability of the RPE cells to clear oxidation products and lipofuscin, 
choriocapillary changes affecting the oxygen supply to the outer retina and thickening of the 
bruch’s membrane result in the photoreceptors experiencing mild but chronic hypoxia. This 
led to the hypothesis that the aged retina is hypoxic. In addition genetic factors might 
contribute to aggravating these features resulting in the diseased situation (AMD). Hypoxic 
response is carried out by the transcription factors HIF1 and HIF2, although their levels have 
never been directly tested in diseased patients. Furthermore, biochemical analysis of drusen, 
which is one of the disctinctive features of AMD revealed that it is composed of fragments of 
complement factors (C3a, C3b, CFB, C5 and C5a) and other proteins. Linkage studies have 
shown mutations in complement factors (C3, Cfh, C2, Cfb) are highly correlated with AMD 
(Anderson et al., 2010).  
Complement hypothesis 
 
Figure 12. Hypoxia and complement hypothesis for AMD. Age-related changes in the bruch’s 
membrane (BM), choriocapillaries (CC) and retinal pigment epithelium (RPE) restrict the oxygen and 
nutrient supply to the outer retina causing hypoxia. This leads to the stabilization of HIF1A and 
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HIF2A, which may result in an upregulation of complement factors. Chronic hypoxia will result in 
accumulation of these factors, which may accumulate as drusen and aggravate the symptoms. 
Our transcriptome data revealed that HIF1A stabilization in the rod photoreceptors resulted in 
the upregulation of several complement factor genes (Table 2- Group4). Also these mice 
showed an age-related degeneration (3.1.1). Hence, we hypothesized that maybe hypoxia in 
the outer retina results in stabilization of HIF1A and this leads to an upregulation of 
complement factors. These factors are not completely cleared away, accumulate over time 
near the bruch’s membrane and form a diffusion barrier, The resulting nutrient and oxygen 
deprivation aggravates the symptoms, eventually leading to death of photoreceptors and 
degeneration. (Figure 12) 
Complement factors are upregulated on HIF1A stabilization 
The expression of complement factor genes were tested in the Opsin-Cre;Vhlflox and 
the Opsin-Cre;Vhlflox;Hif1aflox mice from 11 weeks to 1 year of age. There were huge 
variations in the C3 expression and the levels were much reduced in all the older mice 
(including controls). C4b expression was generally higher on HIF1A stabilization (in Opsin-
Cre;Vhlflox mice). Cfb and Cfh did not appear to be affected much. Cfi and Serping1 were 
slightly upregulated in the younger mice and the effect was lost at older age. Though the 
standard deviations were high due to variation among animals in the same genotype group, 
we observed a general trend in the upregulation of complement factors in the Opsin-
Cre;Vhlflox mice. (Figure 13) 
We also looked at the C3 and CFH protein levels on retinal cryosections of these 
mice. But the immunohistochemical analysis did not produce relaiable results, most likely 
because even the upregulated levels are very low and may be below the detection limit. The 
C3 protein appeared as puncta-like structures near the RPE in some sections. But this 
localization was not consistently observed (data not shown). We analyzed the promoter 
region of C3 and Cfb genes for HRE elements but did not find any canonical HIF binding 
regions. Also a literature search did not show any work suggesting complement factors to be 
targets of HIF1A. Hence, it is likely that complement factors are upregulated indirectly or by 
other mechanisms that are hypoxia and HIF1A regulated. 
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Figure 13. Upregulation of complement factor genes on HIF1A stabilization. Relative expression of 
C3, C4b, Cfb, Cfh, Cfi and Serping1 in Vhlflox (black bars), Opsin-Cre; Vhlflox (red bars), Vhlflox; 
Hif1aflox (black bars) and Opsin-Cre; Vhlflox; Hif1aflox (blue bars) mice at the age of 11 weeks, 4 
months, 6 months and 1 year. Expression was determined by semi-quantitative real-time PCR and 
normalized to Actb. Shown are mean values ± SD of N = 3.  
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Complement factors are upregulated during degeneration 
 Since complement factors did not seem to be direct targets of HIF1 we wanted to test 
if these factors are upregulated during the degeneration process. Thus, we analyzed the 
expression of these genes in WT mice (C57BL/6) and a model for inherited degeneration 
(rd10) mice. We observed a significant upregulation of these factors after PND21 in the rd10 
mice. The degenerative processes already begin by PND21 and by PND56 most 
photoreceptors are lost in the rd10 mice (Samardzija et al., 2012). Most of these factors 
seem to peak between PND42 and PND56 after the peak of degeneration (between PND18-
PND21) and then eventually the levels lower, although they are still higher than the controls 
at PND180. Taken together with the previous data, we could conclude that maybe in the 
Opsin-Cre;Vhlflox mice the stabilization of HIF1A might activate mechanisms resulting in 
degeneration. During these processes complement factors are upregulated not directly by 
HIF1A. Additionally HIF1A is stabilized in the rods of these mice, but in the rd10 mice the 
complement factor genes are upregulated even after loss of all rods, suggesting that other 
cell types might be expressing the complement factors. 
 
Figure 14. Upregulation of complement factor genes during degneration. Relative expression of C3, 
C4b, Cfb, Cfh, Cfi and Serping1 in WT- C57BL/6 (black line) and rd10 (red line) mice from PND10 to 
PND180 (X-axis). Expression was determined by semi-quantitative real-time PCR and normalized to 
Actb. Shown are mean values ± SD of N = 3. Significance was tested using Student’s t-test (* P < 
0.05, ** P < 0.01, *** P < 0.001). 	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3.2.3 Study of a HIF1A target gene - Stanniocalcin 2 
The comparison of transcriptomes of the Opsin-Cre;Vhlflox and Opsin-Cre;Vhlflox;Hif1aflox mice 
revealed the differential regulation of several genes. One of these – Stanniocalcin 2 (Stc2), 
had a 14-fold upregulation in the Opsin-Cre;Vhlflox mice (HIF1A is stabilized in rod 
photoreceptors). A literature search showed several studies in cancer cells wherein Stc2 and 
its paralog Stc1 were upregulated. Since the tumor microenvironment is hypoxic and HIF1A 
is implicated in cancer, Stanniocalcins may indeed play an important role in hypoxic 
mechanisms. The gene chip results were validated by semi-quantitative RT-PCR and the 
Stc2 upregulation was confirmed. As hitherto there has been no study of stanniocalcins in 
the retina, we aimed to characterize this further. Our data suggest that in the retina only Stc2 
and not Stc1 is hypoxia responsive and is a target of HIF1A. Intriguingly the protein localized 
at the neurofilaments although in Opsin-Cre;Vhlflox mice used for the initial transcriptome 
analysis, the stabilization of HIF1A was in rod photoreceptors. Furthermore, by extracting 
RNA from the separate layers by laser capture microdissection (LCM) we were able to show 
that the normal expression of Stc2 is in the INL and GCL of WT mice, whereas there was a 
strong upregulation in the ONL of the Opsin-Cre;Vhlflox mice. Retinal morphologies of the 
Stc2-/- and Stc1-/- mice were comparable to WT controls. This study serves as a first report 
of expression and hypoxic regulation of stanniocalcins in the retina. To understand exact 
molecular/ cellular mechanisms and function of STC2 in the neurofilaments further 
investigation would be required. 
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In the retina, Stc2 and not Stc1, responds to hypoxia in a HIF1A-dependent manner. 
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ABSTRACT 
Stanniocalcins (STC1 and STC2) are secreted glycoproteins that are implicated in different 
cancers and have been shown to be hypoxia regulated in various cell culture studies. The 
retina is sensitive to hypoxia and several retinal disorders have a hypoxic aspect to them. 
Hence we investigated the expression of stanniocalcins in the normal, degenerating and 
hypoxic retina. We show that Stc1 and Stc2 were similarly expressed in the normal and 
degenerating retina. Under hypoxic conditions, however Stc2 showed a strong upregulation 
whereas Stc1 did not. Further we report that hypoxic upregulation of Stc2 expression is 
HIF1A dependent. Although, the lack of Stc1 and Stc2 does not seem to affect the structure 
of the retina, the normal expression is restricted to specific cell types (in the INL and GCL). 
Taken together our data provide evidence for the differential regulation of STC1 and STC2 in 
the retina. 
 
Keywords: Stc1, Stc2, hypoxia, HIF1A, retina. 
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INTRODUCTION 
Stanniocalcin (STC) is a secreted glycoprotein, which was first identified in a gland 
called corpuscle of stannius in fish (Stannius, 1939). It was shown to have an anti-
hypercalcemic effect by preventing Ca2+ influx and hence aiding the fish to survive in high-
calcium surroundings (Lafeber et al., 1988). The human STC1 was first identified in a screen 
for genes attributing the immortalization phenotype to cancer cells (Chang et al., 1995; Olsen 
et al., 1996). Human STC1 is almost 60% identical to fish STC. Later, another paralog called 
STC2 was identified (Chang and Reddel, 1998; DiMattia et al., 1998; Ishibashi et al., 1998), 
which shares only 30% identity with STC1 but the exon-intron boundaries, glycosylation site 
and cystine residues are conserved between the two suggesting a common ancestor 
(Wagner and Dimattia, 2006). STC1 forms homodimers, most likely through the interaction of 
11 cycteine residues in the protein (Hulova and Kawauchi, 1999). STC2 has in addition 15 
conserved histidine residues clustered at the C-terminal region. Both STC1 and STC2 are 
secreted proteins with short signal peptides of about 24 amino acids (Moore et al., 1999). 
The mammalian STC1 gene is expressed as a 4 kb transcript that has a wide distribution in 
kidney, heart, lung, prostrate, thyroid and the highest levels in the ovary. STC2 is also widely 
expressed in tissues including kidney, spleen and pancreas predominantly as a 2 kb 
transcript as well as a 4.4kb transcript in certain tissues (Chang and Reddel, 1998; DiMattia 
et al., 1998).  
Both stanniocalcins have been implicated in the pathophysiology of several cancers. 
The expression of STC1 was elevated in human colorectal cancer, lung cancer, ovarian 
cancer, breast cancer and leukemia. And STC2 was elevated in human gastric cancers, 
neuroblastomas, prostrate cancer, colorectal cancer and renal cell carcinoma, (Yeung et al., 
2012) and suggested as a marker for gastric cancer (Yokobori et al., 2010). The tumor 
microenvironment is hypoxic (Vaupel et al., 1989), so not surprisingly several studies have 
shown Stc1 and Stc2 to be regulated by hypoxia. Elevated levels of Stc1 were reported in 
mice treated with hypoxic preconditioning that resulted in ischemic tolerance in the heart 
(Westberg et al., 2007a) and brain (Westberg et al., 2007b). It was also shown that hypoxic 
treatment of various cancer cell lines derived from colon carcinomas, nasopharangeal cancer 
and ovarian cancer resulted in an upregulation of STC1 (Yeung et al., 2005). STC2 was 
induced by hypoxia in proximal tubular epithelial cells (Leonard et al., 2003), breast cancer, 
ovarian cancer cells (Law and Wong, 2010b). Both the STC1 and STC2 promoter analysis 
revealed putative hypoxia responsive elements (HRE) and in-vitro studies analyzing mutated 
HREs, suggested that both STC1 and STC2 are HIF1A target genes, though the association 
for STC1 was not consistent (Law and Wong, 2010b; Law et al., 2010). 
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The master regulator of hypoxic response is a transcription factor called - Hypoxia-
inducible factor (HIF1) belonging to a family of proteins that also includes HIF2 and HIF3 
(Semenza, 2012). HIF1 is a dimmer composed of a nuclear-localized beta subunit and an 
alpha subunit (Wang et al., 1995) that is constitutively produced but undergoes immediate 
degradation via oxygen-dependent (Maxwell et al., 1999), VHL-mediated proteosomal 
degradation (Jaakkola et al., 2001). Under hypoxic conditions, Vhl cannot bind to the HIF1A, 
which stabilizes by evading degradation, translocates to the nucleus, dimerizes and causes 
transcription of HIF1 responsive gene (Cockman et al., 2000; Ohh et al., 2000). As 
photoreceptors are the major cell-type in the retina and the loss of these is an important 
cause of several vision impairments, we generated mice with rod photoreceptor-specific 
deletion of Vhl. This resulted in a hypoxia-like response by stabilization of HIF1A and HIF2A 
and these mice showed progressive retinal degeneration (Lange et al., 2011).  
There have been few studies aiming at understanding the molecular mechanisms and 
subcellular functions of the stanniocalcins, several of which aimed at elucidating their role in 
calcium homeostasis (Yeung et al., 2012). Other studies reported STC1 binding sites on the 
mitochondrial membrane (McCudden et al., 2002), as well as the uncoupling effect of STC1 
on oxidative phosphorylation, suggesting a role in cellular metabolism (Ellard et al., 2007). 
Using fibroblasts from STC2 knockout mice, it was shown that STC2 is a negative regulator 
of store operated calcium entry (Zeiger et al., 2011). 
 In a presumptive retinal ganglion cell line - RGC-5, it was shown that transduction 
with STC1 resulted in a dose-dependent increase in cell viability (Kim et al., 2013). 
Furthermore, intravitreal injection of STC1 rescued retinal degeneration in two inherited rat 
models (RCS and S334ter-3), wherein they also showed an upregulation of mitochondrial 
uncoupling protein - UPC2 involved in oxidative phosphoryplation (Roddy et al., 2012). But 
so far there has been no study of STC2 in the retina. As the retina is a tissue with a high 
oxygen demand, it is very sensitive to variations in oxygen levels and hypoxia is implicated in 
degenerative diseases of the retina (Arjamaa and Nikinmaa, 2006; Grimm and Willmann, 
2012; Lange and Bainbridge, 2011). Here we report for the first time, the differences in 
hypoxic regulation of both Stc1 and Stc2 in the mouse retina. 
 
Results 
 
 73	  
EXPERIMENTAL PROCEDURES 
Animals and Genotyping - Animals were treated in accordance with the regulations of the 
veterinary authority of Zurich and the statement of the Association for Research in Vision and 
Ophthalmology (ARVO) for the use of animals in vision research. All mice were kept at the 
animal facility of the University Hospital Zurich in a light-dark (12h:12h) cycle with food and 
water ad libitum. Light was maintained at 60 lux at cage level during the light period. Mice 
were euthanized by CO2 inhalation followed by cervical dislocation.  
The C57BL/6 mice were purchased from Charles River (Chatillon-sur-Chalaronne, France) 
and the rd10 (C57BL/6 background) mice from Jackson laboratories (Bar Harbor, ME, USA). 
The 129S-Vhlhtm1jae/J-mice, which have loxP sites flanking exon1 and part of the promoter of 
the Vhl gene (both the alleles are floxed and hereafter these mice are referred to as Vhlflox), 
were purchased from Jackson laboratory (Bar Harbour, USA), the Opsin-Cre mice were 
acquired from Yun-Zheng Le (Oklahoma, USA) and the Opsin-Cre;Vhlflox mice were 
generated as described earlier (Lange et al., 2011). The Hif1αflox/flox mice  (hereafter referred 
to as Hif1αflox) were kindly provided by R.Johnson (UCSD, USA) and M.Gassmann (UZH, 
Switzerland). The Vhlflox mice were crossed with Hif1αflox mice to generate Vhlflox;Hif1αflox and 
further with Opsin-Cre mice to generate Opsin-Cre;Vhlflox;Hif1αflox.These mice were 
genotyped as described before (Section 3.1.1). The hypoxia and reoxygenation treatment 
was performed on 6-week old WT (129S6) mice as described earlier (Grimm et al., 2002). 
The Stc1-/- and Stc2-/- mice were generated by the R. Reddel lab as described (Chang et 
al., 2005; Chang et al., 2008). 
Morphology and light microscopy – To analyze retinal morphology by light microscopy, 
eyes were enucleated and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3) 
at 4°C overnight. After fixation, cornea and lens were removed, and the eyecup was 
separated into a superior and an inferior half by cutting through the optic nerve head. The 
trimmed tissue was washed in cacodylate buffer, contrasted with osmium tetroxide (1%, 1 h, 
room temperature), dehydrated by incubations in increasing ethanol concentrations, and 
embedded in Epon 812. Semi-thin sections (0.5 µm) were prepared and counterstained with 
toluidine blue. An Axioplan digitalized microscope (Zeiss Meditec, Jena, Germany) was used 
to examine the slides.  
Western Blotting – Retinas were homogenized in 0.1 M Tris-HCl (pH 8) at 4°C and the 
protein content was determined using Bradford assay. Proteins (30 µg each) were separated 
by SDS- polyacrylamide gel electrophoresis using a 10% gel, and then blotted onto a 
nitrocellulose membrane by semi-dry transfer. After blocking the membrane for 1 hr with 5% 
non-fat dry milk (Bio-Rad, Munich, Germany) in TBST (10 mM Tris/HCl [pH8], 150 mM NaCl, 
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and 0.05% Tween-20) membranes were incubated overnight with the primary antibodies 
(dilution 1:500) (Table 2). This was followed by incubation with HRP-conjugated secondary 
antibodies for 1 hr at room temperature. The protein bands were then visualized using the 
Renaissance Western Blot Detection Kit (PerkinElmer Life Sciences, Boston, MA, USA). 
RNA isolation, cDNA synthesis and semiquantitative real-time PCR – Retinas were 
isolated through a corneal incision and immediately snap frozen in liquid nitrogen. Total RNA 
was isolated using RNeasy isolation kit (catalogue number: 74104, Qiagen, Hilden, 
Germany) or the High Pure RNA isolation kit (catalogue number: 11828665001, Roche 
Diagonistics, Basel, Switzerland). Residual genomic DNA was removed by a DNase I 
incubation step. RNA (650-1000 ng) was reverse transcribed using oligo(dT) and M-MLV 
reverse transcriptase (catalogue number: M1701, Promega, Madison, WI, USA). 10 ng of 
cDNA was used for gene expression analysis by semiquantitative real-time PCR using a 
LightCycler 480 instrument (Roche Diagnostics), the LightCycler 480 SYBR Green I Master 
mix (catalogue number: 04887352001, Roche Diagonistics), and specific primer pairs (Table 
1). The primer pairs were designed to span large intronic sequences or to cover exon-intron 
boundaries. Gene expression was normalized to actin beta (Actb), and relative quantification 
was calculated using the comparative threshold method (ΔΔCT). 
Laser capture microdissection (LCM) - Eyes from 8-week old WT (129S6) and 11-week 
old Opsin-Cre;Vhlflox mice were enucleated and immediately embedded in tissue freezing 
medium (Leica Microsystems Nussloch GmbH, Nussloch, Germany), and frozen in a 2-
methylbutane bath cooled in liquid nitrogen. 20 µm thick retinal sections were collected on 
Arcturus PEN Membrane Glass Slides (Applied Biosystems, Foster City, CA, USA). The 
slides were then fixed for 5 min in acetone, followed by 5 min of air drying and two 
dehydration steps (30 s with 100% ethanol and 5 min with xylol). Retinal layers were isolated 
using an Arcturus XT Laser Capture Microdissection system (Bucher Biotec AG, Basel, 
Switzerland) and Arcturus CapSure Macro LCM Caps (Applied Biosystems). Extraction of 
RNA was done using the Arcturus PicoPure RNA Isolation Kit (Applied Biosystems) 
according to the manufacturer’s instructions, including a DNase treatment to remove residual 
genomic DNA. cDNA was synthesized using random hexamer primers (High-Capacity cDNA 
Reverse Transcription Kit; Applied Biosystems), and further analyzed by semi-quantitative 
real-time PCR. 
Immunofluorescence on retinal cryosections – Eyes were enucleated and fixed in 4% 
paraformaldehyde (PFA) overnight. Cornea and lens were removed and the eye-cups were 
transferred into 30% sucrose in phosphate buffered saline (PBS). Eye-cups were then 
embedded in tissue cryoprotective medium (Leica Microsystems Nussloch GmbH, Nussloch, 
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Germany) and snap – frozen in a 2-methylbutane bath cooled in liquid nitrogen. 12 µM thick 
sections were cut through the optic nerve head on a cryostat (Leica), air-dried, and stored at 
-80°C until further use. The retinal sections were incubated with blocking solution (3% goat 
serum + 0.3% Triton-X in PBS) for 1 hr at room temperature. Then the primary antibody was 
applied (Table 2) and left at 4°C overnight. The slides were then washed 3 times with PBS 
followed by incubation with Cy2 or Cy3 conjugated secondary antibodies (Jackson 
Immunoresearch, Soham, UK) in blocking solution (dilution = 1:500) for 1 hr at room 
temperature. After 3 PBS washes, nuclei were stained with DAPI, and the slides were 
mounted with the anti-fade medium Mowiol (Calbiochem, San Diego, CA, USA). 
Immunofluorescently labeled proteins were visualized using an Axioplan fluorescence 
microscope (Carl Zeiss AG). 
Statistical analysis – Statistical analysis was performed using Prism 4.0 software 
(GraphPad, San Diego, CA, USA). All data are presented as mean ± standard deviation 
(SD). The number of samples (N) used for individual experiments is given in the figure 
legends. Student’s t-tests were used to measure the statistical differences of means between 
two groups. A P value below 0.05 was considered significant. 
 
RESULTS 
Expression of Stc1 and Stc2 in the retina 
 Stanniocalcins have been implicated in several cancers (Chang et al., 2003), and 
their expression patterns have been shown in diverse tissues (Chang and Reddel, 1998; 
Chang et al., 1995; Olsen et al., 1996; Varghese et al., 1998), but their expression and 
potential role in the retina has not been studied. Hence first we analyzed the expression of 
Stc1 and Stc2 in the mouse retina as well as in brain, heart, kidney, liver, lung and spleen for 
positive controls. Both Stc1 and Stc2 were highly expressed in the retina and the expression 
of Stc1 is highest in the retina compared to all the other tissues tested (Figure1A).  
 We also analyzed the expression of the stanniocalcins during postnatal development 
from PND10 to PND180. In wild type (WT) mice both genes had steady gene expression 
levels that did not vary during ageing. Furthermore, to investigate whether expression of 
these genes is affected by retinal degeneration we analyzed their expression in the rd10 
mice from PND10 to PND180. The rd10 mouse is a model for inherited retinal degeneration. 
It has a spontaneous mutation in the beta subunit of the rod phosphodiesterase (Pde6b) 
resulting in an autosomal recessive and progressive form of retinal degeneration which starts 
around PND18, peaks at PND21 and at PND56 most photoreceptors are lost (Chang et al., 
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2002; Samardzija et al., 2012). The expressions of Stc1 and Stc2 did not show much 
variation in the retinas of rd10 mice during the course of degeneration, suggesting that these 
genes may not have direct or important role in the degenerating retina (Figure1B and 1C).  
In the retina, Stc2 but not Stc1 is responsive to hypoxia 
 Previous studies have shown both STC1 (Lal et al., 2001) and STC2 (Law and Wong, 
2010a) to be responsive to hypoxia. The retina is a metabolically active tissue and has a high 
oxygen consumption rate (Yu and Cringle, 2001a). Hence we tested the expression of these 
genes in response to hypoxia in the retina. Surprisingly, Stc1 expression remained 
unaffected by hypoxia, whereas there was a 9-fold upregulation of Stc2 immediately after 
hypoxia. This reduced to 4-fold, when the mice were reoxygenated for 2 hours after hypoxia 
and retuned to basal levels after 4 hours of reoxygenation (Figure 2A). To test if the hypoxic-
response might be affected by age, 7-week old and 7-months old mice were kept at hypoxia. 
Again, Stc1 did not respond to the hypoxic treatment whereas Stc2 showed an upregulation, 
although the response did not vary in older mice. The known hypoxia-regulated genes Adm 
and Epo were used as controls and showed the expected upregulation (Figure 2B). 
Hypoxic regulation of Stc2 requires HIF1A  
 Stc2 expression was strongly induced in the Opsin-Cre;Vhlflox mice at 11-weeks of 
age and gradually reduced to basal levels in 1-year old mice. This can be attributed to the 
loss of Cre expressing cells and retinal degeneration. Furthermore the Opsin-
Cre;Vhlflox;Hif1aflox mice with a double deletion of Vhl and Hif1a were generated. Stc2 levels 
were not altered in these mice whereas, comparatively the Opsin-Cre;Vhlflox mice showed a 
48-fold, 19-fold and 7-fold upregulation at 11-weeks, 4-months and 6-months respectively 
(Figure 3). Stc1 expression was tested in these mice at 11 weeks of age, but as expected 
there was no alteration in expression (data not shown). 
Stc2 is expressed in the INL and GCL, and the protein localizes to the neurofilaments 
 Immunostaining on retinal flatmounts and sections of WT retina revealed that the 
STC2 protein localizes to the neurofilaments (Figure 4A and B). These sections were then 
co-stained with STC2 and markers for common retinal cell types such as GFAP for activated 
muller cells and astrocytes, GS for muller cells, isolectin for blood vessels, synaptophysin for 
marking the synapses at the plexiform layers and BRN3A for retinal ganglion cells. STC2 did 
not co-localize with any other cell type and the localization was distinctly observed only in the 
neurofilaments (Figure 4C-H). But in the Opsin-Cre;Vhlflox and Opsin-Cre;Vhlflox;Hif1aflox mice 
STC2 protein was observed in the neurofilaments as well as Muller cells (Figure 6D and 6E).  
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 Expression of Stc2 in the inner retina was confirmed by LCM, as the expression was 
analyzed in the retinal pigment epithelium (RPE), outer nuclear layer (ONL), inner nuclear 
layer (INL) and the ganglion cell layer (GCL). We observed that in 8-week old WT mice Stc2 
is normally expressed in the INL and GCL, and is not detectable in the RPE and ONL (Figure 
5A). The amplified PCR product from 3 mice was then run on a gel, which confirmed that 
Stc2 was indeed detected only in the INL and GCL (Figure 5B). Layer specific markers such 
as Mct3 for RPE, Gnat1 for ONL, Vsx2 for INL and Opn4 for GCL showed that the layers 
were separated efficiently with insignificant amounts of cross-contamination (Figure 5C). 
Stc2 is expressed in the ONL when HIF1A is stabilized in the rod photoreceptors 
 There is a 48-fold upregulation of Stc2 in the retinas of Opsin-Cre;Vhlflox mice 
compared to the Opsin-Cre;Vhlflox;Hif1aflox mice on stabilization of HIF1A in the 
photoreceptors. We wanted to test if this increase is in the INL and GCL where the Stc2 is 
normally expressed. The ONL, INL and GCL of Opsin-Cre; Vhlflox retina was separated by 
LCM, and the expression revealed an increase in the ONL where HIF1A is stabilized while 
the levels in INL and GCL remained the same (Figure 6A). But the STC2 protein localization 
did not seem to alter much. The signal was stronger in Opsin-Cre; Vhlflox mice, compared to 
the control – Vhlflox; Hif1aflox and Opsin-Cre; Vhlflox; Hif1aflox mice (Figure 6C-E). Also the 
localization seems to have a more striated pattern (characteristic of Muller cells) compared to 
the WT control (Figure 6B). 
Both Stc1-/- and Stc2-/- mice have normal retinal morphology 
 The two transgenic mouse lines overexpressing STC1 displayed a dwarf phenotype 
suggesting a role for stanniocalcins in muscle and bone development (Filvaroff et al., 2002; 
Varghese et al., 2002), and the transgenic mice overexpressing human-STC2 were shown to 
be about 45% smaller than their littermates, and their growth was affected already by 
embryonic day 12.5 (Gagliardi et al., 2005). On the other hand, Chang et al. generated the 
Stc1-/- mice, which did not show a significant phenotype (Chang et al., 2005). Hence to 
check if the loss of Stc1 is compensated by Stc2 they further generated the Stc2-/- mice and 
the double knockout Stc1-/-, Stc2-/- mice. They showed that the Stc2-/- mice had a growth-
related phenotype - these mice were 10-15% larger and grew at a faster rate from 4-week 
onwards (Chang et al., 2008). We acquired the eyes of Stc1-/- and Stc2-/- mice and 
prepared sections for morphology and immunohistochemistry. The retinal morphology of 9-
month old Stc1-/- and Stc2-/- mice was normal and comparable to the WT controls (Figure 
7A-C). Interestingly, the STC2 protein was not only absent in the Stc2-/- mice, but was also 
not detectable in the Stc1-/- mice, whereas in the WT mice STC2 localized to the 
neurofilaments (Figure 7D-F). The control immunostainings with other proteins - BRN3A, 
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Synaptophysin and GFAP appeared normal in the Stc2-/- mice (Figure 7G-I), and Stc1-/- 
mice (not shown) and comparable to the WT mice. 
 
DISCUSSION 
The retina is a metabolically active tissue and has high oxygen consumption (Yu and 
Cringle, 2001b). Several age-related changes and disease conditions could affect the oxygen 
supply to the retina and cause hypoxia. This local hypoxia is an important aspect of retinal 
degeneration and disease (Lange and Bainbridge, 2011). Secreted proteins are often 
involved in cellular signaling, as well as in the activation of different pro-survival or apoptotic 
mechanisms under stress conditions like hypoxia. Hence study of such proteins might lead to 
a better understanding of disease mechanisms. We show here that the genes for the 
secreted glycoproteins called stanniocalcins – Stc1 and Stc2 are highly expressed in the 
retina of WT mice and does not vary significantly during retinal degeneration as seen in the 
rd10 mice. In a recent study it was shown that intravitreal injection of STC1 rescued 
degeneration in two rat models – S334ter-3 (fast degeneration model) and RCS (a slow 
degeneration model). The rescue was more efficient in the S334ter-3 rats (Roddy et al., 
2012). In the rd10 mice we observe a slight upregulation of Stc1 at PND15 but after the 
onset of degeneration at PND21 there is not much difference compared to the controls. It 
would be interesting to test if maintaining high levels of STC1 prevents degeneration (STC1 
could be injected between PND10-15 to test rescue of degeneration after PND21). 
Since a majority of studies have shown stanniocalcins in cancers and hypoxia (Chang 
et al., 2003), we looked at the hypoxic regulation of these two genes, and surprisingly found 
only Stc2 to be responsive to hypoxia in the retina. Although Stc1 is often implicated in 
cancer and hypoxia we do not observe a change in its expression after hypoxic treatment in 
the retina. However, in NIH3t3 cells treated with hypoxia, both Stc1 and Stc2 were 
upregulated (not shown). It has also been shown that STC1 receptors are at the 
mitochondrial membrane (McCudden et al., 2002), and may be directly involved in the 
uncoupling process of oxidative phosphorylation (Ellard et al., 2007). In the retina study on 
rats, the uncoupling protein-2 was shown to be slightly upregulated and there was a 
reduction in ROS products after treatment with STC1 (Roddy et al., 2012), suggesting the 
involvement of STC1 in mitochondrial or metabolic processes. Furthermore, the activation of 
the transcription factor HIF1A was sufficient to cause an upregulation in Stc2 expression 
even under normoxic conditions. In previous in-vitro studies HIF1A binding sites were 
recognized and characterized in the promoter region of the Stc2 gene (Law and Wong, 
2010b). Though a similar study was done for Stc1, the results were not conclusive, as the 
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luciferase assays could not be repeated for Stc1 gene expression (Law et al., 2010). Taking 
this into account with our present data, we conclude that in the retina Stc2 and not Stc1 is 
regulated by HIF1A under hypoxia. 
Intriguingly, we observed the localization of the STC2 protein at the neurofilaments 
although in Opsin-Cre;Vhlflox mice, HIF1A stabilization was in the rod photoreceptors. Hence 
this raised questions about the exact cell types in the retina that express Stc2. In the WT 
retina we were able to show that the normal expression of Stc2 is in the INL and GCL, and 
this would be consistent with the protein localization at the vicinity of these layers in the 
neurofilaments. However, in the mice with HIF1A stabilized in the photoreceptors, the level of 
Stc2 expression remained the same in the INL and GCL whereas there was strong 
upregulation in the ONL, although the protein did not appear to be accumulating at the 
photoreceptors. This raises questions about if and how the protein is transported to the NFL 
(addressing this is beyond the scope of the present study). In the Opsin-cre;Vhlflox mice 
HIF1A stabilization in the rods results in an age-related degeneration and loss of retinal 
function (Lange et al., 2011), which is rescued in the Opsin-cre;Vhlflox;Hif1aflox mice (Section 
3.1.1). These mice show a strong upregulation of Stc2 in the ONL although the protein is still 
predominantly detected in the NFL hinting towards potential signaling between dying 
photoreceptors and other cell types. 
In the retinas of Stc2-/- mice the protein could not be detected. But surprisingly, STC2 
could not be detected in the retinas of Stc1-/- either, hinting at a potential cross-talk in the 
regulation of the two stanniocalcins. In this respect it would be essential to test the gene 
expression of Stc2 in the Stc1-/- mice and vice versa. The retinal morphology of Stc1-/- and 
Stc2-/- mice appears normal, which is not surprising as these mice generally have mild 
phenotypes. The Stc2-/- mice are 15% larger compared to WT controls, a phenotype that is 
seen in the double Stc1-/-;Stc2-/- knockouts as well (Chang et al., 2008), while the Stc1-/- 
mice do not have an obvious growth phenotype (Chang et al., 2005). Both mice do not have 
any variations in serum calcium or phosphate levels, indicating normal mineral homeostasis. 
STC2 or the lack of it, may not affect the retina under normal physiological conditions, but 
only under stress conditions. Hence, it would be further essential to investigate how Stc2-/- 
and Stc1-/-;Stc2-/- mice respond to hypoxia. Taken together our study shows for the first time 
the expression of stanniocalcins in the normal, degenerating and hypoxic retina, as well as 
the regulation of Stc2 by HIF1A. The differential regulation of Stc1 and Stc2 under hypoxic 
conditions hints towards the possibility of distinct and non-redundant functions for the two 
proteins in the retina, which would require further investigation. 
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FIGURE LEGENDS 
Figure 1. Gene expressions of Stc1 and Stc2 in the developing and degenerating retina. (A) 
Relative expression levels of Stc1 (blue bars) and Stc2 (red bars) in different tissues (X-axis) 
from 11 week old WT (C57BL/6) mice. (B-C) Relative expressions of Stc1 (B) and Stc2 (C) in 
the developing retina of wild-type (C57BL/6) mice (black line) and rd10 mice (red line) from 
PND10 to PND 180. Expression was determined by semi-quantitative real-time PCR and 
normalized to Actb. Shown are mean values ± SD of N = 3. Significance was tested using 
Student’s t-test (* P < 0.05, ** P < 0.01). 
Figure 2. Retinal expression of Stc2 in response to hypoxia. (A) Relative expressions of Stc1 
(blue line) and Stc2 (red line) in retinas of 6-week old WT (Balb/c) mice exposed to hypoxia 
(6 h at 6% O2). Tissue was collected immediately after hypoxia (Imm) or after 2h, 4h and 16h 
of reoxygenation following hypoxia. (B) Relative expressions of Stc1, Stc2, Adm and Epo at 
normoxia (black bars) and hypoxia (6 h at 7% O2) (red bars) in wild-type (129S6) mice aged 
7 weeks and 7 months. Expression levels were determined by semi-quantitative real-time 
PCR, normalized to Actb and shown relative to the levels in untreated controls (set to 1) (A) 
or to normoxic controls at 7 weeks of age (set to 1) (B). Shown are mean values ± SD of N = 
3. Significance was tested using Student’s t-test (* P < 0.05, ** P < 0.01, *** P < 0.001). 
Figure 3. Upregulation of Stc2 on stabilization of HIF1A in the rod photoreceptors under 
normoxia. Relative expression of Stc2 in Vhlflox (black bars), Opsin-Cre;Vhlflox (red bars), 
Vhlflox;Hif1aflox (black bars) and Opsin-Cre;Vhlflox; Hif1aflox (blue bars) mice at the age of 11 
weeks, 4 months, 6 months and 1 year (X axis). Expression was determined by semi-
quantitative real-time PCR, normalized to Actb and shown relative to the levels in Vhlflox (set 
to 1 for each age). Shown are mean values ± SD of N = 3. Significance was tested using 
Student’s t-test (* P < 0.05, ** P < 0.01, *** P < 0.001). 
Figure 4. Localization of STC2 protein at the retinal neurofilaments. Immunostainings of 
STC2 (red channel) in (A) Retinal flatmount of 7 week old WT (129S6) mice and, (B-H) 
retinal sections of 11 week old WT (129S6) mice. Nuclei are stained with DAPI (blue 
channel) and the green channel is used for GFAP (C), GS (D), Isolectin (E), Synaptophysin 
(F) and BRN3A (G and H). Scale bar: 50 µM. 
Figure 5. Expression of Stc2 in INL and GCL of wild-type mice. RNA was extracted from 
different retinal layers of wild-type mice (129S6) at 8 weeks of age, separated by LCM. (A) 
Relative expression of Stc2 in the different retinal layers (X axis) – RPE (retinal pigment 
epithelium), ONL (outer nuclear layer), INL (inner nuclear layer) and GCL (ganglion cell 
layer), (B) The amplified PCR product of Stc2 from the RPE, ONL, INL and GCL of N = 3 
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mice on an agarose gel, (C) Relative expression of layer-specific control genes – Mct3 for 
RPE, Gnat1 for ONL, Vsx2 for INL and Opn4 for GCL. Expression was determined by semi-
quantitative real-time PCR and normalized to Actb. Shown are mean values ± SD of N = 3. 
Figure 6. Upregulation of Stc2 in the ONL on stabilization of HIF1A in rods. (A) Relative 
expression of Stc2 in the ONL, INL and GCL of Opsin-Cre;Vhlflox at 11 weeks of age. 
Expression was determined by semi-quantitative real-time PCR and normalized to Actb (N = 
1), (B-E) Immunostaining of STC2 (red channel) and DAPI for nucleus (blue channel) in 
retinal sections of wild-type (129S6) (B), Vhlflox;Hif1aflox (C), Opsin-Cre;Vhlflox (D) and Opsin-
Cre;Vhlflox;Hif1aflox (E) mice at 11 weeks of age. Scale bar: 50 µM. 
Figure 7. Normal retinal morphology in the absence of STC1 and STC2. (A-C) Retinal 
morphology of WT (C57BL/6) mice at 6 months (A), Stc1-/- (B) and Stc2-/- (C) at 9 months of 
age. (D-F) Immunostainings for STC2 in WT (C57BL/6), Stc1-/- and Stc2-/- retinal sections. 
(G-I) Immunostainings of BRN3A, SYN and GFAP in Stc2-/- mice. Images were acquired at 
200 µm from the optic nerve head. Shown are representative images of N = 3 retinas per 
genotype. Scale bar: 50 µm. 
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Table 1. Primers used for semiquantitative real-time PCR 
 
Gene Forward primer Reverse primer Annealing temp (°C) 
Amplicon 
(bp) 
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 62 153 
Adm TTCGCAGTTCCGAAAGAAGT GGTAGCTGCTGGATGCTTGTA 62 77 
Epo GCCCTGCTAGCCAATTCC GGCGACATCAATTCCTTCTG 60 128 
Gnat1 GAGGATGCTGAGAAGGATGC TGAATGTTGAGCGTGGTCAT 58 209 
Mct3 GGCTCAACCCTAAATCCAGA CTTCGGAGTTTCCTCACCAG 62 75 
Opn4 CCAGCTTCACAACCAGTCCT CAGCCTGATGTGCAGATGTC 62 111 
Stc1 CCGGAAGCCATCACTGAA GGCTTCGGACAAGTCGTTG 62 76 
Stc2 AGCAGGAAGTGTCCAGCAAT GGTTCACAAGGTCCACATAGG 62 166 
Vsx2 CCAGGAGACAGGATACAGGTG GGCTCCATAGAGACCATACT 62 111 
 
 
 
Table 2. Antibodies used for immunofluorescence on retinal sections 
 
Protein Host Supplier Catalogue number Dilution 
BRN3A mouse Chemicon (Millipore); USA MAB1585 1:300 
ISOLECTIN mouse Life Technologies, USA 121413 1:300 
GS mouse Millipore, USA MAB302 1:500 
STC2 rabbit Acris antibodies, Herford, Germany 10314-1-AP 1:300 
SYN mouse Novocastra, Mutenz, Switzerland NCL-L-SYNAP-299 1:500 
500  
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3.3. pH stress in the retina 
Increased expression of the proton-sensing G protein-coupled receptor Gpr65 during 
retinal degeneration 
 
Divya Ail (DA), Véronique Rüfenacht (VR), Christian Caprara (CC), Marijana Samardzija 
(MS), and Christian Grimm (CG) 
 
Author contributions: 
Design: CG 
Experiment: DA (RT-PCR, Imaging, Maintenance of mice), VR, CC 
Interpretation: DA, VR, MS, CG 
Manuscript: DA, CG 
Manuscript correction: DA, VR, CC, MS, CG 
 
Summary: The retina is sensitive to pH changes and hence in this paper we aimed to study 
the role of proton-sensing G-protein coupled receptors (GPCR) in the healthy and 
degenerating retina. We studied 3 GPCRs – Gpr4, Gpr65 and Gpr68 and showed their 
normal expression in WT retinas during development and ageing. Additionally we observed 
that only Gpr65 is upregulated in both the induced and inherited models of retinal 
degeneration, while Gpr4 and Gpr68 were not responsive hinting towards their distinct 
functions in the retinas. The Gpr65 KO mice had normal retinal morphology and function. 
However, the Gpr65-/-;rd10 mice degenerated slightly faster, suggesting that the additional 
lack of Gpr65 during degeneration tends to accelerate the process. Previous studies have 
shown the expression of Gpr65 in several immune cells including macrophages; hence we 
looked at the activation of the microglia (the resident immune cells of the retina), in the 
presence or absence of Gpr65. We observed a slight increase in microglia activation 
although the expression of cytokines was not differentially regulated. 
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ABSTRACT 
The retina is a metabolically highly active tissue that is sensitive to pH changes. Blinding 
diseases of the retina are often characterized by degeneration of photoreceptor cells altering 
the acid-base homeostasis of the tissue microenvironment and by an accompanying 
inflammatory response. GPR4, GPR65 and GPR68 are G protein-coupled receptors that aid 
cells to sense and survive conditions of acidic pH and inflammatory cells express Gpr65 
enhancing their viability. Hence, we investigated expression and function of these proton-
sensing GPRs in the normal and degenerating retina. We observed increased retinal 
expression of Gpr65, but not of Gpr4 and Gpr68, in mouse models of both inherited (rd10) 
and induced (light damage) retinal degeneration. Lack of GPR65 slightly accelerated 
photoreceptor degeneration in rd10 mice and resulted in a strong activation of microglia after 
light-injury. Since GPR65 was dispensable for normal retinal development, function and 
ageing as evidenced by the evaluation of Gpr65–/– mice, our results indicate that the proton-
sensing G protein coupled receptor GPR65 may be involved in a mechanism that supports 
survival of photoreceptors in the degenerating retina. 
 
Keywords: Gpr65, TDAG8, retinal degeneration, light damage, rd10, microglia 
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INTRODUCTION 
G protein-coupled receptor 65 (GPR65; also known as T-cell death-associated gene 
8, TDAG8) belongs to a sub-family of proton-sensing receptors. Other members of this family 
include GPR4, GPR68 (OGR1; ovarian-cancer G-protein-coupled receptor) and GPR132 
(G2A; G2 accumulation) (Justus et al., 2013; Okajima, 2013). Proteins of this family were 
originally characterized as receptors for lipid messengers such as 
sphingosylphosphorylcholine (SPC) (Mogi et al., 2005), lysophosphatidylcholine (LPC) 
(Kabarowski et al., 2002) and psychosine (Im et al., 2001; Wang et al., 2004). However, 
increasing evidence in recent years established their function as proton-sensors (Ludwig et 
al., 2003). Analysis of the extracellular domains of the membrane-bound GPR68 revealed 
that histidine residues at positions 17, 20, 84 and 269 mediate its pH sensitivity. At slightly 
alkaline pH, GPR68 is stabilized in an inactive state by direct hydrogen-bonding between 
these histidines. Loss of the bonding by protonation at lower pH causes a conformational 
change and renders the receptor active (Ludwig et al., 2003). Similarly, the histidine residues 
necessary for the activity of GPR4 (79, 165 and 269) (Liu et al., 2010) and GPR65 (10 and 
14) (Radu et al., 2005) have been identified. The pH sensitivity of the more distantly related 
GPR132 has not been established, and hence, we excluded the gene from this study. 
Whereas metabolic acidosis is a hallmark of various diseases such as diabetes 
(English and Williams, 2004) and chronic kidney disease (Bailey, 2005), local acidosis is 
found in the microenvironment of many tumors. This may be caused by insufficient blood 
perfusion, hypoxia, inflammation, and/or glycolytic cell metabolism, and might affect the 
malignancy and development of the tumor (Vaupel et al., 1989; Gatenby and Gillies, 2004). 
GPR65 might be involved in the regulation of tumor growth by supporting cell survival in such 
acidic conditions. It has been shown for example that overexpression of Gpr65 in Lewis lung 
carcinoma cells increases tumor growth in mice possibly through evasion of acidosis induced 
cell death (Ihara et al., 2010). Similarly, overexpression of Gpr65 might malignantly transform 
mammary epithelial cells (Sin et al., 2004) and acidic activation of GPR65 protein may render 
lymphoma cell lines resistant to apoptosis under stress conditions (Ryder et al., 2012). 
Furthermore, shRNA-mediated knockdown of GPR65 in NCI-H460 human lung cancer cells 
decreased cell survival under acidic conditions (Ihara et al., 2010). Thus, GPR65 may act as 
a prosurvival factor in an acidic environment. However, it has also been reported, that 
GPR65 expression is reduced by 50% in human lymphoma samples and that activation of 
GPR65 stimulates glucocorticoid-induced apoptosis and inhibits c-Myc oncogene expression 
(Li et al., 2013). 
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Acidosis and GPR65 may also influence the immune and inflammatory response 
associated with tumor growth as several studies indicate diverse effects of acidosis on 
inflammatory cells such as neutrophils, eosinophils, monocytes and macrophages (Lardner, 
2001; Martinez et al., 2006; Jancic et al., 2012), as well as on the activation of the 
complement system (Hecke et al., 2001). Gpr65 expression inhibits cytokine production in 
peritoneal macrophages under acidic conditions (Mogi et al., 2009) and supports viability of 
eosinophils by acting as the main proton-sensor and by reducing apoptosis (Kottyan et al., 
2009). Gpr65 expression has also been shown in natural killer cells (Maghazachi et al., 
2004) and neutrophils (Murata et al., 2009). 
The retina is a highly specialized tissue with an extraordinarily high energy demand. 
Due to the increased metabolism of photoreceptors in darkness, retinal pH follows a 
circadian rhythm with lower values at night (Dmitriev and Mangel, 2001). Furthermore, retinal 
function is sensitive to pH changes (Yang et al., 2005) and protons that are released with 
glutamate at the photoreceptor ribbon synapses act as feedback inhibitors for 
neurotransmitter release (Barnes et al., 1993; DeVries, 2001). Many blinding diseases of the 
retina are characterized by a degeneration of photoreceptor cells. Since photoreceptor cell 
death results in increased extracellular acidifcation (Perron et al., 2013) retinal degeneration 
may disturb pH homeostasis of the retinal microenvironment. In addition, such diseases often 
have an inflammatory component (Detrick and Hooks, 2010; Perez et al., 2013). Hence, we 
investigated the potential involvement of proton-sensing G protein-coupled receptors in 
retinal pathophysiology. 
 
EXPERIMENTAL PROCEDURES 
Animals and Genotyping - Animals were treated in accordance with the regulations of the 
veterinary authority of Zurich and the statement of the Association for Research in Vision and 
Ophthalmology (ARVO) for the use of animals in vision research. All mice were kept at the 
animal facility of the University Hospital Zurich in a 12h:12h light-dark cycle with food and 
water ad libitum. Light was maintained at 60 lux at cage level during the light period. Mice 
were euthanized by CO2 inhalation followed by cervical dislocation. BALB/c mice were 
purchased from Harlan (Horst, The Netherlands), C57BL/6 mice from Charles River 
(Chatillon-sur-Chalaronne, France), 129S6 mice from Taconics (Ejby, Denmark) and rd10 
(C57BL/6 background) mice from Jackson laboratories (Bar Harbor, ME, USA). Gpr65 
knockout mice were generated by Deltagen (San Mateo, CA, USA) by replacing 74 bp in 
exon 2 by a LacZ-Neo insertion. Gpr65–/– mice were backcrossed for more than 6 
generations on the C57BL/6 background (Kumar et al., in press). Genotyping for Gpr65 was 
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done by conventional PCR using the following primers: forward primer 5’-TAA CTG CCA 
CTG TGA AGA CCA TGG C-3’, reverse primer 5’-CAG GTC TGA CAG GGA CAG ACT GAA 
G-3’, neo primer 5’-CCA TTC GAC CAC CAA GCG AAA CATC-3’. The neo-primer is 
knockout specific and binds to the neomycin cassette that replaces part of the Gpr65 gene in 
Gpr65–/– mice. Amplification fragments were 208 bp for the wild type and ≈1 kb for the 
Gpr65–/– allele. Genotyping for rd10 was done by PCR using the following primers: forward 
primer 5’-CTT TCT ATT CTC TGT CAG CAA AGC-3’; reverse primer 5’-CAT GAG TAG GGT 
AAA CAT GGT CTG-3’. Digestion of the amplification product with HhaI resulted in a 97 bp 
fragment for rd10 or two fragments of 43 bp and 54 bp for wild type mice. 
Light Exposure - Mice aged 6-8 weeks were dark-adapted overnight (16 h). Pupils were 
dilated with 1% cyclogyl (Alcon, Risch, Switzerland) and 5% neosynephrine (UrsaPharm, 
Saarbrücken, Germany) 30 minutes before exposure to 15’000 lux of white light for 2 hours 
(pigmented mice) or to 5’000 lux for 1 h (BALB/c) as described (Grimm and Reme, 2013). 
After exposure mice were kept in darkness overnight before being returned to the normal 
light-dark cycle until analysis. Age-matched mice that were dark-adapted but not exposed to 
light served as controls. 
Electroretinogram (ERG) - ERGs were performed following a previously described protocol 
(Tanimoto et al., 2009). The ERG equipment consisted of a Ganzfeld bowl, a direct current 
amplifier, a PC-based control and recording unit (LKC UTAS-E 3000, LKC Technologies, 
Gaithersburg, MD, USA). Mice were dark-adapted overnight and anesthetized using 85 
mg/kg ketamine (Parke-Davis, Berlin, Germany) and 4 mg/kg xylazine (Bayer AG, 
Leverkusen, Germany). The pupils were dilated with 1% cyclogyl (Alcon) and 5% 
neosynephrine (UrsaPharm), 30 minutes prior to performing single flash ERG recordings 
under dark-adapted (scotopic) and light-adapted (photopic) conditions. Light adaptation was 
accomplished with low background illumination starting 5 minutes before photopic 
recordings. Single white flash stimulus intensities ranged from -3.7 to 1.9 log cd*s/m2 under 
scotopic and from -0.6 to 2.9 log cod*s/m2 under photopic conditions, divided into ten and 
eight steps respectively. Ten responses per light intensity were averaged with an 
interstimulus interval of either 4.95 s (for -3.7, -3, -2.6, -2, -1.6, -1, -0.6, -0.02, 0.4 and 0.9 log 
cd*s/m2) or 16.95 s (for 1.4, 1.9, 2.4 and 2.9 log cd*s/m2). 
Morphology and light microscopy - To analyze retinal morphology by light microscopy, 
eyes were enucleated and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3) 
at 4°C overnight. After fixation, cornea and lens were removed, and the eyecup was 
separated into a superior and an inferior half by cutting through the optic nerve head (ONH). 
The trimmed tissue was washed in cacodylate buffer, contrasted with osmium tetroxide (1%, 
Results 
 
96 
1 h, room temperature), dehydrated by incubations in increasing ethanol concentrations, and 
embedded in Epon 812. Semi-thin sections (0.5 µm) were prepared and counterstained with 
toluidine blue. An Axioplan digitalized microscope (Zeiss Meditec, Jena, Germany) was used 
to examine the slides. Retinal thickness from the nerve fiber layer to the retinal pigment 
epithelium (RPE) was measured at fixed distances (200, 400, 600, 800, 1000, 1200, 1400, 
1600 and 1800 µm) from the ONH using Photoshop software (Version CS5 extended, Adobe 
Systems, San Jose, CA, USA). 
RNA isolation, cDNA synthesis and semiquantitative real-time PCR  - Retinas were 
isolated through a corneal incision and immediately snap frozen in liquid nitrogen. Total RNA 
was isolated using RNeasy isolation kit (#74104, Qiagen, Hilden, Germany) or the High Pure 
RNA isolation kit (#11828665001, Roche Diagonistics, Basel, Switzerland). Residual 
genomic DNA was removed by a DNase I incubation step. RNA (650-1000 ng) was reverse 
transcribed using oligo(dT) and M-MLV reverse transcriptase (catalogue number: M1701, 
Promega, Madison, WI, USA). Ten ng of cDNA was used for gene expression analysis by 
semiquantitative real-time PCR using a LightCycler 480 instrument (Roche Diagnostics), the 
LightCycler 480 SYBR Green I Master mix (# 04887352001, Roche Diagnoistics), and 
specific primer pairs (Table 1). The primer pairs were designed to span large intronic 
sequences or to cover exon-exon boundaries. Gene expression was normalized to actin beta 
(Actb), and relative quantification was calculated using the comparative threshold method 
(ΔΔCT). 
Immunofluorescence on retinal flatmounts  - Eyes were enucleated and incubated for 3 to 
5 minutes in 2% paraformaldehyde prepared in phosphate-buffered saline (PBS). After 
having removed cornea and lens, the eyeball was cut in a cloverleaf shape by making four 
incisions. The retina was dissected from the sclera and placed in PBS in a 48-well plate. 
Dissected retinas were post-fixed at room temperature for 1 h with 4% paraformaldehyde in 
PBS, washed with PBS, and incubated with blocking solution (3% normal goat serum, 0.3% 
Triton X-100 in PBS) for 1 h at room temperature. Anti-IBA1 antibodies (#019-19741; Wako 
Chemicals, Richmond, VA, US) were applied over night at 4°C. Tissue was washed 3 times 
with PBS and incubated with Cy3-conjugated secondary antibodies (Jackson 
ImmunoResearch, Soham, UK) for 1 h at room temperature. After three washing steps with 
PBS, the retinas were flat mounted onto slides, covered with anti-fade medium (10% Mowiol, 
Calbiochem, San Diego, CA, USA) and protected with cover slips. Labeled proteins were 
visualized using an Axioplan fluorescence microscope (Zeiss Meditec). 
Statistical analysis  - Statistical analysis was performed using Prism 4.0 software 
(GraphPad, San Diego, CA, USA). All data are presented as mean ± standard deviation 
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(SD). The number of samples (N) used for individual experiments is given in the figure 
legends. ANOVA or student’s t-tests were used to check for significance between of means 
of groups. A P-value below 0.05 was considered significant. 
 
RESULTS 
Expression of proton-sensing GPCRs in the retina 
It has been shown that Gpr4, Gpr65 and Gpr68 have diverse expression patterns in 
various tissues (Tomura et al., 2005), but their expression in the retina has not yet been 
studied. Hence we first analyzed the expression of these genes in the adult retina of 
pigmented (129S6, C57BL/6) and albinotic (BALB/c) wild type mouse strains. Since 
sequencing of all three genes in all three strains revealed several strain-specific single 
nucleotide polymorphisms (data not shown), we adapted the sequences of the PCR primers 
for perfect base pairing to the target sequences (Table 1). All primer pairs used for a 
particular gene amplified the product with similar efficiencies (data not shown). Whereas 
Gpr4 and Gpr65 had comparable expression levels in the three strains (Fig. 1A, B), 
expression of Gpr68 was significantly lower in 129S6 mice (Fig. 1C). The reason for the 
reduced levels of Gpr68 in retinas of 129S6 mice is not clear but indicates strain-specific 
differences in the expression of these receptors. 
We also tested expression of the three Gpr genes during postnatal retinal 
development from post-natal day (PND) 1 to PND42. Expression of all three genes increased 
three to four-fold after PND1 and reached plateaus between PND15 and PND21. Whereas 
expression of Gpr4 and Gpr65 increased gradually, Gpr68 levels showed a prominent 
increase between PND5 and PND15 (Fig. 1D-F).  
Upregulation of Gpr65 in models of inherited and induced retinal degeneration  
Since degeneration of photoreceptors may influence extracellular pH (Perron et al., 
2013) we tested whether expression of Gpr4, Gpr65 and/or Gpr68 might be affected in an 
inherited and an induced mouse model for retinal degeneration. Rd10 mice carry a 
spontaneous mutation in the beta subunit of the rod phosphodiesterase (Pde6b) (Chang et 
al., 2002) leading to an autosomal recessive and progressing degeneration of photoreceptors 
starting around PND15, with loss of most photoreceptors by PND42 (Samardzija et al., 
2012). Whereas expression of rod cell markers like rhodopsin (Rho) and rod transducin 
(Gnat1) is drastically reduced already during the degenerative process (Samardzija et al., 
2012), expression of Gpr65 was strongly increased between PND21 and PND180 (Fig. 2B). 
Results 
 
98 
In contrast, expression of Gpr4 and Gpr68 did not differ from control wild type mice, except 
for a slightly reduced expression of Gpr4 at PND10 and PND15, and increased expression of 
Gpr68 at PND180 (Fig. 2A, C). This pattern of expression suggests that only Gpr65 is 
responsive to photoreceptor degeneration. Furthermore, it is likely that none of the three 
genes is strongly expressed in photoreceptors since no downregulation was observed 
despite loss of all photoreceptors after PND42. Similar to the expression in rd10 mice, 
expression of Gpr65 was strongly induced after exposure of wild type mice to high levels of 
white light, a treatment that induces rapid and severe loss of photoreceptors through 
apoptosis (Wenzel et al., 2005; Grimm and Reme, 2013). Expression increased already at 24 
hours after exposure and peaked at 3 days, before levels sharply declined at day 5 and 
approached basal levels at around 30 days post exposure (Fig. 2E). Again, Gpr4 and Gpr68 
did not respond to the degeneration and their expression remained at basal levels throughout 
the period of analysis (Fig. 2D, F). Interestingly, the peak of Gpr65 expression coincided with 
the known time of strong microglia activity in the light damaged retina (Joly et al., 2009). 
Normal retinal morphology and function in the absence of GPR65  
Our data suggest that GPR65 may have a function in the degenerating retina. To 
evaluate whether GPR65 might be important for the normal, non-stressed retina, we 
examined retinal morphologies of Gpr65–/– mice at 12 weeks and 6 months of age. The 
retinal architecture including arrangement of cells and thickness of layers appeared normal in 
young and old mice lacking GPR65 (Fig. 3A). Absence of a phenotype was further supported 
by similar expression levels of marker genes for rods (Gnat1), cones (cone transducin, 
Gnat2), bipolar cells (visual system homeobox 2, Vsx2), horizontal cells (calbindin 1, Calb1), 
amacrine cells (calbindin 2, Calb2), ganglion cells (POU class 4 homeobox 1, Pou4f1) and 
Müller glia cells (glutamate-ammonia ligase, Glul) in retinas of Gpr65–/– and Gpr65+/– mice 
(Fig. 3B). The apparent differences in Calb2 and Glul expression levels did not reach 
statistical significance (Student’s t-test). Loss of Gpr65 expression had no influence on the 
expression of Gpr4 and Gpr68 suggesting that these genes did not compensate for the 
absence of Gpr65 (Fig 3B). In addition, expression of genes that are frequently found 
upregulated in the stressed retina (Samardzija et al., 2012) such as caspase1 (Casp1), glial 
fibrillary acidic protein (Gfap), fibroblast growth factor 2 (Fgf2), signal transducer and 
activator of transcription 3 (Stat3), endothelin 2 (Edn2) and leukemia inhibitory factor (Lif), 
and of the cytokines tumor necrosis factor (Tnf) and transforming growth factor beta 1 
(Tgfb1) was not significantly different in mice of the two genotypes (Fig. 3B). Furthermore, 
ERG analyses revealed normal scotopic and photopic responses in Gpr65–/– mice with a- 
and b-wave amplitudes similar to controls (Fig. 3C). In summary, GPR65 may be 
dispensable for the development and maintenance of a normal retinal architecture and 
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function, and its absence from the adult retina may not cause tissue stress as evidenced by 
basal expression of stress-related genes. 
Accelerated retinal degeneration in rd10 mice in the absence of GPR65 
Our analysis revealed that Gpr65 was upregulated during retinal degeneration (Fig. 2) 
suggesting a potential role of GPR65 in the degenerative process. Thus, we tested whether 
lack of GPR65 would influence degeneration in rd10 mice by analyzing Gpr65–/–;rd10 double 
mutant mice. Retinal morphology of Gpr65–/–;rd10 mice appeared comparable to wild type 
and rd10 mice at PND15, before onset of degeneration (Fig 4A). This is consistent with our 
conclusion that GPR65 is not essential for normal retinal development (Fig. 3). At PND21, 
rd10 mice showed the typical signs of photoreceptor degeneration such as appearance of 
pyknotic nuclei, thinning of the ONL and disorganization of the outer segments. These 
features were slightly further enhanced in the Gpr65–/–;rd10 mice suggesting that absence of 
GPR65 may accelerate photoreceptor loss under pathological conditions (rd10). At PND42, 
both rd10 and Gpr65–/–;rd10 mice had lost most photoreceptor cells (Fig. 4A). These 
observations were corroborated by measurements of the thicknesses of the entire retina (Fig. 
4B) and the ONL (Fig. 4C), which differed slightly between Gpr65–/–;rd10 and rd10 mice at 
PND21 but not at PND15 and PND42. 
Increased microglia activation in the degenerating retina in the absence of GPR65 
Several studies have shown that acidosis and Gpr65 are involved in inflammatory 
responses affecting diverse immune cells such as neutrophils (Martinez et al., 2006; Murata 
et al., 2009), eosinophils (Kottyan et al., 2009), macrophages (Mogi et al., 2009), monocytes 
(Jancic et al., 2012) and natural killer cells (Maghazachi et al., 2004). Microglia are the 
resident immune cells of the retina and express high levels of Gpr65 (Siegert et al., 2012). 
They are responsible for immune surveillance and homeostasis to ensure normal retinal 
function (Karlstetter et al., 2010) and are activated when the retina experiences stress or 
injury. Activated microglia change from their resting ramified to an amoeboid shape and 
migrate towards the site of injury (Schwartz et al., 2006; Langmann, 2007). Hence, we tested 
the response of microglia in the retina of Gpr65–/– mice during degeneration. Gpr65+/– 
(controls) and Gpr65–/– mice were exposed to bright light to induce photoreceptor cell death, 
and microglia were observed five days after light exposure in damaged and non-damaged 
areas of the retina. Ramified resting microglia in non-damaged retinal areas as well as 
amoeboid activated microglia in damaged areas appeared slightly more numerous in mice 
lacking GPR65 (Fig. 5). Thus, microglia do not seem to depend on GPR65 to survive and 
function in the degenerating retina but the receptor may influence distribution and activation 
of microglia either directly or indirectly via enhanced cell death of photoreceptors (Fig. 4). 
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Expression of cytokines and chemokines in the degenerating retina 
Cytokines and chemokines are expressed by various cell types in the retina and may 
be involved in neurodegenerative disease mechanisms by regulating tissue response to cell 
damage and/or attracting immune cells to the site of degeneration (Kreutzberg, 1995; 
Langmann, 2007). Since GPR65 may slightly affect photoreceptor death in disease models 
(Fig. 4), we tested whether individual genes involved in the above pathways might be 
differentially expressed in Gpr65–/– mice before and at 1 day after exposure to 2 hours of 
bright light, a treatment that induces photoreceptor degeneration. However, basal gene 
expression before and induced expresssion levels after light exposure (Fig. 6) were similar in 
control (Gpr65+/–) and Gpr65–/– mice with either a strong and significant (Edn2, Fgf2, Casp1, 
chemokine (C-C motif) ligand 2 (Ccl2), Ccl4, Ccl8, Ccl12), a moderate (Lif, Stat3, Gfap, Ccl5) 
or no (Tnf, Ccl9, colony stimulating factor 1 receptor (Csfr1), chemokine (C-X3-C motif) 
ligand 1 (Cx3cl1)) upregulation. Note that at the time point analyzed (24 h after light 
exposure) some of the early responsive genes such as Lif may already approaching again 
basal expression levels after an initial strong upregulation (Samardzija et al., 2006a). The 
only exception may be Tgfb1, which was significantly upregulated in retinas of mice lacking 
GPR65 but not in controls. Upregulation of Ccl2 and Ccl4 did not reach significance in Gpr65 
knockouts because of highly variable expression levels. 
 
DISCUSSION 
Changes in extracellular and/or intracellular pH seem important for proper retinal 
function (Hirasawa et al., 2012; Wang et al., 2014), may play a role in degenerative 
processes (Reber et al., 2002; Takahashi et al., 2004; Perron et al., 2013), and follow the 
circadian rhythm (Dmitriev and Mangel, 2001) in the retina. Thus, it may not be surprising 
that the proton-sensing protein encoding genes Gpr4, Gpr65 and Gpr68 were expressed 
already in the early postnatal retina of the mouse, and that expression levels increased 
during development until adulthood. Although the expression pattern was similar for the three 
mouse strains tested, some strain specificity may nevertheless exist since Gpr68 was found 
at significantly lower levels in retinas of adult 129S6 mice as compared to BALB/c and 
C57BL/6 mice. The reason behind this observation and the potentially ensuing physiological 
or functional consequences remain to be investigated. 
Although all three genes showed a similar expression profile in the normal retina, only 
Gpr65, but not Gpr4 or Gpr68, was affected by retinal degeneration. Exposure to damaging 
levels of white light induced a strong but transient increase of Gpr65 expression that peaked 
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at 3 days post exposure. Expression of Gpr65 declined sharply already at 5 days, but basal 
levels were reached only at about 30 days after light exposure. In the rd10 mouse, timing of 
induction was similar with strongly increased levels shortly after onset of degeneration (which 
is around PND15 (Chang et al., 2007; Barhoum et al., 2008; Samardzija et al., 2012)). In 
contrast to the light damage model, however, Gpr65 levels in the rd10 mouse remained at 
elevated levels at least until 6 months of age. These different time courses may reflect the 
sharp and synchronous induction of cell death by acute light exposure and the slower and 
extended period of photoreceptor loss in rd10 mice. Although most photoreceptors are lost 
already by PND42, some cells, especially cones, persist preferentially in the peripheral retina 
of the rd10 mouse. These cells degenerate slowly over an extended period of time since 
expression of cone cell markers is detectable for several months (Samardzija et al., 2012). 
High Gpr65 expression correlated with the published increased levels of Caspase-1 and 
GFAP proteins in the two models (Samardzija et al., 2006b; Samardzija et al., 2012) and 
coincided with microglial activation (Joly et al., 2009; Peng et al., 2014). This may suggest a 
function of GPR65 in the regulation of an immune-like response in the retina. Indeed, a 
recent report suggested that GPR65 acts as a negative regulator of inflammation (Onozawa 
et al., 2011), a conclusion that may be supported by our observation that microglia activation 
may have been stronger in degenerating retinas that lack GPR65 (see below). 
Although Gpr65 was not required for normal retinal development and function, its 
absence slightly accelerated photoreceptor loss in the retina of rd10 mice. It has been 
reported previously that GPR65-mediated signaling can support survival of cells under acidic 
conditions, such as cancer cells in tumors (Sin et al., 2004; Ihara et al., 2010; Ryder et al., 
2012) and some immune cells (Kottyan et al., 2009). Since degenerative processes and cell 
death lead to changes in the tissue microenvironment including acidification, increased 
Gpr65 expression may contribute to processes that adapt cells to the changing tissue 
environment during retinal degeneration. Especially responsive to retinal alterations are the 
resident macro- and microglial cells that fulfill a variety of functions in retinal physiology and 
pathophysiology. Müller glia cells, for example, are highly reactive to stress and retinal 
degeneration, and support survival of neurons through production of protective growth 
factors, cytokines and other signaling molecules (Joly et al., 2008; Rhee et al., 2013). 
However, their (over) activation can also lead to gliosis contributing to degeneration and loss 
of vision (Bringmann et al., 2006). Similarly, microglia, which are the resident immune cells of 
the retina (Karlstetter et al., 2010), respond quickly to retinal injury in various ways. In the 
normal retina they localize mainly to the ganglion cell layer and have a ramified structure with 
extended processes surveying the surroundings for stress signals. After detection of such 
stress signals microglia become activated, acquire an amoeboid shape and migrate to the 
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site of injury or stress where they transform into phagocytes and participate in the clearance 
of cellular debris (Schwartz et al., 2006; Langmann, 2007; Karlstetter et al., 2014b). Although 
it is difficult to label microglia as ‘good’ or ‘bad’, increasing evidence indicate that activated 
microglia may be neurotoxic and may contribute to processes of retinal inflammation 
accelerating neurodegeneration (Xu et al., 2009; Karlstetter et al., 2014a; Karlstetter et al., 
2014b; Zeng et al., 2014). Recently it was shown that Gpr65 is one of the major transcripts in 
mouse microglia (Siegert et al., 2012), that GPR65 is the major acid sensing receptor 
expressed in these cells (Jin et al., 2014) and that GPR65 mediated signaling may repress 
expression of inflammatory genes, effectively blunting the inflammatory response to cell 
damage (Jin et al., 2014). Here we observed that expression of Gpr65 peaked at three days 
after light exposure (Fig. 2), at a time that correlates with strong microglial activity in the light-
damaged retina (Joly et al., 2009). We showed that microglia were still activated at five days 
after light exposure and seemingly even more so in retinas of Gpr65–/– mice (Fig. 5). Whether 
this was a direct consequence of the absence of GPR65 signaling or was indirectly caused 
by increased retinal stress remains to be investigated. However, it may suggest that 
increased microglia activity in Gpr65–/– may have contributed to the slightly accelerated 
photoreceptor degeneration observed in rd10 mice because activated retinal microglia elicit 
production and secretion of several cytokines and chemokines, a response that contributes 
to neurodegenerative disease mechanisms (Kreutzberg, 1995; Langmann, 2007). In this 
respect it is interesting to note that several cytokine or chemokine encoding genes such as 
Tgfb1, Ccl2, Ccl4 and Ccl5 showed a tendency towards a higher expression after light 
exposure in the Gpr65–/– mice. Although the effect was rather weak, cells in the retina of 
Gpr65–/– mice may thus produce more inflammatory cytokines, thereby increasing retinal 
stress and cell death. In conclusion, this study shows that Gpr65 is not essential for normal 
retinal development and function, but may be part of the tissue response to retinal stress or 
degeneration.  
 
ACKNOWLEDGEMENTS 
The authors are grateful to Marie-Gabrielle Ludwig and Dr. Klaus Seuwen (Novartis 
Institute for BioMedical Research (NIBR), Basel, Switzerland) for discussions and for sharing 
the Gpr65–/– mice, and to Carsten Wagner (University of Zürich, Zürich, Switzerland) for 
providing breeding pairs of these mice. We thank Cornelia Imsand, Andrea Gubler and 
Christel Beck for their skillful assistance in experimental procedures. This work was 
supported by the Swiss National Science Foundation (31003A_133043 and 
31003A_149311). 
Results 
 
103 
REFERENCES 
Bailey, J. L. (2005) Metabolic acidosis: an unrecognized cause of morbidity in the patient with 
chronic kidney disease. Kidney Int Suppl S15-S23. 
Barhoum, R., Martinez-Navarrete, G., Corrochano, S., Germain, F., Fernandez-Sanchez, L., 
de la Rosa, E. J., de la Villa, P. and Cuenca, N. (2008) Functional and structural 
modifications during retinal degeneration in the rd10 mouse. Neuroscience 155, 698-
713. 
Barnes, S., Merchant, V. and Mahmud, F. (1993) Modulation of transmission gain by protons 
at the photoreceptor output synapse. Proc Natl Acad Sci U S A 90, 10081-10085. 
Bringmann, A., Pannicke, T., Grosche, J., Francke, M., Wiedemann, P., Skatchkov, S. N., 
Osborne, N. N. and Reichenbach, A. (2006) Muller cells in the healthy and diseased 
retina. Prog Retin Eye Res 25, 397-424. 
Chang, B., Hawes, N. L., Hurd, R. E., Davisson, M. T., Nusinowitz, S. and Heckenlively, J. R. 
(2002) Retinal degeneration mutants in the mouse. Vision Res 42, 517-525. 
Chang, B., Hawes, N. L., Pardue, M. T., German, A. M., Hurd, R. E., Davisson, M. T., 
Nusinowitz, S., Rengarajan, K., Boyd, A. P., Sidney, S. S., Phillips, M. J., Stewart, R. 
E., Chaudhury, R., Nickerson, J. M., Heckenlively, J. R. and Boatright, J. H. (2007) Two 
mouse retinal degenerations caused by missense mutations in the beta-subunit of rod 
cGMP phosphodiesterase gene. Vision Res 47, 624-633. 
Detrick, B. and Hooks, J. J. (2010) Immune regulation in the retina. Immunol Res 47, 153-
161. 
DeVries, S. H. (2001) Exocytosed protons feedback to suppress the Ca2+ current in 
mammalian cone photoreceptors. Neuron 32, 1107-1117. 
Dmitriev, A. V. and Mangel, S. C. (2001) Circadian clock regulation of pH in the rabbit retina. 
J Neurosci 21, 2897-2902. 
English, P. and Williams, G. (2004) Hyperglycaemic crises and lactic acidosis in diabetes 
mellitus. Postgrad Med J 80, 253-261. 
Gatenby, R. A. and Gillies, R. J. (2004) Why do cancers have high aerobic glycolysis? Nat 
Rev Cancer 4, 891-899. 
Grimm, C. and Reme, C. E. (2013) Light damage as a model of retinal degeneration. 
Methods Mol Biol 935, 87-97. 
Hecke, F., Hoehn, T., Strauss, E., Obladen, M. and Sonntag, J. (2001) In-vitro activation of 
complement system by lactic acidosis in newborn and adults. Mediators Inflamm 10, 
27-31. 
Hirasawa, H., Yamada, M. and Kaneko, A. (2012) Acidification of the synaptic cleft of cone 
photoreceptor terminal controls the amount of transmitter release, thereby forming the 
receptive field surround in the vertebrate retina. J Physiol Sci 62, 359-375. 
Ihara, Y., Kihara, Y., Hamano, F., Yanagida, K., Morishita, Y., Kunita, A., Yamori, T., 
Fukayama, M., Aburatani, H., Shimizu, T. and Ishii, S. (2010) The G protein-coupled 
receptor T-cell death-associated gene 8 (TDAG8) facilitates tumor development by 
serving as an extracellular pH sensor. Proc Natl Acad Sci U S A 107, 17309-17314. 
Im, D. S., Heise, C. E., Nguyen, T., O’Dowd, B. F. and Lynch, K. R. (2001) Identification of a 
molecular target of psychosine and its role in globoid cell formation. J Cell Biol 153, 
429-434. 
Jancic, C. C., Cabrini, M., Gabelloni, M. L., Rodriguez Rodrigues, C., Salamone, G., Trevani, 
A. S. and Geffner, J. (2012) Low extracellular pH stimulates the production of IL-1beta 
by human monocytes. Cytokine 57, 258-268. 
Jin, Y., Sato, K., Tobo, A., Mogi, C., Tobo, M., Murata, N., Ishii, S., Im, D. S. and Okajima, F. 
(2014) Inhibition of interleukin-1beta production by extracellular acidification through 
the TDAG8/cAMP pathway in mouse microglia. J Neurochem 129, 683-695. 
Joly, S., Francke, M., Ulbricht, E., Beck, S., Seeliger, M., Hirrlinger, P., Hirrlinger, J., Lang, K. 
S., Zinkernagel, M., Odermatt, B., Samardzija, M., Reichenbach, A., Grimm, C. and 
Reme, C. E. (2009) Cooperative phagocytes: resident microglia and bone marrow 
immigrants remove dead photoreceptors in retinal lesions. Am J Pathol 174, 2310-
Results 
 
104 
2323. 
Joly, S., Lange, C., Thiersch, M., Samardzija, M. and Grimm, C. (2008) Leukemia inhibitory 
factor extends the lifespan of injured photoreceptors in vivo. J Neurosci 28, 13765-
13774. 
Justus, C. R., Dong, L. and Yang, L. V. (2013) Acidic tumor microenvironment and pH-
sensing G protein-coupled receptors. Front Physiol 4, 354. 
Kabarowski, J. H., Xu, Y. and Witte, O. N. (2002) Lysophosphatidylcholine as a ligand for 
immunoregulation. Biochem Pharmacol 64, 161-167. 
Karlstetter, M., Ebert, S. and Langmann, T. (2010) Microglia in the healthy and degenerating 
retina: insights from novel mouse models. Immunobiology 215, 685-691. 
Karlstetter, M., Nothdurfter, C., Aslanidis, A., Moeller, K., Horn, F., Scholz, R., Neumann, H., 
Weber, B. H., Rupprecht, R. and Langmann, T. (2014a) Translocator protein (18 kDa) 
(TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation 
and phagocytosis. J Neuroinflammation 11, 3. 
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M. and Langmann, T. (2014b) 
Retinal microglia: Just bystander or target for therapy? Prog Retin Eye Res  
Kottyan, L. C., Collier, A. R., Cao, K. H., Niese, K. A., Hedgebeth, M., Radu, C. G., Witte, O. 
N., Khurana Hershey, G. K., Rothenberg, M. E. and Zimmermann, N. (2009) Eosinophil 
viability is increased by acidic pH in a cAMP- and GPR65-dependent manner. Blood 
114, 2774-2782. 
Kreutzberg, G. W. (1995) Microglia, the first line of defence in brain pathologies. 
Arzneimittelforschung 45, 357-360. 
Kumar, N., Velic, A., Soliz, J., Shi, Y., Li, K., Wang, S., Weaver, J. L., Sen, J., Abbott, S. B. 
G., Lazarenko, R. M., Ludwig, M.-G., Peres-Reyes, E., Mohebbi, N., Bettoni, C., 
Gassmann, M., Suply, T., Seuwen, K., Guyenet, P. G., Wagner, C. A. and Bayliss, D. 
A. (in press) Regulation of breathing by CO2 requires the proton-activated receptor 
GPR4 in retrotrapezoid nucleus neurons. Science  
Langmann, T. (2007) Microglia activation in retinal degeneration. J Leukoc Biol 81, 1345-
1351. 
Lardner, A. (2001) The effects of extracellular pH on immune function. J Leukoc Biol 69, 522-
530. 
Li, Z., Dong, L., Dean, E. and Yang, L. V. (2013) Acidosis decreases c-Myc oncogene 
expression in human lymphoma cells: a role for the proton-sensing G protein-coupled 
receptor TDAG8. Int J Mol Sci 14, 20236-20255. 
Liu, J. P., Nakakura, T., Tomura, H., Tobo, M., Mogi, C., Wang, J. Q., He, X. D., Takano, M., 
Damirin, A., Komachi, M., Sato, K. and Okajima, F. (2010) Each one of certain histidine 
residues in G-protein-coupled receptor GPR4 is critical for extracellular proton-induced 
stimulation of multiple G-protein-signaling pathways. Pharmacol Res 61, 499-505. 
Ludwig, M. G., Vanek, M., Guerini, D., Gasser, J. A., Jones, C. E., Junker, U., Hofstetter, H., 
Wolf, R. M. and Seuwen, K. (2003) Proton-sensing G-protein-coupled receptors. Nature 
425, 93-98. 
Maghazachi, A. A., Knudsen, E., Jin, Y., Jenstad, M. and Chaudhry, F. A. (2004) D-
galactosyl-beta1-1’-sphingosine and D-glucosyl-beta1-1’-sphingosine induce human 
natural killer cell apoptosis. Biochem Biophys Res Commun 320, 810-815. 
Martinez, D., Vermeulen, M., Trevani, A., Ceballos, A., Sabatte, J., Gamberale, R., Alvarez, 
M. E., Salamone, G., Tanos, T., Coso, O. A. and Geffner, J. (2006) Extracellular 
acidosis induces neutrophil activation by a mechanism dependent on activation of 
phosphatidylinositol 3-kinase/Akt and ERK pathways. J Immunol 176, 1163-1171. 
Mogi, C., Tobo, M., Tomura, H., Murata, N., He, X. D., Sato, K., Kimura, T., Ishizuka, T., 
Sasaki, T., Sato, T., Kihara, Y., Ishii, S., Harada, A. and Okajima, F. (2009) 
Involvement of proton-sensing TDAG8 in extracellular acidification-induced inhibition of 
proinflammatory cytokine production in peritoneal macrophages. J Immunol 182, 3243-
3251. 
Mogi, C., Tomura, H., Tobo, M., Wang, J. Q., Damirin, A., Kon, J., Komachi, M., Hashimoto, 
K., Sato, K. and Okajima, F. (2005) Sphingosylphosphorylcholine antagonizes proton-
Results 
 
105 
sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol 
phosphate production and cAMP accumulation. J Pharmacol Sci 99, 160-167. 
Murata, N., Mogi, C., Tobo, M., Nakakura, T., Sato, K., Tomura, H. and Okajima, F. (2009) 
Inhibition of superoxide anion production by extracellular acidification in neutrophils. 
Cell Immunol 259, 21-26. 
Okajima, F. (2013) Regulation of inflammation by extracellular acidification and proton-
sensing GPCRs. Cell Signal 25, 2263-2271. 
Onozawa, Y., Komai, T. and Oda, T. (2011) Activation of T cell death-associated gene 8 
attenuates inflammation by negatively regulating the function of inflammatory cells. Eur 
J Pharmacol 654, 315-319. 
Peng, B., Xiao, J., Wang, K., So, K. F., Tipoe, G. L. and Lin, B. (2014) Suppression of 
microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa. 
J Neurosci 34, 8139-8150. 
Perez, V. L., Saeed, A. M., Tan, Y., Urbieta, M. and Cruz-Guilloty, F. (2013) The eye: A 
window to the soul of the immune system. J Autoimmun 45, 7-14. 
Perron, N. R., Beeson, C. and Rohrer, B. (2013) Early alterations in mitochondrial reserve 
capacity; a means to predict subsequent photoreceptor cell death. J Bioenerg 
Biomembr 45, 101-109. 
Radu, C. G., Nijagal, A., McLaughlin, J., Wang, L. and Witte, O. N. (2005) Differential proton 
sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and 
G2A expressed in immune cells. Proc Natl Acad Sci U S A 102, 1632-1637. 
Reber, F., Kasper, M., Siegner, A., Kniep, E., Seigel, G. and Funk, R. H. (2002) Alteration of 
the intracellular pH and apoptosis induction in a retinal cell line by the AGE-inducing 
agent glyoxal. Graefes Arch Clin Exp Ophthalmol 240, 1022-1032. 
Rhee, K. D., Nusinowitz, S., Chao, K., Yu, F., Bok, D. and Yang, X. J. (2013) CNTF-
mediated protection of photoreceptors requires initial activation of the cytokine receptor 
gp130 in Muller glial cells. Proc Natl Acad Sci U S A 110, E4520-E4529. 
Ryder, C., McColl, K., Zhong, F. and Distelhorst, C. W. (2012) Acidosis promotes Bcl-2 
family-mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled 
receptor Gpr65 signaling to Mek/Erk. J Biol Chem 287, 27863-27875. 
Samardzija, M., Wariwoda, H., Imsand, C., Huber, P., Heynen, S. R., Gubler, A. and Grimm, 
C. (2012) Activation of survival pathways in the degenerating retina of rd10 mice. Exp 
Eye Res 99, 17-26. 
Samardzija, M., Wenzel, A., Aufenberg, S., Thiersch, M., Reme, C. and Grimm, C. (2006a) 
Differential role of Jak-STAT signaling in retinal degenerations. FASEB J 20, 2411-
2413. 
Samardzija, M., Wenzel, A., Thiersch, M., Frigg, R., Reme, C. and Grimm, C. (2006b) 
Caspase-1 ablation protects photoreceptors in a model of autosomal dominant retinitis 
pigmentosa. Invest Ophthalmol Vis Sci 47, 5181-5190. 
Schwartz, M., Butovsky, O., Bruck, W. and Hanisch, U. K. (2006) Microglial phenotype: is the 
commitment reversible? Trends Neurosci 29, 68-74. 
Siegert, S., Cabuy, E., Scherf, B. G., Kohler, H., Panda, S., Le, Y. Z., Fehling, H. J., 
Gaidatzis, D., Stadler, M. B. and Roska, B. (2012) Transcriptional code and disease 
map for adult retinal cell types. Nat Neurosci 15, 487-95, S1. 
Sin, W. C., Zhang, Y., Zhong, W., Adhikarakunnathu, S., Powers, S., Hoey, T., An, S. and 
Yang, J. (2004) G protein-coupled receptors GPR4 and TDAG8 are oncogenic and 
overexpressed in human cancers. Oncogene 23, 6299-6303. 
Takahashi, A., Masuda, A., Sun, M., Centonze, V. E. and Herman, B. (2004) Oxidative 
stress-induced apoptosis is associated with alterations in mitochondrial caspase activity 
and Bcl-2-dependent alterations in mitochondrial pH (pHm). Brain Res Bull 62, 497-
504. 
Tanimoto, N., Muehlfriedel, R. L., Fischer, M. D., Fahl, E., Humphries, P., Biel, M. and 
Seeliger, M. W. (2009) Vision tests in the mouse: Functional phenotyping with 
electroretinography. Front Biosci (Landmark Ed) 14, 2730-2737. 
Tomura, H., Mogi, C., Sato, K. and Okajima, F. (2005) Proton-sensing and lysolipid-sensitive 
Results 
 
106 
G-protein-coupled receptors: a novel type of multi-functional receptors. Cell Signal 17, 
1466-1476. 
Vaupel, P., Kallinowski, F. and Okunieff, P. (1989) Blood flow, oxygen and nutrient supply, 
and metabolic microenvironment of human tumors: a review. Cancer Res 49, 6449-
6465. 
Wang, J. Q., Kon, J., Mogi, C., Tobo, M., Damirin, A., Sato, K., Komachi, M., Malchinkhuu, 
E., Murata, N., Kimura, T., Kuwabara, A., Wakamatsu, K., Koizumi, H., Uede, T., 
Tsujimoto, G., Kurose, H., Sato, T., Harada, A., Misawa, N., Tomura, H. and Okajima, 
F. (2004) TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled 
receptor. J Biol Chem 279, 45626-45633. 
Wang, T. M., Holzhausen, L. C. and Kramer, R. H. (2014) Imaging an optogenetic pH sensor 
reveals that protons mediate lateral inhibition in the retina. Nat Neurosci 17, 262-268. 
Wenzel, A., Grimm, C., Samardzija, M. and Reme, C. E. (2005) Molecular mechanisms of 
light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. 
Prog Retin Eye Res 24, 275-306. 
Xu, H., Chen, M. and Forrester, J. V. (2009) Para-inflammation in the aging retina. Prog 
Retin Eye Res 28, 348-368. 
Yang, Z., Alvarez, B. V., Chakarova, C., Jiang, L., Karan, G., Frederick, J. M., Zhao, Y., 
Sauve, Y., Li, X., Zrenner, E., Wissinger, B., Hollander, A. I., Katz, B., Baehr, W., 
Cremers, F. P., Casey, J. R., Bhattacharya, S. S. and Zhang, K. (2005) Mutant 
carbonic anhydrase 4 impairs pH regulation and causes retinal photoreceptor 
degeneration. Hum Mol Genet 14, 255-265. 
Zeng, H., Ding, M., Chen, X. X. and Lu, Q. (2014) Microglial NADPH oxidase activation 
mediates rod cell death in the retinal degeneration in rd mice. Neuroscience 275, 54-
61. 	  	  
Results 
 
107 
 
FIGURE LEGENDS 
Figure 1. Gene expression levels of proton-sensing GPCRs in the retina. (A-C) Relative 
expression levels of (A) Gpr4, (B) Gpr65 and (C) Gpr68 in retinas of 129S6, BALB/c and 
C57BL/6 mice at PND60 – PND74. (D-F) Relative expressions of (D) Gpr4, (E) Gpr65 and 
(F) Gpr68 during retinal development in BALB/c mice. Expression was determined by semi-
quantitative real-time PCR, normalized to Actb and expressed relative to the levels in 129S6 
(A-C) or to PND1 (D-F). Shown are mean values ± SD of N = 3. Significance was tested 
using two-way ANOVA analysis (*** P < 0.001). 
Figure 2. Upregulation of Gpr65 expression during inherited and induced retinal 
degeneration. (A-C) Relative expression of (A) Gpr4, (B) Gpr65 and (C) Gpr68 in rd10 (red) 
and control wild type C57BL/6 (black) mice at time points as indicated. (D-F) Relative 
expressions of (D) Gpr4, (E) Gpr65 and (F) Gpr68 before (dark ctrl), immediately (imm) or at 
various time points (as indicated) after exposure of wild type BALB/c mice to 5’000 lux of 
white light for 1 h. Expression levels were determined by semi-quantitative real-time PCR, 
normalized to Actb and expressed relative to the levels of controls at PND10 (A-C) or to 
controls not exposed to light (D-F). Shown are mean values ± SD of N = 3. Significance at 
individual time points was tested using Student’s t-test (* P < 0.05, ** P < 0.01, *** P < 
0.001). 
Figure 3. Normal retinal morphology and function in absence of GPR65 (A) Retinal 
morphology of Gpr65+/– and Gpr65–/– mice at 12 weeks and 6 months of age. Images were 
taken from the temporal retina at 200 µm from the optic nerve head. Shown are 
representative images of N = 3 retinas per genotype and time point. Scale bar, 50 µm. (B) 
Relative expression levels of selected genes in retinas of 12-week-old Gpr65+/– (black 
columns) and Gpr65–/– (red columns) mice. Expression levels were determined by semi-
quantitative real-time PCR, normalized to Actb and expressed relative to the levels of 
Gpr65+/– control mice. Shown are mean values ± SD of N = 3. Significance was tested using 
Student’s t-test. * P < 0.05. (C) Scotopic and photopic electroretinograms of Gpr65+/– and 
Gpr65–/– mice at 12 weeks of age. Top panels: representative traces of individual mice, 
Bottom panels: Scotopic a- and b- wave amplitudes and photopic b-wave amplitudes as a 
function of light intensity for N = 3 mice (6 retinas) per genotype.  
Figure 4. Slight acceleration of retinal degeneration in rd10 mice in the absence of GPR65. 
(A) Retinal morphology of C57BL/6, rd10 and Gpr65–/–;rd10 mice at PND15, PND21 and 
PND42. Shown are representative sections of N = 3 animals for all genotypes and ages, 
except for C57BL/6 at PND21 and Gpr65–/–;rd10 at PND42 (N = 2). Scale bar: 50 µm. (B) 
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Retinal thickness and (C) ONL thickness of C57BL/6 (black), rd10 (red) and Gpr65–/–;rd10 
(blue) mice, measured at 200, 400, 600, 800, 1000, 1200, 1400, 1600 and 1800 µm from the 
optic nerve head (0). Shown are mean values ± SD of N = 3 animals for all genotypes and 
ages, except for C57BL/6 at PND21 and Gpr65–/–;rd10 at PND42 (N = 2). Significance was 
tested using Student’s t-test. 
Figure 5. Strong activation of microglia in light damaged retinas lacking GPR65. Gpr65+/– 
and Gpr65–/– mice were exposed to 15’000 lux of white light for 2 h, and tested for microglia 
after 5 days of recovery by immunostaining of retinal flat mounts with an antibody against 
IBA1. Shown are representative images of non-damaged and damaged retinal areas as 
indicated. Focal plane was at the outer plexiform layer. Scale bar: 50 µM. N = 2. 
Figure 6. Gene expression in light damaged retinas of 6-8 week old Gpr65+/– and Gpr65–/– 
mice. Expression of selected genes was determined before (dark control, DC, black 
columns) and at 1 day after exposure to 15’000 lux of white light for 2 h (LE, red columns) by 
real-time PCR. Levels were normalized to Actb and expressed relative to the dark control of 
Gpr65+/– mice (set to 1). As expression of Ccl8 was below detection limit in retinas of dark 
controls, Ccl8 levels in light exposed mice were expressed relative to Actb. Shown are mean 
values ± SD of N = 3. n.d. - not detectable. Significance was tested using Student’s t-test (* P 
< 0.05, ** P < 0.01, *** P < 0.001).  
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Figure 1 
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Figure 2 
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Figure 4 
 
 
 
 
C57BL/6 rd10 Gpr65-/-;rd10 A 
P
N
D
15
 
P
N
D
21
 
P
N
D
42
 
ONL 
INL 
GCL 
ONL 
INL 
GCL 
ONL 
INL 
GCL 
A 
C 
-2000 -1000 0 1000 2000 
PND15 
-2000 -1000 0 1000 2000 
PND21 
-2000 -1000 0 1000 2000 
PND42 
B 
-2000 -1000 0 1000 2000 
PND15 
-2000 -1000 0 1000 2000 
PND21 
-2000 -1000 0 1000 2000 
PND42 
C57BL/6 rd10 Gpr65-/-;rd10 
C57BL/6 rd10 Gpr65-/-;rd10 
300 
250 
200 
150 
100 
50 
0 
70 
60 
50 
40 
30 
20 
0 
10 
 1000 1000 10  
 1000  1000  1000 
B 
C 
Results 
 
113 
Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
G
pr
65
 +
/- 
G
pr
65
 -/
- 
not damaged damaged 
Results 
 
114 
Figure 6 
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Table 1. Primers used for semiquantitative real-time PCR 
 
 
 
Gene Forward primer Reverse primer Annealing 
temp(°C) 
Amplicon 
size (bp) 
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 62 153 
Gpr4  (BALB/c) CGGAGCAGGCCTAGCAATCT TGAGTAAGTGGCAGAGCACAGG
A 
60 158 
Gpr4  (C57BL/6) CGGAGCAGGCCTAGCAATCT TGAGTAAGTGGTGGAGCACAGG
A 
60 158 
Gpr4  (129S6) CGGAGCAGCCTAGCAGTCG TGAGTAAGTGGCAGAGCACAGG
A 
60 157 
Gpr65  (BALB/c) GCCAGCCTCCTCAGTCAAGA GATTGGAGATTGGTCGATGC 60 125 
Gpr65  (C57BL/6) GCCAGCCTCCTCAGTCAAGA GATTGGAGATTGGTCGGTGC 60 125 
Gpr65  (129S6) GCCAGCCTCCTCAGTCAAGA GATAGGAGATTGGTCGGTGC 60 125 
Gpr68 GACCTACCTGTGGGACAGAA GCCAATCCCTCTCTTGCCAT 58 178 
Gnat1 GAGGATGCTGAGAAGGATGC TGAATGTTGAGCGTGGTCAT 58 209 
Gnat2 GCATCAGTGCTGAGGACAAA CTAGGCACTCTTCGGGTGAG 58 192 
Vsx2 CCAGAAGACAGGATACAGGTG GGCTCCATAGAGACCATACT 60 111 
Calb1 GGATTGGAGCTATCACCGGA GACTTCAGTTGCTGGCATCG 60 146 
Calb2 TTCCTGTCTGACCTCCTGA ACATCCGTAGTATGGTCTGG 62 85 
Pou4f1 CGCCGCTGCAGAGCAACCTCTT TGGTACGTGGCGTCCGGCTT 62 130 
Glul TCCGCAAAGACCCCAACAAG CCATTATCCGTTTACAGATGTGC
C 
62 99 
Casp1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC 60 138 
Gfap CCACCAAACTGGCTGATGTCTA
C 
TTCTCTCCAAATCCACACGAGC 62 240 
Fgf2 TGTGTCTATCAAGGGAGTGTGT
GC 
ACCAACTGGAGTATTTCCGTGA
CCG 
62 158 
Stat3 CAAAACCCTCAAGAGCCAAGG T ACTCACAATGCTTCTCCGC 62 133 
Edn2 AGACCTCCTCCGAAAGCTG CTGGCTGTAGCTGGCAAAG 60 64 
Lif AATGCCACCTGTGCCATACG CAACTTGGTCTTCTCTGTCCCG 60 216 
Tnf CCACGCTCTTCTGTCTACTGA GGCCATAGAACTGATGAGAGG 62 92 
Tgfb1 GCAACATGTGGAACTCTACCAG CAGCCACTCAGGCGTATCA 62 94 
Ccl2 GGCTCAGCCAGATGCAGTTA CTGCTGCTGGTGATCCTCTT 60 108 
Ccl4 CAAGCCAGCTGTGGTATTC AGCTGCTCAGTTCAACTCC 62 109 
Ccl5 GCTCCAATCTTGCAGTCGT CTAGAGCAAGCGATGACAGG 62 165 
Ccl8 CCAGATAAGGCTCCAGTCA ACAGAGAGACATACCCTGCT 62 147 
Ccl9 CAACTGCTCTTGGAATCTGG AGGCAGCAATCTGAAGAGTC 62 136 
Ccl12 CCTCAGGTATTGGCTGGAC GACACTGGCTGCTTGTGATT 62 124 
Csf1r CCCTGGAGGCTATGGAGTTG CCACTAGGCTCGATGACAGG 62 91 
Cx3cl1 CCGCGTTCTTCCATTTGT CTGTGCTGTGTCGTCTCCA 62 175 
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4. CONCLUDING DISCUSSION 
A mouse model to study hypoxic aspects of retinal degeneration 
AMD is a multifactorial disease and a major cause of visual impairment resulting in a 
huge social and economic burden. Age-related retinal changes – such as reduced density of 
choriocapillaries, thickening of the bruch’s membrane, accumulation of lipofuscin and by-
products of oxidative processes in the RPE, drusen accumulation, reduced ability of the RPE 
to clear the remnants of oxidative stress (Seddon and Chen, 2004), can affect the oxygen 
and nutrient supply to the photoreceptors causing a mild but chronic hypoxic situation, as the 
photoreceptors rely on the choroid for O2 and nutrient supply. In addition to these age-related 
changes, lifestyle choices contribute to the chances of developing the disease. Smoking and 
obesity are two lifestyle factors that are highly correlated to the disease. Finally the most 
important factor is genetic propensity to acquire the disease as mutations in many genes 
involved in complement pathways (Cfb, CFh, C3, Cfi and C2), cholesterol metabolism (Cetp, 
Lipc, Abca1 and ApoE), extracellular matrix remodelling (Htra1, Timp3, Col8a1) and 
oxidative stress (Arms2) are linked to the disease (macularisk.com). The disease is 
characterized by drusen accumulation, loss of photoreceptors, RPE atrophy and in certain 
cases aberrant vessel formation and leakage (CNV). Hence, apart from several factors that 
contribute to the chances of acquiring the disease, there are also several features of the 
disease that manifest to varying degrees in different patients, making the development of a 
standard animal model for study quite challenging.  
As mentioned earlier, attempts have been made to develop models to study 
specific causes or features of the disease, but the hypoxic aspect has not been considered 
before. The age-related changes that affect oxygen supply and consumption may have a 
major impact on disease development and progression. And since HIFs are major 
transcription factors that regulate cellular responses to hypoxia, we aimed at developing 
mouse models that accumulate HIF1A (Opsin-Cre;Vhlflox) or lack HIF1A (Opsin-
Cre;Vhlflox;Hif1aflox) specifically in the rod photoreceptors. Earlier models using a Pax6 
promoter to delete Vhl in the developing retina resulted in degeneration in peripheral retina 
(Lange et al., 2011b), but the vascular phenotype was most obvious in these mice, as the 
vessels were severely malformed (Kurihara et al., 2010). Also the deletion of Hif1a using a 
Pax6 promoter resulted in failure of development of the intermediate plexus of the retinal 
vessels (Caprara et al., 2011). We used an Opsin promoter to drive Cre expression in the 
rods to delete the floxed Vhl gene, which led to loss of photoreceptors on HIF1A 
accumulation (Lange et al., 2011a) and this degeneration phenotype was completely rescued 
in the Opsin-Cre;Vhlflox;Hif1aflox mice. In the developing retina HIF1A is required mainly for the 
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correct formation of vessels, but in the adult retina when the blood vessels are completely 
developed HIF1A is not important.  
Another reason these mice are a good ‘hypoxia model for degeneration’ is that the 
degeneration is age-related. We observed that at 11 weeks of age the retinas of the HIF1A 
stabilized mice appear stressed, with upregulation of stress-pathway related genes, 
indications of gliosis and minor morphological changes especially in the outer segments of 
the photoreceptors. These features are further worsened at 4 months, 6 months and 1 year 
of age. This slow and progressive manner of degeneration is a distinctive feature of AMD. 
Hence, these mice not only mimic the slow progression of the disease as it might occur in 
humans, but also provide a large window of opportunity to test therapies, which can be 
administered between 10-16 weeks of age and monitored at 6-12 months. This would be a 
major advantage over some other mouse models wherein the degeneration is often faster 
and more dramatic. 
Photoreceptors are the major and the most abundant cells in the retina, and rely on 
choroidal blood supply the most, whereas the other cells of the INL and GCL rely on the 
retinal vasculature. Since age-related changes affect the choroidal supply to the retina the 
outer retina (photoreceptors and RPE) is most likely to experience hypoxia. Thus, our mice 
(Opsin-Cre;Vhlflox and Opsin-Cre;Vhlflox;Hif1aflox) enable the study of a hypoxia-like situation 
specifically the role of HIF1A, in the rods (most abundant photoreceptors). In both the 
genotypes, the other cell types (even the RPE cells) as well as the retinal vessels are not 
majorly affected. 
Apart from age-related degeneration, these mice do not display other features of 
AMD. Drusen accumulation is one of the most distinctive features of the disease, but drusen 
deposits (as in humans) have not been observed in mice, although drusen-like deposits have 
been reported (Imamura et al., 2006; Luhmann et al., 2009). RPE atrophy often occurs 
before or along with loss of photoreceptors in the disease, which could be due to the fact that 
the RPE depends on choroidal blood supply too and may experience hypoxia as much as the 
photoreceptors. In the Opsin-Cre;Vhlflox mice, the RPE is not majorly affected, except at older 
age, which may be a secondary effect of photoreceptor degeneration. Mice were developed 
with the deletion of Vhl specifically in the RPE, but due to the usage of an early promoter the 
observed phenotype related to developmental defects such as aniridia, microphthalmia and 
persistence of embryonic vascular structures into adulthood in addition to loss of RPE cells 
(Lange et al., 2012) (A conditional knockdown of Vhl in the RPE of adult mice may be a 
plausible solution). Thus, the Opsin-Cre;Vhlflox mice may not emulate all features of the 
disease but yet would prove useful for studying hypoxic aspects of degeneration and testing 
therapies over a larger time frame. 
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Several cellular mechanisms are affected by hypoxia in the retina 
We established that the stabilization (Opsin-Cre;Vhlflox mice) or deletion of HIF1A  
(Opsin-Cre;Vhlflox;Hif1aflox mice) respectively caused or prevented degeneration. But the 
exact mechanisms are not clearly understood yet. This led us to perform a transcriptome 
analysis comparing the two genotypes, resulting in a list of many differentially regulated 
genes, which were part of diverse pathways. One such group of genes found to be 
upregulated were the complement factors. This was an exciting turn of events as 
complement factors are genetically linked to AMD and the biochemical analyses of drusen 
deposits revealed fragments of complement factors. But a connection to hypoxia was never 
established, hence we hypothesized that maybe the aged hypoxic retina stabilizes HIF1A, 
which upregulates complement factors that accumulate and aggravate the effect, finally 
causing cell death. We confirmed an upregulation in the different complement factors – C3, 
C4b, Cfh, Cfi, Cfb and Serping1 tested by real-time PCR, but there were huge variations 
within the same group. Further these factors were also upregulated in rd10 mice, after the 
onset of degeneration suggesting that complement pathway activation may not be a direct 
but a secondary effect of HIF1A mediated mechanisms in the Opsin-Cre;Vhlflox mice. The 
complement factors are not known to be direct targets of HIF1A, and we did not identify any 
HRE elements on analyzing a 2 kb region upstream of the coding sequence of C3 gene, 
hence not providing evidence of HIF1A binding. 
Metabolic adaptations occur in cells in response to nutrient availability, stress and 
environmental changes. Although these adaptations help the cells to cope with and survive 
the periods of stress, they may be detrimental to cellular function and survival in the long run. 
One such hypoxia-mediated adaptation is a shift from the efficient energy production by 
oxidative phosphorylation to the less efficient process of glycolysis. This low metabolic 
activity (essentially like a stand-by mode for cells) helps cells in the short-term, but extended 
periods of glycolysis affects pH homeostasis, accumulates metabolites which may not be 
cleared away and most importantly causes ATP depletion affecting essentially all ATP 
dependent cellular mechanisms. Some preliminary tests in our mice indicated that stabilized 
HIF1A might cause such a metabolic shift in the retina, hinting towards one possible 
mechanism responsible for degeneration, but detailed analyses of the metabolites and 
proteins involved will be required to establish a connection. 
 Mechanisms that degrade the extracellular matrix are a common feature of 
degenerative processes (Nita et al., 2014). Our transcriptome data contained several matrix 
metalloproteinases (MMPs) that are involved in the degradation of ECM. Cytokines and 
chemokines that are part of stress-related signalling pathways and inflammatory responses 
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were also found to be upregulated. Further analyses of these pathways will result in a better 
understanding of the degeneration mechnisms. 
A systematic approach for better understanding of the impact of hypoxia 
As several pathways directly or indirectly related to HIF1A converge to finally cause 
degeneration, a systematic approach would be required to understand each aspect 
individually and collectively with respect to hypoxia and retinal degeneration. As a first step 
towards this goal we compared the transcriptomes of the mice with HIF1A stabilized (Opsin-
Cre;Vhlflox) to the ones lacking HIF1A (Opsin-Cre;Vhlflox;Hif1aflox) in the rods. Analysis of 
some pathways/ mechanisms was done as described earlier and in addition we also verified 
individual candidates by real-time PCR (Section 3.2.1).  
One such candidate – Stc2 was highly upregulated in response to hypoxia, and its 
role in the retina has not been previously described. Unlike Stc2, Stc1 was not identified in 
the transcriptome data. We were able to show that Stc2 has normal and comparable 
expression during development and retinal degeneration. However, under hypoxic conditions 
it was upregulated in the retina while its paralog Stc1 was not. Further, using our mouse 
models with HIF1A stabilized and deleted in the rods we were able to show that only Stc2 
and not Stc1 was HIF1A regulated as the presence of HIF1a in the rods even under 
normoxia was sufficient to increase gene expression of Stc2. The retinas of Stc1-/- and Stc2-
/- mice seem to develop normally, indicating their non-essential role during development, 
which may become essential if these mice undergo hypoxic stress. The normal expression of 
the gene is in the INL and GCL and the protein localized to the neurofilaments (STC2 is a 
secreted protein). Hence it is worthwhile to further investigate the exact retinal processes that 
Stc2 may be involved in, as this will shed light on how hypoxia in the photoreceptors affects 
other cell types. 
Anti-Hif1a as a therapy to prevent degeneration 
Anti-VEGF is used as a therapy for the wet form of AMD that is characterized by 
neovascularization. But, the effectiveness of the therapy is not consistent, as there are 
variations in patient response to therapy. Nonetheless it is still the treatment provided for wet 
AMD patients mostly because of the lack of an alternative. Vegf is a target of HIF1A, and 
hence, blocking/ knocking down Hif1a, might be a better alternative. Like Vegf, many other 
genes are targets of HIF1A and blocking the main regulator, will prevent the effects of the 
targets. HIF1A is required during early stages for the correct vascular development, but in 
adult mice loss of HIF1A does not have a major effect. On the contrary the accumulation of 
HIF1A, as could be the case in the aged hypoxic retinas, causes degeneration. Hence, 
targeting and knocking down Hif1a in diseased retinas might be an effective therapy. 
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Therapy for dry-AMD is an unmet medical need. The Opsin-Cre;Vhlflox mice serve as a model 
for dry form of the disease, wherein knocking down Hif1a would prevent degeneration (as is 
the case of Opsin-Cre;Vhlflox;Hif1aflox mice). 
I tested several siRNA sequences against Hif1a, and selected the most effective one. 
siRNAs are unstable, easily degraded by cellular mechanisms and cannot be packaged into 
Adeno-associated viruses (AAVs) for injections, hence usage of shRNAs is preferred. Thus, 
the selected shRNA against Hif1a was sent for packaging into AAVs. These AAVs containing 
the shRNA against Hif1a would be injected sub-retinally into the Opsin-Cre;Vhlflox mice at 11 
weeks of age, and the rescue of degeneration would be analyzed at 6 months of age. If 
these studies prove successful, this could be translated to the clinics, as already subretinal 
injections of AAVs containing CNGB1 is proposed as a therapy for a form of autosomal 
recessive retinitis pigmentosa (Koch et al., 2012) and gene therapy by injections of AAVs 
containing RPE65 for a form Leber’s congenital amaurosis is in clinical trials (Hauswirth et 
al., 2008). 
Stress beyond hypoxia and HIF1A 
 Apart from hypoxia, the retina is sensitive to other stresses that can alter the cellular 
function and tissue homeostasis - one such stress being acidosis/ pH stress. G-protein 
coupled receptors (GPRs) might aid the retinal cells in coping with pH changes. We analyzed 
three Gprs - Gpr4, Gpr65 and Gpr68 and were able to show the normal expression of in the 
retinas of WT mice. When the expression was tested in inherited and induced models of 
retinal degeneration, only Gpr65 was upregulated during degeneration, hinting towards 
specific and distinct roles of the GPRs in the retina. The Gpr65-/- mice had normal retinal 
structure and function, suggesting that the protein is not required during development or for 
normal function, but might have an essential role in stress response. Furthermore, the 
additional loss of Gpr65 in degenerating mice (rd10;Gpr65-/-) caused accelerated 
degeneration and more activated microglia were observed in the Gpr65-/- following light 
exposure. This study provided evidence for the differential response (in healthy and 
degenerating conditions) of Gprs in the retina.   
Taken together, the results of my work contribute to a better understanding of hypoxic 
stress specifically the role of HIF1A in the retina, as well as open up interesting dimensions 
for further investigation.  
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5.2. Additional methods 
Fundus imaging and fluorescein angiography  - Pupils were dilated with 1% cyclogyl and 
5% phenylephrine. 30 min post-dilation, mice were anesthetized with ketamine (66.7 mg/kg) 
and xylazine (11.7 mg/kg) and corneas were moistened with 2% methocel (OmniVision, 
Puchheim, Germany). Fundi were monitored and photographed using a mouse imaging 
system (Micron III, Phoenix Research Laboratories, Pleasanton, CA, USA). Fluorescein 
solution (2% in PBS; AK-FLUOR; Lake Forest, IL, USA) was injected intraperitoneally and 
eyes were analyzed immediately.  
 
Retinal flatmounts and immunofluorescence – Enucleated eyes were fixed for 3-5 min in 
2% (w/v) paraformaldehyde (PFA) in PBS. The sclera was dissected from the eyes and the 
lens, iris and vitreous were removed. The retina was flattened and stored in methanol at -
20°C. before use, the retina was post-fixed in 4% PFA in PBS for 10 min. For 
immunofluorescence, the flatmounted retina was washed in PBS and incubated in blocking 
solution (1% fetal bovine serum, 0.1% tritonX-100 in PBS) for 1 h. Flatmounts were then 
incubated with Alexa594-conjugated isolectin-A4 (Invitrogen, Basel, Switzerland, Catalogue 
number – 121413) at 4°C overnight, washed and mounted in MOWIOL anti-fade medium 
(Calbiochem, San Diego, CA, USA). The flatmounts were then imaged and analyzed using a 
digitalized Axiovision microscope (Carl Zeiss AG, Feldbach, Switzerland). 
 
siRNA knockdown of Hif1a in vitro – Mouse fibroblast cells – NIH3t3 (LGC standards, 
Wesel Germany, #ATCC-CRL-1658) were seeded in a 6 well plate at a density of 25000 
cells/well and left at 37°C, 21% O2 overnight. Cells were transfected with Hif1a siRNAs 
(Dharmacon, Fischer scientific, Wohlen, Switzerland), using the lipofectamine RNAiMAX 
reagent (Life Technologies, Zug, Switzerland, Catalogue no. 13778) and incubated overnight 
at 37°C, 21% O2. Then the control plate was left at normoxia and the other plate was kept at 
hypoxia (37°C, 0.2% O2 for 6 hr) in a hypoxic chamber (Baker Ruskinn InvivO2 400, South 
Wales, UK). After 6 h, the cells were lysed, centrifuged and the supernatant collected for 
proteins that were analyzed for HIF1A by western blotting. 
 
Other experimental procedures are listed in the corresponding sections, as follows – 
 
Section 3.1.1 – Transcriptome analysis, Morphology and light microscopy, Hypoxic 
treatment of animals, Western blotting, RNA isolation, cDNA preparation, Semi-quantitative 
real-time PCR, Immunofluorescence on retinal cryosections, RPE flatmounts preparation and 
analysis, Lactate assay and Statistical analysis. 
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Section 3.2.3 - Morphology and light microscopy, Western blotting, RNA isolation, cDNA 
preparation, Semi-quantitative real-time PCR, Immunofluorescence on retinal cryosections, 
Laser capture microdissection and Statistical analysis. 
 
Section 3.3 – Light exposure, Electroretinogram, Morphology and light microscopy, Western 
blotting, RNA isolation, cDNA preparation, Semi-quantitative real-time PCR, 
Immunofluorescence on retinal flatmounts, Statistical analysis. 
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Entrez ID Gene Symbol Description fold change pValue
71957 Cpsf3l cleavage and polyadenylation specific factor 3-like 228.5 5.20E-09
619297 C430049E01Rik RIKEN cDNA C430049E01 gene 143.5 5.39E-09
223780 Adm2 adrenomedullin 2 70.8 1.19E-06
13615 Edn2 endothelin 2 65.8 3.12E-08
76487 Ppp1r3g protein phosphatase 1, regulatory (inhibitor) subunit 3G 59.1 5.15E-06
213742 Xist inactive X specific transcripts 35.3 3.01E-02
240913 Adamts4 a disintegrin-like and metallopeptidase with thrombospondin type 1 motif, 4 24.7 2.89E-04
236220 LOC236220 hypothetical protein LOC236220 24.3 1.34E-05
11535 Adm adrenomedullin 23.6 6.34E-08
16763 Lad1 ladinin 23.3 3.38E-05
67573 Loxl4 lysyl oxidase-like 4 22.4 2.51E-04
381359 Prdm12 PR domain containing 12 19.6 1.37E-05
12051 Bcl3 B-cell leukemia/lymphoma 3 18.7 4.52E-06
233187 Lim2 lens intrinsic membrane protein 2 17 2.37E-02
17339 Mip major intrinsic protein of eye lens fiber 16.3 2.49E-02
21818 Tgm3 transglutaminase 3, E polypeptide 15.6 4.76E-04
75290 4930557B15Rik RIKEN cDNA 4930557B15 gene 14.4 1.07E-02
20856 Stc2 stanniocalcin 2 13.8 5.69E-07
319506 7530428D23Rik RIKEN cDNA 7530428D23 gene 13.6 5.51E-02
276829 Smtnl2 smoothelin-like 2 13.3 2.79E-07
14663 Glycam1 glycosylation dependent cell adhesion molecule 1 13 1.27E-03
67573 Loxl4 lysyl oxidase-like 4 12.6 1.99E-05
15006 H2-Q1 histocompatibility 2, Q region locus 1 12.3 9.49E-06
68380 0610042G04Rik RIKEN cDNA 0610042G04 gene 11.9 3.10E-08
14173 Fgf2 fibroblast growth factor 2 11.7 7.27E-06
192199 Rspo1 R-spondin homolog (Xenopus laevis) 11.4 2.04E-02
213742 Xist inactive X specific transcripts 11.3 2.45E-02
12954 Cryaa crystallin, alpha A 11 1.64E-02
100039660 Ect2l epithelial cell transforming sequence 2 oncogene-like 10.9 3.46E-05
77998 Grifin galectin-related inter-fiber protein 10.7 1.75E-02
15019 H2-Q8 histocompatibility 2, Q region locus 8 10.6 2.15E-09
238692 Zfp874a zinc finger protein 874a 10.4 4.21E-06
54382 Tcstv1 2-cell-stage, variable group, member 1 10.4 2.32E-04
214301 Crygn crystallin, gamma N 10.3 1.19E-02
12268 C4b complement component 4B (Childo blood group) 10.2 1.60E-05
UPREGULATED GENES
 Opsin-Cre;Vhlflox (Single) vs Opsin-Cre;Vhlflox;Hif1aflox (Double)
5.3.1  DIFFERENTIALLY REGULATED GENES (TRANSCRIPTOME ANALYSIS)
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18073 Nid1 nidogen 1 10.2 1.54E-02
12962 Crybb3 crystallin, beta B3 10.2 1.19E-02
19013 Ppara peroxisome proliferator activated receptor alpha 9.9 4.40E-06
12609 Cebpd CCAAT/enhancer binding protein (C/EBP), delta 9.5 2.12E-06
100043899 R3hdml R3H domain containing-like 9.4 1.68E-03
434280 Gm5607 predicted gene 5607 9.4 3.64E-02
94224 Srd5a2 steroid 5 alpha-reductase 2 9.2 1.74E-02
79554 Gltpd1 glycolipid transfer protein domain containing 1 9.2 1.19E-04
30923 Foxe3 forkhead box E3 9.1 4.89E-03
68662 Scgb3a1 secretoglobin, family 3A, member 1 9.1 8.28E-05
19153 Prx periaxin 8.7 4.70E-03
14611 Gja3 gap junction protein, alpha 3 8.6 1.76E-02
74492 Kbtbd13 kelch repeat and BTB (POZ) domain containing 13 8.6 2.12E-03
13646 Klk1b22 kallikrein 1-related peptidase b22 8.6 5.57E-05
Entrez ID Gene Symbol Description fold change pValue
329478 C130078N14 hypothetical protein C130078N14 137.6 1.52E-12
76681 Trim12a tripartite motif-containing 12A 70.8 8.54E-09
80509 Med8 mediator of RNA polymerase II transcription, subunit 8 homolog (yeast) 40.7 1.54E-06
69301 1700008P20Rik RIKEN cDNA 1700008P20 gene 40.5 2.20E-07
30939 Pttg1 pituitary tumor-transforming gene 1 38.1 1.81E-10
258198 Olfr224 olfactory receptor 224 37 2.80E-05
433100 AA388235 expressed sequence AA388235 36.6 3.36E-11
54631 Nphs1 nephrosis 1 homolog, nephrin (human) 36.4 4.80E-07
69301 1700008P20Rik RIKEN cDNA 1700008P20 gene 34 1.95E-06
17996 Neb nebulin 31.8 0.09391
75764 Slx1b SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) 29.5 4.22E-09
14537 Gcnt1 glucosaminyl (N-acetyl) transferase 1, core 2 28.7 3.59E-11
26908 Eif2s3y eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked 25.7 0.06617
26900 Ddx3y DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked 20.4 0.06557
30939 Pttg1 pituitary tumor-transforming gene 1 19.6 3.72E-06
109685 Hyal3 hyaluronoglucosaminidase 3 19.3 3.57E-06
73061 3110007F17Rik RIKEN cDNA 3110007F17 gene 19.2 3.63E-10
72154 Zfp157 zinc finger protein 157 18.9 2.11E-07
67705 1810058I24Rik RIKEN cDNA 1810058I24 gene 17.4 9.13E-06
74602 4833428L15Rik RIKEN cDNA 4833428L15 gene 14.5 2.38E-07
17921 Myo7a myosin VIIA 14.1 3.64E-08
26450 Rbbp9 retinoblastoma binding protein 9 13.7 0.06114
214523 Tmprss4 transmembrane protease, serine 4 12 2.07E-08
DOWNREGULATED GENES
134
72461 Prcp prolylcarboxypeptidase (angiotensinase C) 10 9.91E-09
100040410 Gm14957 predicted gene 14957 9.8 1.31E-07
269209 Stk36 serine/threonine kinase 36 (fused homolog, Drosophila) 9.7 4.68E-06
94216 Col4a6 collagen, type IV, alpha 6 9 0.0003704
140709 Emid2 EMI domain containing 2 8.9 9.73E-07
70979 4931417G12Rik RIKEN cDNA 4931417G12 gene 8.2 2.47E-08
73061 3110007F17Rik RIKEN cDNA 3110007F17 gene 8.1 0.005393
76681 Trim12a tripartite motif-containing 12A 7.9 0.0001357
209760 Tmc7 transmembrane channel-like gene family 7 7.8 1.24E-05
68668 Klk5 kallikrein related-peptidase 5 7.5 0.0122
229613 6330549D23Rik RIKEN cDNA 6330549D23 gene 7.1 4.86E-07
71687 Tmem25 transmembrane protein 25 6.5 7.66E-08
100040412 LOC100040412 lysine-specific demethylase 5D-like 6.4 0.09181
234138 BC019943 cDNA sequence BC019943 6.1 4.28E-08
19223 Ptgis prostaglandin I2 (prostacyclin) synthase 6 2.71E-06
16181 Il1rn interleukin 1 receptor antagonist 6 0.09192
74528 8430406I07Rik RIKEN cDNA 8430406I07 gene 5.9 0.00656
18261 Ocm oncomodulin 5.8 1.41E-05
75080 4930518C09Rik RIKEN cDNA 4930518C09 gene 5.7 0.01449
234199 Fgl1 fibrinogen-like protein 1 5.7 0.0005564
66442 Spc25 SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) 5.5 0.0001349
107047 Psmg2 proteasome (prosome, macropain) assembly chaperone 2 5.4 0.03946
234138 BC019943 cDNA sequence BC019943 5.3 1.72E-07
231507 Plac8 placenta-specific 8 5.2 0.0001051
72902 Spock3 sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 5.1 0.01586
12319 Car8 carbonic anhydrase 8 5.1 5.94E-06
Entrez ID Gene Symbol Description fold change pValue
213742 Xist inactive X specific transcripts 472.78 6.51E-09
71957 Cpsf3l cleavage and polyadenylation specific factor 3-like 162.92 4.09E-07
619297 C430049E01Rik RIKEN cDNA C430049E01 gene 151.07 4.52E-09
76487 Ppp1r3g protein phosphatase 1, regulatory (inhibitor) subunit 3G 79.68 8.93E-10
213742 Xist inactive X specific transcripts 79.02 2.37E-07
223780 Adm2 adrenomedullin 2 71.96 9.09E-08
13615 Edn2 endothelin 2 62.64 4.30E-08
67573 Loxl4 lysyl oxidase-like 4 33.95 1.83E-05
240913 Adamts4 a disintegrin-like and metallopeptidase with thrombospondin type 1 motif, 4 31.92 0.0001611
70045 2610528A11Rik RIKEN cDNA 2610528A11 gene 30.83 2.05E-08
Opsin-Cre;Vhlflox (Single) vs Vhlflox;Hif1aflox (Control) 
UPREGULATED GENES
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16763 Lad1 ladinin 30.3 6.58E-07
236220 LOC236220 hypothetical protein LOC236220 26.36 9.73E-06
14663 Glycam1 glycosylation dependent cell adhesion molecule 1 25.18 3.39E-05
11535 Adm adrenomedullin 23.71 1.12E-07
17339 Mip major intrinsic protein of eye lens fiber 22.92 0.008083
214301 Crygn crystallin, gamma N 22.34 0.006261
192199 Rspo1 R-spondin homolog (Xenopus laevis) 21.68 0.007823
233187 Lim2 lens intrinsic membrane protein 2 21.61 0.004186
12954 Cryaa crystallin, alpha A 20.93 0.007343
20856 Stc2 stanniocalcin 2 20.74 1.13E-06
77998 Grifin galectin-related inter-fiber protein 19.81 0.003584
12051 Bcl3 B-cell leukemia/lymphoma 3 19.46 1.62E-06
276829 Smtnl2 smoothelin-like 2 17.03 9.83E-08
381359 Prdm12 PR domain containing 12 16.16 1.72E-05
75290 4930557B15Rik RIKEN cDNA 4930557B15 gene 16.03 0.008547
100039660 Ect2l epithelial cell transforming sequence 2 oncogene-like 15.46 1.72E-05
67573 Loxl4 lysyl oxidase-like 4 15.31 9.15E-06
12962 Crybb3 crystallin, beta B3 14.55 0.003442
21818 Tgm3 transglutaminase 3, E polypeptide 14.54 2.99E-05
667977 Gm8909 predicted gene 8909 14.18 0.007455
74492 Kbtbd13 kelch repeat and BTB (POZ) domain containing 13 13.33 1.03E-05
22300 Vmn2r123 vomeronasal 2, receptor 123 12.97 4.27E-09
68662 Scgb3a1 secretoglobin, family 3A, member 1 11.88 4.83E-05
20296 Ccl2 chemokine (C-C motif) ligand 2 11.87 0.0003137
210321 BC048679 cDNA sequence BC048679 11.86 0.01211
12268 C4b complement component 4B (Childo blood group) 11.8 3.69E-06
15019 H2-Q8 histocompatibility 2, Q region locus 8 11.48 6.27E-08
68380 0610042G04Rik RIKEN cDNA 0610042G04 gene 11.43 1.66E-07
18073 Nid1 nidogen 1 11.19 0.007656
12310 Calca calcitonin/calcitonin-related polypeptide, alpha 11.06 1.77E-07
18542 Pcolce procollagen C-endopeptidase enhancer protein 10.99 0.0001002
12957 Cryba1 crystallin, beta A1 10.96 0.009598
12958 Cryba2 crystallin, beta A2 10.93 0.009546
14611 Gja3 gap junction protein, alpha 3 10.84 0.003981
238692 Zfp874a zinc finger protein 874a 10.84 5.79E-06
12960 Crybb1 crystallin, beta B1 10.83 0.01173
12609 Cebpd CCAAT/enhancer binding protein (C/EBP), delta 10.74 1.59E-06
100043899 R3hdml R3H domain containing-like 10.71 0.001889
12960 Crybb1 crystallin, beta B1 10.68 0.01213
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329478 C130078N14 hypothetical protein C130078N14 170 3.04E-11
258198 Olfr224 olfactory receptor 224 68.41 2.21E-06
80509 Med8 mediator of RNA polymerase II transcription, subunit 8 homolog (yeast) 68.14 3.21E-07
76681 Trim12a tripartite motif-containing 12A 42.19 2.23E-08
30939 Pttg1 pituitary tumor-transforming gene 1 38.46 1.03E-09
26908 Eif2s3y eukary translation initiation factor 2, subunit 3, structural gene Y-linked 32.27 0.05194
77936 BC065403 cDNA sequence BC065403 32.14 1.52E-07
54631 Nphs1 nephrosis 1 homolog, nephrin (human) 31.05 1.02E-07
69301 1700008P20Rik RIKEN cDNA 1700008P20 gene 27.89 1.07E-06
14537 Gcnt1 glucosaminyl (N-acetyl) transferase 1, core 2 25.32 1.14E-09
30939 Pttg1 pituitary tumor-transforming gene 1 23.56 1.84E-06
69301 1700008P20Rik RIKEN cDNA 1700008P20 gene 22.76 1.02E-05
26900 Ddx3y DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked 22.54 0.05882
75764 Slx1b SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) 19.69 2.71E-09
72154 Zfp157 zinc finger protein 157 17.27 4.90E-07
73061 3110007F17Rik RIKEN cDNA 3110007F17 gene 16.56 2.97E-08
74602 4833428L15Rik RIKEN cDNA 4833428L15 gene 15.67 5.37E-08
26450 Rbbp9 retinoblastoma binding protein 9 13.03 0.06533
433100 AA388235 expressed sequence AA388235 12.37 0.0134
67705 1810058I24Rik RIKEN cDNA 1810058I24 gene 12.13 4.14E-05
269209 Stk36 serine/threonine kinase 36 (fused homolog, Drosophila) 10.94 4.27E-06
214523 Tmprss4 transmembrane protease, serine 4 10.51 2.39E-08
17427 Mns1 meiosis-specific nuclear structural protein 1 9.951 1.01E-06
100040410 Gm14957 predicted gene 14957 9.301 7.81E-08
100040412 LOC100040412 lysine-specific demethylase 5D-like 8.768 0.05389
72461 Prcp prolylcarboxypeptidase (angiotensinase C) 8.663 1.35E-08
16061 Igh-VJ558 immunoglobulin heavy chain (J558 family) 8.56 0.0004181
73162 Otud3 OTU domain containing 3 8.453 0.06001
140709 Emid2 EMI domain containing 2 8.323 1.01E-06
17921 Myo7a myosin VIIA 8.034 1.77E-07
94216 Col4a6 collagen, type IV, alpha 6 7.748 0.0003292
78609 8030411F24Rik RIKEN cDNA 8030411F24 gene 6.854 1.46E-05
69611 Lce1d late cornified envelope 1D 6.772 0.01599
20592 Kdm5d lysine (K)-specific demethylase 5D 6.665 0.05474
71687 Tmem25 transmembrane protein 25 6.476 6.43E-08
229613 6330549D23Rik RIKEN cDNA 6330549D23 gene 6.44 8.57E-07
DOWNREGULATED GENES
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12769 Ccr9 chemokine (C-C motif) receptor 9 6.149 0.00552
66442 Spc25 SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) 5.952 7.49E-05
67133 Gp2 glycoprotein 2 (zymogen granule membrane) 5.727 0.02909
67828 Lce1f late cornified envelope 1F 5.707 0.00443
68694 Lce1e late cornified envelope 1E 5.555 0.0036
76681 Trim12a tripartite motif-containing 12A 5.55 0.0004647
74528 8430406I07Rik RIKEN cDNA 8430406I07 gene 5.487 0.008492
73061 3110007F17Rik RIKEN cDNA 3110007F17 gene 5.415 0.01026
271221 5031414D18Rik RIKEN cDNA 5031414D18 gene 5.399 0.09344
209760 Tmc7 transmembrane channel-like gene family 7 5.343 4.51E-05
319742 Mpzl3 myelin protein zero-like 3 5.332 0.006575
22290 Uty ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome 5.085 0.04838
16061 Igh-VJ558 immunoglobulin heavy chain (J558 family) 5.068 3.86E-05
Entrez ID Gene Symbol Description fold change pValue
70045 2610528A11Rik RIKEN cDNA 2610528A11 gene 24.04 2.38E-09
213742 Xist inactive X specific transcripts 13.42 8.96E-02
17996 Neb nebulin 13.39 1.97E-01
213742 Xist inactive X specific transcripts 7.028 5.04E-02
109685 Hyal3 hyaluronoglucosaminidase 3 6.959 1.26E-02
70979 4931417G12Rik RIKEN cDNA 4931417G12 gene 6.84 1.02E-06
19076 Prim2 DNA primase, p58 subunit 5.255 7.60E-09
232801 Lilra5 leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 4.874 9.85E-02
272643 Prss43 protease, serine, 43 4.814 5.00E-02
77044 Arid2 AT rich interactive domain 2 (ARID, RFX-like) 4.807 3.88E-02
382109 Fbxw26 F-box and WD-40 domain protein 26 4.708 9.60E-02
434794 Xlr4a X-linked lymphocyte-regulated 4A 4.484 8.59E-03
331529 Gm5128 predicted gene 5128 4.13 2.66E-02
106610 AI504002 expressed sequence AI504002 4.01 2.89E-01
223332 Ranbp3l RAN binding protein 3-like 3.692 1.05E-01
16816 Lcat lecithin cholesterol acyltransferase 3.592 2.17E-01
434540 Psg20 pregnancy-specific glycoprotein 20 3.536 1.57E-01
12040 Bckdhb branched chain ketoacid dehydrogenase E1, beta polypeptide 3.503 2.70E-01
18216 Ntsr1 neurotensin receptor 1 3.475 1.09E-01
50500 Ttpa tocopherol (alpha) transfer protein 3.417 1.32E-01
628171 Olfr936 olfactory receptor 936 3.39 5.31E-03
67722 4921517D21Rik RIKEN cDNA 4921517D21 gene 3.386 2.20E-02
73748 Gadl1 glutamate decarboxylase-like 1 3.326 1.48E-02
 Opsin-Cre;Vhlflox;Hif1aflox (Double) vs Vhlflox;Hif1aflox (Control)
UPREGULATED GENES
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71078 Adam30 a disintegrin and metallopeptidase domain 30 3.298 8.24E-02
100042761 Gm10697 predicted gene 10697 3.258 1.69E-01
246229 Bivm basic, immunoglobulin-like variable motif containing 3.25 2.97E-01
329972 Spata21 spermatogenesis associated 21 3.172 8.72E-02
258757 Olfr1013 olfactory receptor 1013 3.152 6.98E-02
100046359 LOC100046359 ig heavy chain V region VH558 A1/A4-like 3.119 5.72E-02
234311 Ddx60 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 3.105 1.12E-01
70896 Speer1-ps1 spermatogenesis associated glutamate (E)-rich protein 1, pseudogene 1 2.97 5.28E-02
114662 Prss29 protease, serine, 29 2.968 1.56E-01
433100 AA388235 expressed sequence AA388235 2.956 2.10E-01
545548 Lce3a late cornified envelope 3A 2.933 3.65E-03
258408 Olfr463 olfactory receptor 463 2.934 1.85E-01
258927 Olfr481 olfactory receptor 481 2.927 6.82E-02
277345 Wfdc16 WAP four-disulfide core domain 16 2.924 9.92E-02
12534 Cdk1 cyclin-dependent kinase 1 2.903 8.44E-03
244071 Agbl1 ATP/GTP binding protein-like 1 2.899 8.76E-02
98763 AA407782 expressed sequence AA407782 2.895 4.34E-01
171186 Vmn1r38 vomeronasal 1 receptor 38 2.881 2.25E-01
12770 Ccr1l1 chemokine (C-C motif) receptor 1-like 1 2.864 1.06E-01
213402 Armc2 armadillo repeat containing 2 2.86 1.24E-01
258354 Olfr168 olfactory receptor 168 2.86 2.08E-01
27083 Xlr4b X-linked lymphocyte-regulated 4B 2.853 3.77E-02
56773 Chst5 carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 2.844 5.65E-02
268482 Krt12 keratin 12 2.833 6.68E-02
268482 Krt12 keratin 12 2.812 6.74E-02
57277 Slurp1 secreted Ly6/Plaur domain containing 1 2.808 2.82E-02
Entrez ID Gene Symbol Description fold change pValue
77936 BC065403 cDNA sequence BC065403 14.45 0.001686
435845 Tmprss11c transmembrane protease, serine 11c 11.06 0.2154
277773 BC049635 cDNA sequence BC049635 6.02 0.4197
12836 Col7a1 collagen, type VII, alpha 1 5.74 0.2868
353371 Oxct2b 3-oxoacid CoA transferase 2B 5.46 0.01235
271221 5031414D18Rik RIKEN cDNA 5031414D18 gene 5.32 0.09902
11808 Apoa4 apolipoprotein A-IV 5.27 0.0973
668501 Zfp507 zinc finger protein 507 4.24 0.2897
84095 Pi4k2a phosphatidylinositol 4-kinase type 2 alpha 4.23 0.3137
17427 Mns1 meiosis-specific nuclear structural protein 1 3.94 0.01575
51925 D2Ertd640e DNA segment, Chr 2, ERATO Doi 640, expressed 3.85 0.0002779
DOWNREGULATED GENES
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77394 9530025H10Rik RIKEN cDNA 9530025H10 gene 3.83 0.09673
54486 Hpgds hematopoietic prostaglandin D synthase 3.81 0.06928
100043706 Gm4598 predicted gene 4598 3.76 0.02922
224552 Vmn2r98 vomeronasal 2, receptor 98 3.75 0.1685
26876 Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide 3.73 0.3138
436003 Gm5736 predicted gene 5736 3.58 0.09749
68789 Trmt61b tRNA methyltransferase 61 homolog B (S. cerevisiae) 3.45 0.1156
22696 Zfp37 zinc finger protein 37 3.32 0.3113
98736 1700034H15Rik RIKEN cDNA 1700034H15 gene 3.32 0.1861
102144 AI746383 expressed sequence AI746383 3.26 0.1173
224079 Atp13a4 ATPase type 13A4 3.25 0.1649
207854 Fmr1nb fragile X mental retardation 1 neighbor 3.2 0.06387
69319 1700001K23Rik RIKEN cDNA 1700001K23 gene 3.2 0.0002839
258310 Olfr145 olfactory receptor 145 3.13 0.09426
73252 1600022D10Rik RIKEN cDNA 1600022D10 gene 3.11 0.06589
93689 Lmod1 leiomodin 1 (smooth muscle) 3.09 0.03443
666021 2300003K06Rik RIKEN cDNA 2300003K06 gene 3.07 0.1078
76585 Lce1i late cornified envelope 1I 2.99 0.00587
69611 Lce1d late cornified envelope 1D 2.96 0.02876
100038617 Gm10466 predicted gene 10466 2.95 0.1431
237890 Slfn14-ps schlafen family member 14, pseudogene 2.95 0.1693
546903 Vmn1r39 vomeronasal 1 receptor 39 2.95 0.0906
16867 Lhcgr luteinizing hormone/choriogonadotropin receptor 2.94 0.1029
277667 Gm13089 predicted gene 13089 2.91 0.06277
80287 Apobec3 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 2.91 0.1317
258744 Olfr875 olfactory receptor 875 2.9 0.09924
319229 Sctr secretin receptor 2.89 0.1336
69566 2310016D03Rik RIKEN cDNA 2310016D03 gene 2.82 0.02048
56057 Btg4 B-cell translocation gene 4 2.81 0.0473
384244 Gm5294 predicted gene 5294 2.81 0.1151
93671 Cd163 CD163 antigen 2.81 0.1767
16061 Igh-VJ558 immunoglobulin heavy chain (J558 family) 2.8 0.007337
71206 Katnal2 katanin p60 subunit A-like 2 2.79 0.3081
56092 Cts7 cathepsin 7 2.78 0.05438
387513 Tas2r138 taste receptor, type 2, member 138 2.77 0.3596
258097 Olfr1500 olfactory receptor 1500 2.75 0.09798
100504089 LOC100504089 calcium-binding protein p22-like 2.74 0.2235
106763 Ttbk1 tau tubulin kinase 1 2.73 0.08259
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214301 Crygn crystallin, gamma N 10.3 1.19E-02
12966 Crygc crystallin, gamma C 5.2 2.33E-02
12969 Crygf crystallin, gamma F 4.3 1.93E-05
12957 Cryba1 crystallin, beta A1 6.5 2.68E-02
12965 Crygb crystallin, gamma B 6.3 6.89E-03
12960 Crybb1 crystallin, beta B1 6.8 3.44E-02
12970 Crygs crystallin, gamma S 3.7 4.01E-02
12959 Cryba4 crystallin, beta A4 4.6 5.95E-02
12968 Cryge crystallin, gamma E 6.2 4.65E-07
12962 Crybb3 crystallin, beta B3 10.2 1.19E-02
12961 Crybb2 crystallin, beta B2 6.9 3.60E-02
12958 Cryba2 crystallin, beta A2 7 3.48E-02
12967 Crygd crystallin, gamma D 5.1 6.78E-03
12964 Cryga crystallin, gamma A 7.8 4.88E-03
Entrez ID Gene Symbol Description fold change pValue
654812 Angptl7 angiopoietin-like 7 4.6 2.84E-02
192199 Rspo1 R-spondin homolog (Xenopus laevis) 11.4 2.04E-02
280635 Emilin3 elastin microfibril interfacer 3 3.4 1.57E-02
228796 Bpil3 bactericidal/permeability-increasing protein-like 3 5.7 8.06E-05
68662 Scgb3a1 secretoglobin, family 3A, member 1 9.1 8.28E-05
20284 Scrg1 scrapie responsive gene 1 3 3.17E-02
240913 Adamts4 a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4 24.7 2.89E-04
20856 Stc2 stanniocalcin 2 13.8 5.69E-07
77673 Defb41 defensin beta 41 3 8.34E-02
100043899 R3hdml R3H domain containing-like 9.4 1.68E-03
99543 Olfml3 olfactomedin-like 3 3.1 3.25E-03
100689 Spon2 spondin 2, extracellular matrix protein 3.8 9.11E-04
Entrez ID Gene Symbol Description fold change pValue
232345 A2m alpha-2-macroglobulin 4.8 7.72E-03
20730 Spink3 serine peptidase inhibitor, Kazal type 3 3.9 2.25E-04
100043899 R3hdml R3H domain containing-like 9.4 1.68E-03
75526 Spinlw1 serine protease inhibitor-like, with Kunitz and WAP domains 1 (eppin) 3 1.51E-04
5.3.2  FUNCTIONAL GROUPS
 Opsin-Cre;Vhlflox (Single) vs Opsin-Cre;Vhlflox;Hif1aflox (Double)  - Upregulated genes 
GROUP 1 (Enrichment score = 17.02)
GROUP 2  (Enrichment score = 7.36)
GROUP 3 (Enrichment score = 5.16)
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12266 C3 complement component 3 3.1 9.52E-05
14962 Cfb complement factor B 3.2 2.89E-02
12268 C4b complement component 4B (Childo blood group) 10.2 1.60E-05
18050 Klk1b3 kallikrein 1-related peptidase b3 6.9 7.95E-05
12630 Cfi complement component factor i 6 2.02E-05
13646 Klk1b22 kallikrein 1-related peptidase b22 8.6 5.57E-05
12258 Serping1 serine (or cysteine) peptidase inhibitor, clade G, member 1 3.3 1.13E-04
Entrez ID Gene Symbol Description fold change pValue
15945 Cxcl10 chemokine (C-X-C motif) ligand 10 7.4 2.25E-04
20296 Ccl2 chemokine (C-C motif) ligand 2 6.8 8.04E-04
20293 Ccl12 chemokine (C-C motif) ligand 12 2.9 9.22E-03
20311 Cxcl5 chemokine (C-X-C motif) ligand 5 4.7 8.04E-04
Entrez ID Gene Symbol Description fold change pValue
15019 H2-Q8 histocompatibility 2, Q region locus 8 10.6 2.15E-09
15007 H2-Q10 histocompatibility 2, Q region locus 10 3.2 1.64E-04
15002 H2-Ob histocompatibility 2, O region beta locus 2.4 3.43E-02
667977 Gm8909 predicted gene 8909 5.4 4.67E-07
Entrez ID Gene Symbol Description fold change pValue
231832 Tmem184a transmembrane protein 184a 3.7 1.54E-04
71862 Gpr160 G protein-coupled receptor 160 2.9 5.52E-02
76718 Catsperg2 cation channel, sperm-associated, gamma 2 3.8 4.56E-05
327766 Tmem26 transmembrane protein 26 3.2 1.05E-03
83961 Nrg4 neuregulin 4 5.7 6.03E-04
14611 Gja3 gap junction protein, alpha 3 8.6 1.76E-02
69354 Slc38a4 solute carrier family 38, member 4 5.4 1.19E-02
17339 Mip major intrinsic protein of eye lens fiber 16.3 2.49E-02
18414 Osmr oncostatin M receptor 3.2 7.73E-05
14616 Gja8 gap junction protein, alpha 8 7 2.41E-02
235435 Lctl lactase-like 6.3 4.55E-02
94346 Tmem40 transmembrane protein 40 5.7 3.88E-02
233187 Lim2 lens intrinsic membrane protein 2 17 2.37E-02
80879 Slc16a3 solute carrier family 16 (monocarboxylic acid transporters), member 3 4 7.99E-05
63959 Slc29a1 solute carrier family 29 (nucleoside transporters), member 1 2.9 8.74E-06
GROUP 6 (Enrichment score = 2.19)
GROUP 7 (Enrichment score = 0.98)
GROUP 4 (Enrichment score = 3.38)
GROUP 5 (Enrichment score = 3.32)
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19013 Ppara peroxisome proliferator activated receptor alpha 9.9 4.40E-06
14283 Fosl1 fos-like antigen 1 5.3 8.74E-06
12609 Cebpd CCAAT/enhancer binding protein (C/EBP), delta 9.5 2.12E-06
26424 Nr5a2 nuclear receptor subfamily 5, group A, member 2 3.4 4.01E-02
14462 Gata3 GATA binding protein 3 4.7 1.16E-02
GROUP 9 (Enrichment score = 0.07)
Entrez ID Gene Symbol Description fold change pValue
238692 Zfp874a zinc finger protein 874a 10.4 4.21E-06
69368 Wdfy1 WD repeat and FYVE domain containing 1 5.4 7.77E-08
329581 Birc7 baculoviral IAP repeat-containing 7 (livin) 4.4 0.0007944
232966 Zfp114 zinc finger protein 114 5.8 2.22E-07
GROUP 8 (Enrichment score = 0.59)
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5.3.3 Abbreviations 
A2M Alpha 2 macroglobulin 
AAV Adeno-associated virus 
Actb Actin beta subunit 
Adamts4 A disintegrin-like and metallopeptidase with thrombospondin type 1 motif, 4 
Adm Adrenomedullin 
AMD Age related macular degeneration 
BM Bruch's membrane 
Brn3a Brain-specific homeobox/ POU domain protein 3A 
C3 Complement fcator 3 
C4b Complement factor 4b 
Casp Caspase 
Ccl2 Chemokine (C-C motif) ligand 2 
cDNA Complementary DNA  
Cepbd CCAAT/enhancer binding protein (C/EBP), delta  
Cfb Complement factor b 
Cfh Complement fcator h 
Cfi Complement factor i 
Calb2 Calbindin 2 
CNV Choroidal neovascularization 
Cpsf3l Cleavage and polyadenylation specific factor 3-like 
Csfr Colony stimulating factor receptor 
Cx3cl chemokine (C-X3-C motif) ligand 
ECM Extra cellular matrix 
Edn2 Endothelin 2 
Fgf2 Fibroblast growth factor 2 
Fih Factor inhibiting HIF 
GCL Ganglion cel layer 
Gfap Glial fibrillary acidic protein  
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Glul Glutamate-ammonia ligase (glutamine synthetase) 
Glycam1 Glycosylation dependent cell adhesion molecule 1  
Gnat1 Guanine nucleotide binding protein, alpha transducing 1 (rods) 
Gnat2 guanine nucleotide binding protein, alpha transducing 2 (cones) 
GPR G-protein coupled receptor 
Hif1a Hypoxia inducible factor- alpha subunit 
Hif1b Hypoxia inducible factor - beta subunit 
HRP Horse raddish peroxidase 
INL Inner nuclear layer 
IPL Inner plexiform layer 
IS Inner segments 
Lad1 Ladinin 
LCM Laser capture microdissection 
Ldha Lactate dehydrogenase, isoform a 
Lif Leukemia inhibitory factor 
Loxl4 Lysyl oxidase-like 4 
Mct Monocarboxylate transporter 
Myo7a Myosin VIIA 
Nrg4 Neuregulin4 
Obox6 Oocyte specific homeobox 6 
ONL Outer nuclear layer 
OPL Outer plexiform layer 
Opn4 Opsin 4 (melanopsin) 
OS Outer segments 
PCR Polymerase chain reaction 
Pdc Pyruvate dehydrogenase complex 
Pdk Pyruvate dehydrogenase kinase 
Pdp Pyruvate dehydrogenase phosphatase 
Phd Prolyl hydroxylase 
PND Postnatal day 
Appendix 	  
	   145	  
Ppara Peroxisome proliferator activated receptor alpha 
Pttg1 Pituitary tumor-transforming gene 1  
qPCR Quantitative PCR 
rd10 Retinal degeneration 10 
Rpe Retinal pigment epithelium 
shRNA Short hairpin RNA 
siRNA small interfering RNA 
Smtnl2 Smoothelin-like 2 
Stat3 Signal transducer and activator of transcription 3 
Stc1 Stanniocalcin 1 
Stc2 Stanniocalcin 2 
Tgf Tissue growth factor 
Tgm3 Transglutaminase 3, E polypeptide 
Tnf Tissue necrosis factor 
Vegf Vascular endothelial growth factor 
Vhl Von-Hippel Lindau 
Vsx2 Visual system homeobox 2  
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5.3.4. PRIMERS USED FOR SEMIQUANTITATIVE REAL-TIME PCR 
Gene Forward primer Reverse primer Annealing temperature (°C) 
Amplicon 
size (bp) 
A2M ACTCGATGAGGAGGCGGTA GGTAAGATAAGCCAGGAGCA 62 148 
Adamts4 CGGGCACTGGGCTACTACT TCACAGCCAGCATGGATACA 62 113 
Cpsf3l CAGACAGTTCAGGTGGATGAT CAGACTCCGAGCCCACTTTA 62 100 
Glycam1 GCTCTCCTGCCTGGGTCCAAAG GATTCTATCACCACATTATCTT 62 185 
Lad1 CACCCAGAATGGAGCTCAG CACCTGCCGCCTCTGTCTCCG 62 154 
Loxl4 GTTGCACAACTGCCACACA GGAGTGCAGTAATGGCTTC 62 108 
Myo7a CACGATGACTGGCAGATTGGCA TCTGTCTGTATGGCCTTGT 62 96 
Nrg4 GTAATCTGTCGGCAGCTT TGTTCTCTGTGGCTGTGACG 62 169 
Obox6 TCACTAGAGGACTCTGGCACA GCAACCCTCTGATTTCAGGTTCT 62 190 
Ppara GCCAAGTTGAAGTTCAAGGC TCCACCATGTTGGATGGATGT 62 133 
Pttg1 GGACAGTCAACAGAGTTGCCGA GCATCATCAGGAGCAGGAACA 62 136 
Smtln2 GCATCTTGGAGAACGGACA CAGAGAATTTCTCGGACTCG 62 168 
Tgm3 TGTACTACGATGCCATGGGA GACCTGCCATCCATTGTATG 62 125 
C3 TACCTGGACCAGACCGAA GAGCTGGGCTGTTTGAAG 62 113 
C4b TGGACATGGCTCTGTATGCT AGCATCCTGGAACACCTGAA 62 140 
Cfb GTGAACATCAATGCCTTAGCTTCC CCATGCCACAGAGACTCAGAGA 62 133 
Cfh GGCAAGTGGAAGTGATGTGT CATTGTCAATAGGTGGAGGAG 62 99 
Cfi GACTGCTGCGCACTGTGTCA GAAGGTGGCTCCATTATATT 62 148 
SerpinG1 CCATTCAGCATTGCCAGCCT TTAGTGCTTGGTGGACACAG 62 121 
 
Other primers are listed in the corresponding sections, as follows 
Section 3.1.1 – Actb, Adm, Casp1, Cepbd, Edn2, Fgf2, Gnat1, Hif1a, Hif2a, Ldha, Mct4, Pdk1, Stat3, Vhl 
Section 3.2.3 – Actb, Adm, Epo, Gnat1, Mct3, Opn4, Stc1, Stc2, Vsx2 
Section 3.3 – Actb, Gpr4, Gpr65, Gpr68, Gnat1, Gnat2, Vsx2, Calb1, Calb2, Pou4f1, Glul, Casp1, Gfap, Fgf2, Stat3, Edn2, Lif, Tnf, Tgfb, Ccl2, 
Ccl4, Ccl5, Ccl8, Ccl9, Ccl12, Csfr1, Cx3cl 
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